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particular, Latin terms in common usage are neither italicized nor underlined [op. 
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SUMMARY 
The aims of the experiments recorded in this thesis were to identify and 
characterize the cell(s) responsible for T cell activation in the murine and human 
intestinal lamina propria. 
Following the development of a method for the disaggregation of murine 
small intestinal lamina propria into single cell suspensions, antigen-presenting 
cell activity (as determined by the ability to stimulate the one-way primary 
allogeneic mixed leucocyte reaction {MLR}) was found to be comparable to that 
of splenic cell populations. Cell depletion experiments determined that the 
stimulatory cell expressed Class II Major Histocompatibility Complex antigens, 
but did not express features characteristic of macrophages, B cells or T cells. 
A method was developed for isolating intestinal macrophages. These 
cells were compartmentalized, comprising 10% of the yields from non-Peyer's 
patch lamina propria tissue, but < 1 % of the yields from Peyer's patches. The 
expression of cell surface markers of intestinal macrophages indicated that they 
were in an "activated" state - they expressed Class 11 M HC antigens, and had low 
level expression of the macrophage-specific F4 /80 antigen, the F c receptor and 
the receptor for the complement component, C3bi. Isolated intestinal lamina 
propria macrophages inhibited MLR stimulatory activity in an indomethacin-
sensitive manner, suggesting a prostaglandin-mediated effect. 
Unfractionated cell suspensions from the lamina propria were ten times 
more potent MLR stimulators per cell than unfractionated Peyer's patch cells . 
Dendritic cells were obtained from the intestinal lamina propria and from Peyer's 
patches by density gradient centrifugation following the removal of adherent 
cells (macrophages). Dendritic cell-enriched populations from both sites were 
potent MLR stimulators with activity indistinguishable from that of splenic 
dendritic cells. 
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Parallel experiments undertaken using human colonic lamina propria 
produced similar results. Isolated colonic macrophages were in an "activated" 
state and did not stimulate the allogeneic MLR, whilst enriched (30-50%) 
populations of dendritic cells were potent stimulators. 
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CHAPTER 1 
ANTIGEN-PRESENTING CELLS IN INTESTINAL IMMUNE 
RESPONSES 
"The truth is rarely pure, and never simple." 
From 'The Importance of Being Earnest" (1895) Act I 
Oscar Wilde (1854-1900) 
1.1 INTRODUCTION 
A distinctive characteristic of the vertebrate immune system is antigen 
specificity, a property conferred by well-characterized cell surface receptors 
present on T and B lymphocytes. The B cell antigen receptor (surface 
immunoglobulin) recognizes either bound or soluble antigen in a single inter-
action. In contrast, the T cell antigen receptor (TCR) has a requirement for dual 
recognition. That is, antigen must be ''seen 11 in association with proteins coded 
by the Major Histocompatibility Complex (M HC) on specialized antigen-
presenting cells. For this reason, the T cell repertoire is limited to those antigens 
that can bind to MHC molecules, and the net result is that immune 
responsiveness genes map to the MHC region . This introduction is concerned 
with the mechanisms involved in the regulation of T lymphocyte function. 
Precursors of T cells arise in the bone marrow and migrate to the thymus 
where they differentiate to express antigen-specific receptors and other cell 
surface molecules [reviewed in 6]. During thymic maturation, T cells are also 
subjected to selective pressures resulting in the induction of tolerance to self-
antigens and the phenomenon of MHC-restriction. After release from the 
thymus, mature T cells migrate through the peripheral blood and other tissues. If 
they come into contact with their cognate antigen in association with self-MHC 
molecules (MHC-restriction) on the surface of specialized antigen-presenting 
cells, T cell activation results [reviewed in 417] . In this process T cells undergo 
blastogenesis, proliferate and differentiate into immunological effector cells with 
functions including cytotoxicity, immune suppression and the provision of helper 
factors (for B cell antibody production, and for the control of other effector arms 
of the immune response [reviewed in 323]). 
1.1.1 Molecules involved in T cell interactions 
Interactions between T cells , foreign antigen and other components of the 
immune system are mediated by a number of cell surface molecules involved in 
antigen-recognition, intercellular adhesion and/or signal transduction (Fig. 1.1). 
The majority are members of two families of structurally-related integral 
membrane proteins, the immunoglobulin gene superfamily (Table 1.1) [reviewed 
in 13, 39, 175, 511] and the integrin receptor superfamily (Table 1.2) [reviewed in 
298, 408]. 
1.1.1.1 T cell antigen receptor 
The TCR is a disulphide-linked heterodimer (comprising o: and /3 poly-
peptides which contain the variant domains involved in antigen specificity) which 
is associated with a collection of at least five invariant proteins called CD3 
[Reviewed in 30, 97, 297]. The receptor complex appears to be present on all 
helper and cytotoxic T cells. A second type of TCR heterodimer (1:0) has also 
been recognized. It is found on a small proportion of peripheral blood T cells, 
but is more common in certain anatomical locations eg. the dendritic T cells of 
the skin [243] and the intraepithelial lymphocyte in the mouse [51, 137]. The 
function of the -y:o heterodimer is unknown. The four recognized TCR 
polypeptides are similar to the immunoglobulins in both structure and gene 
organization. Each has V, J and C regions and f3 and o also have D regions. 
Diversity is apparent in three regions equivalent to the classical immunoglobulin 
hypervariable regions which form the points of contact with antigens - the 
complementarity-determining regions (CDRs). The V gene codes for the CDR1 
and CDR2 regions whilst the CDR3-equivalent region is formed by the junction of 
V and J (in o: and 'Y) and V, D and J (in f3 and o). 
1.1.1.2 Major Histocompatibility Complex gene products 
The TCR ligand comprises MHC molecules complexed with a peptide 
fragment [7, 75]. MHC molecules are the products of highly polymorphic genes, 
termed Class I and Class II, within the major histocompatibility gene complex 
[reviewed in 209]. The nature of the crystalline structure of the Class I MHC 
molecule, Human Leucocyte Antigen (HLA)-A2 [44] and the hypothetical model 
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of antigen binding to Class II MHC molecules [66] suggest that the binding site 
for peptide is on the top surface of the molecules located between the a-helical 
regions of the polymorphic a1 and a2 domains in Class I MHC and the a1 and ,81 
domains in Class II MHC proteins. 
A model for the alignment of the TCR over a peptide-MHC complex 
proposes that the Va and V ,8 CDR1- and CDR2-equivalent regions contact the 
side chains of the MHC a-helices. The centrally located CDR3-equivalent regions 
would then be aligned with the bound peptide (Fig. 1.1) [97]. This model 
explains both antigen-specificity and MHC restriction. The formation of the 
trimolecular complex leads to signal transduction via the CD3 complex and, in 
association with other signals, induction of primary T cell responses. 
1.1.1.3 Antigen processing 
Antigen processing at the molecular level has recently been reviewed by 
Allen (1987) [9] and Benacerraf (1988) [30]. Unlike the B cell antigen receptor 
(the surface immunoglobulin molecule) which recognizes the tertiary 
configuration of an antigen (which may be in a soluble state), the T cell antigen 
receptor generally recognizes a denatured form of antigen in association with 
MHC molecules on the surface of a target or an antigen-presenting cell. The 
conversion of a native form to a non-native form is termed antigen-processing. 
For many exogenous antigens proteolytic degradation and contact with the 
acidic intracellular lysosmal compartment is presumably the major pathway of 
antigen processing. Another pathway involving nonendosomal proteases was 
originally believed to be accessible only to endogenous viral antigens 
synthesized in infected cells. Recent work examining the processing of a viral 
antigen showed that both pathways could handle antigen regardless of its 
source [202]. Thus, there are at least two pathways for antigen processing - an 
endosomal, chloroquine-sensitive and a non-endosomal, chloroquine-
3 
insensitive. A third pathway utilizing a cell-surface, proteolytic "ectoenzyme" 
system also has been proposed [80]. 
1.1.1.4 CD4 and CDS molecules 
CD4 and CDS glycoproteins are nonpolymorphic members of the 
immunoglobulin gene superfamily which are expressed on the surface of 
functionally distinct populations of peripheral T lymphocytes. The expression of 
CD4 and CDS molecules on peripheral T cells correlates with the class of MHC 
determinant recognized (Class II MHC and Class I MHC respectively). In 
addition to the demonstration of direct binding between C04 and Class II MHC 
molecules [100] and COS to Class I MHC molecules [404, 411], other evidence 
[reviewed in 39] suggests that this interaction increases adhesion between 
antigen-presenting cells and T cells. There is also evidence for an intrinsic, low 
affinity interaction between C04 and the C03-T cell receptor complex [ 410, 
reviewed in 13]. Thus, the C04 molecule may adhere to the Class II MHC 
molecule and stabilize its association with the TCR. A role for these molecules in 
signal transduction is also suggested by the demonstration of their association 
with cytoplasmic protein tyrosine kinases [339]. 
1.1.1.5 CD2 and leucocyte function antigen-3 (LFA-3) 
CO2 is a glycoprotein with limited tissue distribution (thymocytes, T cells 
and some natural killer {NK} cells) which plays an important role in cell adhesion 
and T cell activation [38]. Monoclonal antibodies against CO2 inhibit or stimulate 
T cells, depending on the epitope specificity. 
Its natural ligand is a widely distributed glycoprotein, LFA-3. Both these 
molecules are generally considered to be members of the immunoglobulin gene 
superfamily, although there is some debate [175]. The interaction between these 
molecules, together with a co-stimulatory signal (anti-CD3 antibody or 
suboptimal doses of the plant lectin, phytohaemagglutinin) can stimulate T cell 
proliferation [38]. 
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1.1.1.6 LFA-1 and intercellular adhesion molecules 1 and 2 {ICAM-1 
and ICAM-2) 
The LFA-1 molecule is a member of a family comprising three related 
heterodimers found on lymphoid and myeloid cells [reviewed in 39, 101]. These 
proteins share a common /3 chain (CD18) noncovalently associated with a 
unique n: subunit. The n: chain of LFA-1 is termed CD11 a; the other proteins in 
the family are CD11 b (CR3) and CD11 c (the p150,95 protein) . Binding of LFA-1 
is temperature-sensitive and cation-dependent. 
The ligand for LFA-1 is ICAM-1, a glycoprotein that is also widely 
distributed. A recent paper [11] demonstrated that co-expression of ICAM-1 is 
critical for effective MHC Class II-restricted and allospecific T cell activation in 
transfected cells expressing modest levels of HLA-DR antigens. This implies an 
important role for ICAM-1 in the induction of T cell responses. The presence of 
other ligands for LFA-1 was suggested by the failure of anti-lCAM-1 monoclonal 
antibodies to inhibit LFA-1 dependent adhesion to all cell types. An alternative 
ligand, ICAM-2, expressed on endothelial cells has now also been identified 
[439]. 
1.1.1.7 VLA proteins {very late proteins of activation) 
Studies on the adhesion of cells to the extracellular matrix led to the 
discovery of a family of cell attachment receptors recognising similar amino acid 
structures in the matrix proteins (the RGD { arginine-glycine-aspartic acid} 
sequence) [reviewed in 408, 39]. These receptors include the fibronectin and 
vitronectin . receptors, and VLA proteins 1-4 which bind other matrix proteins 
including laminin and collagen. Structural similarities with the LFA-1 family were 
identified, and together these proteins comprise part of the integrin receptor 
superfamily. 
The VLA proteins -1 and -2 were initially identified on the surface of stim-
ulated T cells, but are also found elsewhere. VLA-4 is found on all lymphocytes, 
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thymocytes and monocytes, whilst VLA-3 and VLA-5 (the fibronectin receptor) 
are not expressed on peripheral blood lymphocytes. 
Antibody blocking studies have shown that the VLA proteins mediate cell 
adhesion to matrix proteins, but inhibition of T cell function has not been demon-
strated. T cells, once activated, express increased levels of ICAM-1 [101] and 
VLA-1 and -2 [39]. 
1.1.1.8 Summary 
Many cell surface molecules are involved in both the stabilization of inter-
actions between T cells and antigen-presenting cells, and in signal transduction. 
The ultimate determinant of antigen-specificity, however, is the TCR. 
1.1.2 Mechanisms and measurement of T cell activation 
[Reviewed in 91, 177, 285, 505] 
The specificity of T cell receptors can be bypassed using various physio-
logical or non-physiological stimuli leading to non-specific T cell activation. 
Examples include calcium ionophores, plant lectins, and certain antibodies to 
either the T cell receptor, the CD3 molecule or the CO2 molecule. In addition, 
agents that activate protein kinase C (eg. phorbol myristate acetate {PMA}) are 
thought to reproduce the requirement for accessory cells and their products. 
The role of interleukin 1 (IL-1) in T cell activation is considered in Section 
1.2.5.3.2. 
The membrane and intracellular events initiated by these stimuli are 
similar to . those induced by many hormones [8, 91, 278, 34 7]. Inositol 
phospholipids are hydrolysed, intracellular stores of calcium are mobilized and 
membrane and cytosolic proteins are phosphorylated. The process continues 
for at least 10 days and involves a complex sequence of gene activation 
resulting in the regulation of more than 70 molecules [91], and the acquisition of 
specialized effector functions. For at least a subset of T cells, these events result 
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in increased production of the T cell growth factor, interleukin 2 (IL-2), increased 
expression of the cell surface IL-2 receptor and an autocrine mode of 
proliferation. 
The consequences of these cell surface interactions can therefore be 
measured by end-point assays that detect T cell functions (eg. proliferation, 
target cell cytotoxicity, help for antibody production or the production of 
lymphokines such as IL-2) or T cell activation markers (eg. Class II MHC 
antigens or receptors for IL-2 {CD25} or transferrin {CD71} ). 
1.1.2.1 Activation requirements for resting and sensitized T cells 
Activation requirements for resting and memory T cells differ from those 
for sensitized or activated T cells [21, 442, 446]. Steinman (1988) [ 442] 
described two broad functions of accessory cells. The first is the 11presentation 11 
of antigen in association with Class 11 M HC products to form a complex on the 
accessory cell surface. This structure can then be recognized by an antigen-
specific clonotypic T cell receptor. The subsequent response depends on the 
nature of both the accessory cell and the responding T lymphocyte. A resting T 
cell requires an additional 11sensitization 11 or co-stimulatory signal. As a result the 
T cells 11blast transform 11 , secrete and become responsive to lymphokines, and 
proliferate vigorously. In the absence of such a signal there is no response. A 
previously sensitized T cell does not require this second function and will 
respond vigorously to the antigen-MHC complex alone. 
The magnitude of this secondary response correlates with the concen-
tration of antigen and the surface density of Class II M HC molecles on an 
antigen-presenting cell [265, 302]. The complex may be present on 
macrophages, resting B cells, endothelial cells, epithelial cells or fibroblasts. 
Fundamental differences in activation requirements between resting and 
sensitized T cells were demonstrated using antibodies directed against the CD3 
molecule - the signal transducing element for the T cell receptor molecule [176] -
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and other cell surface molecules. In experiments measuring the activation of T 
cell clones (ie. sensitized cells), accessory cell activity was replaced by anti-CD3 
coupled to Sepharose beads [321]. When resting T cells were used, accessory 
cells were necessary for IL-2 production [476, 506]. Similarly, whilst studying T 
cell activation, Odum et al (1988) [357] showed that, in contrast to unprimed 
cells, the proliferation of sensitized cells was independent of the interaction with 
the CD5 and CD11 molecules, and IL-1 /3" Thus, activation requirements for 
sensitized and unsensitized T cells differ. 
1.1.2.2 The primary allogeneic mixed leucocyte reaction (MLR) 
The best physiological stimulus for studying primary T cell activation 
would be previously "unseen" antigen in association with syngeneic antigen-
presenting cells. However, the frequency of a particular antigen-specific T cell in 
an unprimed population is very low, making the study of primary antigen-specific 
responses difficult. A relatively large proportion ( > 1-3% of unprimed T cells) is 
activated by allogeneic MHC products so that this model is often used for the 
study of T cell activation. 
Co-culturing leucocytes which differ at the MHC loci results in cell prolifer-
ation and the development of cytotoxic T lymphocytes (reviewed in Steinman 
and Inaba (1986) [445]). Both Class I MHC and Class II MHC molecules can 
stimulate the MLR as can non-MHC encoded determinants, such as the product 
of the Mis locus (loci) in the mouse. 
The interactions between antigen, Class II MHC gene products and the 
clonotypic T cell receptor have been studied recently by gene transfer studies. It 
is now clear that a single T cell receptor a/3 heterodimer can recognise self-MHC 
molecules complexed with fragments of antigen, allogeneic MHC molecules and 
an Mis-encoded determinant [221, 294]. These observations verify that the 
primary MLR is a valid and physiological model for studying T cell activation. 
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1.1.2.3 The oxidative mitogenesis model 
Treatment with the oxidizing agent, sodium metaperiodate, induces 
extensive blastogenesis as the result of the oxidation of the terminal sialic 
residue of a specific membrane glycoprotein or glycolipid [reviewed in 17 4]. The 
effect of periodate can be reproduced by the removal of sialic acid with 
neuraminidase followed by oxidation of exposed galactose residues with 
galactose oxidase. Both these treatments cause cross-linking of membrane 
components and subsequent transformation and proliferation of a responder T 
cell population if accessory cells are present. Antigenic changes induced by 
oxidation of surface glycoproteins of a stimulatory cell population may be 
analogous to the MLR if the Class II MHC molecules are involved. 
1.1.3 Putative intestinal lamina propria antigen-presenting cells 
Cell types that express Class II MHC antigens, and might therefore act as 
antigen-presenting cells in the intestinal lamina propria (at least in a secondary 
immune response), include dendritic cells [446], macrophages [479], B cells 
[84], activated T cells [204], endothelial cells [352], and epithelial cells [ 48, 308]. 
In order to generate a T-cell-mediated immune response in the intestinal 
mucosa, antigen must cross the epithelial barrier. The major emphasis in studies 
of intestinal mucosal immunity has focused on Peyer's patches and their asso-
ciated specialized epithelium which is believed to be the main site of antigen 
contact and sampling. A number of observations, however, suggest an 
important role for the non-Peyer's patch epithelium and associated lamina 
propria lymphoid tissue. Firstly, presumptive antigens have been demonstrated 
in the lamina propria or within lamina propria macrophages. Examples include 
enterotoxin (by receptor-mediated transport [467]); infectious agents (Shigella, 
Salmonella [ 467], and Campylobacter antigens [ 407]), soluble protein antigens 
(eg. bovine serum albumin [37]) ; and carageenan [3]. Secondly, 
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immunohistochemical techniques have identified all of the putative antigen-
presenting cells described above in the small intestinal lamina propria. In 
particular, there are large numbers of Class II MHC antigen-bearing 
macrophages in the intestinal lamina propria of mouse, rat and human [169, 
170, 172, 197, 312, 437] and some evidence has been presented concerning a 
population of large irregularly-shaped antigen-presenting cells which lack 
macrophage markers (presumptive dendritic cells) [169, 172, 197, 312] (Figs. 
1.2a, 1.2b). Thirdly, the lamina propria contains T cells responsive to stimulation 
by the lectins, phytohaemagglutinin and concanavalin A, and by alloantigens in 
the mixed leukocyte reaction (MLR) [reviewed in 310]. 
1.1.4 Aims: 
The aims of the experiments reported in the following chapters of this 
thesis were to isolate and characterize the antigen-presenting cell from the 
intestinal lamina propria. This first chapter will review the current information on 
the nature of putative intestinal lamina propria antigen-presenting cells, 1n 
particular, the dendritic cell, the macrophage, the B cell and the epithelial cell. 
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1.2 THE DENDRITIC CELL 
Since the initial recognition of the dendritic cell by Steinman and Cohn 
(1973) [443], evidence has accumulated to suggest that it plays a unique role in 
the initiation of T cell dependent immune responses. Several recent papers have 
reviewed the properties and functions of these cells, and their proposed mech-
anisms of action [21, 442, 446, 448]. This review will concentrate on the 
following aspects of dendritic cells: 
1.2.1 Physical and phenotypic features; 
1.2.2 Functional properties; 
1.2.3 Origin, tissue distribution and pattern of circulation; 
1.2.4 Ontogeny and cell lineage; and 
1.2.5 Mechanisms of action. 
Because of the vast literature on dendritic cells wherever possible the 
evidence will be summarized in tabular form. 
1.2.1 Properties and phenotype of dendritic cells 
The initial studies of in vitro T cell activation identified a requirement for 
accessory cells, which were derived from the adherent fraction of munne 
lymphoid cell suspensions [reviewed in 446]. The study of the cellular 
composition of these adherent populations identified dendritic cells which were 
potent activators of T lymphocytes. Prior to these studies, all adherent cells were 
regarded as macrophages and the antigen-presenting cell activity of the 
adherent cell fraction was therefore thought to be a macrophage-mediated 
function. Over many years, the relationship between dendritic cells and 
macrophages has been the focus of considerable debate. 
Several properties distinguish the dendritic cell from the mononuclear 
phagocyte system. Dendritic cells are large, irregular in shape, low-density, non-
phagocytic and become non-adherent after overnight culture. They lack features 
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characteristic of other cell lineages including F c receptors, non-specific esterase 
(NSE), membrane adenosine triphosphatase (ATPase), and the F4/80 antigen 
(mononuclear phagocytes) , and surface markers of the T and B cell lineage. The 
dendritic cell constitutively expresses high levels of both Class I and Class II 
MHC molecules which do not change with time in culture and are not inducible 
by IFN--y [442]. The kinetics of dendritic cells are different from the mononuclear 
phagocyte system [ 482]. A rat lgG2b anti-murine splenic dendritic cell-specific 
antibody has been raised, and is useful when used with complement lysis to 
deplete dendritic cells [356]. 
Using immunohistochemical techniques, cells with the phenotype of 
dendritic cells have been identified in the interstitial tissues of all non-lymphoid 
organs studied except for the brain [150, 312]. The isolation and enrichment of 
dendritic cells from different tissues has also been possible. Recent extensive 
phenotypic analysis of dendritic cells obtained from three different tissues 
confirmed previous observations regarding the absence of key macrophage and 
lymphocyte antigens [93]. Of interest was the demonstration of heterogeneity 
amongst the dendritic cell populations studied (see Table 1.3). These 
phenotypic differences may reflect functional differences in dendritic cells or may 
be due to varying stages of development eg. migratory dendritic cells vs fixed 
tissue interdigitating dendritic cells [93]. These observations also raise the 
question of the relationship between phenotype and tissue distribution ie. does 
the phenotype determine the destination of the dendritic cell or does the 
phenotype_ develop after a common precursor is localized at a particular site? 
1.2.1.1 Electron microscopic appearances of dendritic cells 
Transmission electron microscopy of dendritic cells demonstrates an 
extremely irregular nucleus with a peripheral or rim heterochromatin pattern, few 
nuclear pores, and small nucleoli. The cytoplasm contains well developed mito-
chondria, rough endoplasmic reticulum and scattered smooth vesicles. The 
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Golgi region lacks typical lysosomes and secretory granules but contains a 
variety of multivesicular bodies comprised of large vacuoles surrounded by, or 
containing, smaller vesicles. Phagolysosomes are absent [ 44 7]. 
Scanning electron microscopy of cultured dendritic cells shows an array 
of bulbous cytoplasmic protrusions of varying size and shape, including the 
characteristic veils associated with the veiled cell of afferent lymph [378, 311]. 
1.2.2 Dendritic cell function 
Before summarizing the functional properties of dendritic cells, it is 
important to emphasize a number of principles in the study of T cell activation 
using the MLR to explain the inconsistencies in the published literature. Firstly, 
accessory cell requirements for resting T cells differ from those for sensitized or 
activated T cells (see 1.1.2.1 ). 
Secondly, given the potent stimulatory activity of dendritic cells, it is 
important to determine whether a small contaminating population could explain 
the observed experimental results. This is best done by removing possible 
contaminants and determining their relative contribution eg. by using the anti-
dendritic cell monoclonal antibody, 33D1, with splenic adherent cells in the 
mouse [ 444]. 
Finally, the accessory cell requirements of a responder population must 
be absolute. The presence of accessory cells in the responding T cells may 
result in a syngeneic MLR and the production of helper factors eg. IL-2 [178]. 
This will be of even greater magnitude if xenogeneic antigens (eg. foetal calf 
serum) are used in the culture medium [353]. There is also the theoretical 
possibility of "back-stimulation" ie. the "responder" accessory cells may interact 
with T lymphocytes in the stimulator population and cause sensitization. 
Although these stimulator cells could not proliferate themselves (eg. if treated 
with mitomycin C or irradiation), the signal may "spill over" onto the responder 
cells which would then proliferate. Depletion of accessory cells from the 
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responder population is best undertaken by removing Class II MHC-bearing 
cells using specific monoclonal antibodies. Methods using adherence or nylon-
wool adherence alone are unreliable. Comparisons of different methods for 
obtaining responder cells showed that la+ cell-depleted T cell populations had 
more stringent requirements for accessory cells than conventional T cell 
preparations [217]. For example, the removal of a small population (3%) of Class 
II MHC positive responder cells using monoclonal antibodies and complement 
lysis resulted in abrogation of 1a+-macrophage-induced T cell proliferation. This 
indicated that the 1a+-macrophages induced proliferation not as autonomous 
accessory cells, but by acting synergistically with dendritic or other cells in the 
responder T cell population. 
1.2.2.1 Dendritic cell functions 
The functional properties of dendritic cells as determined by many 
independent groups are summarized in Table 1.4 [ adapted from 446 and 21] 
and will not be discussed further. The evidence for MLR stimulatory activity of 
other putative accessory cells is considered below. 
1.2.3 Origin and tissue distribution of dendritic cells 
Studies on the origin and tissue distribution of dendritic cells indicate a 
definite circulatory pattern. In summary, dendritic cells (lymphoid dendritic cells, 
Langerhans cells and veiled cells) are bone-marrow derived [139, 216, 366, 378, 
449] and migrate to peripheral tissues via the blood. In tissues, they may be 
functionally immature, eg. Langerhans cells, but following exposure to antigen 
develop the ability to act as potent T cell activators whilst migrating in the 
afferent lymphatics as veiled cells to draining lymph nodes. Trapped as the 
interdigitating cells in T cell dependent areas, they interact with antigen-specific 
T cells in the initiation of T cell responses. In certain inflammatory exudates, eg. 
the synovial fluid of rheumatoid arthritis or the lamina propria of inflammatory 
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bowel disease, dendritic cells are recruited by mechanisms which remain to be 
determined. 
1.2.3.1 Human peripheral blood dendritic cells 
Human peripheral blood contains a small proportion of dendritic cells 
which have been enriched to varying degrees [41, 118, 129, 187, 237, 251, 322, 
384,412,413,485,486,487,492,521,522]. 
These cells possess properties similar to those of murine dendritic cells 
including: 
a) characteristic morphology at light- and electron microscopy; 
b) low density and poor adherence with time in culture; 
c) constitutively high level expression of Class I and Class II MHC 
antigens (including HLA-DR, -DP and -DO); 
d) absence of other cell surface markers and functions associated with 
macrophages, B cells, T cells and N K cells, including phago-
cytosis, F cR expression, surface immunoglobulin and the CD1 , 3, 
4, 8, 14 and 16 epitopes [521. CD nomenclature reviewed in 82, 
123]. (There is conflicting evidence about the presence [522] or 
absence [412, 494] of the CR3 antigen (CD11 b). The expression of 
this receptor on murine Langerhans cells is lost in culture [ 416], so 
these differences may reflect in vitro manipulation); 
e) potent stimulatory activity for many T cell responses including: 
i) oxidative mitogenesis [ 485, 487]; 
ii) mitogen- and antigen-induced T cell proliferation [ 41, 322, 487] ; 
iii) T cell-dependent antibody production [187]; 
iv) syngeneic and allogeneic MLR [237, 251, 384, 412, 413, 485, 
487]; and 
v) cluster formation with T cells [118, 251, 521]. 
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1.2.3.2 Langerhans cells 
[Reviewed in 57, 426, 453] 
Langerhans cells are Class II MHC antigen-bearing leucocytes found in 
the suprabasal region of the epidermis. Their dendritic processes form an 
extensive but non-overlapping network [173] which appears to be ideally suited 
for the trapping of antigens passing through the epidermis. In vitro and in vivo 
experiments using both enriched and purified epidermal Langerhans cells have 
demonstrated the ability of these cells to present antigen to T cells in various 
systems [2, 40, 111, 156, 181, 211, 365, 371, 416, 424, 441 , 460, 461, 515] . 
Recent work in vitro has shown that the ability of Langerhans cells to stimulate 
primary immune responses is weak upon initial isolation, but increases consid-
erably in culture under the influence of GM-CSF and IL-1 [156, 181, 371 , 416, 
424, 515]. Associated with this functional change is a change in phenotype (see 
Table 1.3) and morphology so that cultured Langerhans cells become indistin-
guishable from dendritic cells. 
There is evidence to suggest that, in the development of contact hyper-
sensitivity in vivo, Langerhans cells acquire antigen in the epidermis, migrate via 
the afferent lymph to the draining lymph nodes and, having matured, present 
antigen to T cells as dendritic cells [239, 281 , 282, 426]. Macatonia et al (1987) 
[282] after painting the skin of mice with fluorescein-isothiocyanate 
demonstrated a rapid increase in the number of dendritic cells in lymph nodes, 
the preferential location of antigen on dendritic cells and potency of antigen-
bearing dendritic cells in inducing syngeneic T cell responses. In addition, they 
showed 11transitional 11 forms of dendritic cells containing Birbeck granules, 
generally thought to be characteristic of Langerhans cells. 
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1.2.3.3 
1.2.3.3.1 
Other tissue dendritic cells 
Thymic dendritic cells 
Human and murine thymic dendritic cells have been isolated and charac-
terized in vitro [28, 93, 255, 259, 367]. The properties they share with the 
dendritic cell lineage include morphology, physical properties (low density and 
non-adherent), high level expression of HLA-DR surface antigens, the 
expression of the CD1 a (OKT6) and CD4 (weakly) molecules (also expressed by 
Langerhans cells), the expression of the S-100 protein (found on interdigitating 
cells in T cell-dependent areas of human lymph nodes [367] and on tonsillar 
dendritic cells [504]) and potent stimulation of the MLR. 
1.2.3.3.2 Tonsillar dendritic cells 
There are several reports on the isolation of dendritic cells from human 
tonsillar tissue [63, 149, 227, 317]. These cells had the features described 
above. Purified populations of tonsillar dendritic cells expressed the following 
markers: HLA-A, -8, -C; HLA-DR, -DP, -DO; CD4 (Leu3 only), CD11a, CD13, 
CD18, CD39, CDw40, CD45 and CD45R and lacked epitopes characteristic of T 
cells, B cells, macrophages and N K cells. 
1.2.3.3.3 Synovial dendritic cells 
Dendritic cells have been isolated from the synovial fluid of patients suffer-
ing from inflammatory joint diseases (in particular, rheumatoid arthritis) [147, 
478, 490, 491, 493, 494, 495, 496, 522, reviewed in 492] and, in lesser numbers, 
from joints affected by non-inflammatory arthritis [147, 478]. These cells had 
features characteristic of lymphoid dendritic cells. They expressed high levels of 
Class II MHC antigens (HLA-DR, -DP and -DO), even after 3-5 days in culture, 
bore the common leucocyte antigen (CD45) indicating bone-marrow origin 
[ 494], and had the typical features of dendritic cells, including characteristic veils 
at electron microscopy [478, 493, 496]. Functional studies demonstrated the 
ability of dendritic cell-enriched populations to stimulate oxidative mitogenesis 
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[522], antigen- [ 495] and mitogen- [ 4 78, 493, 496] induced proliferation of 
autologous peripheral blood lymphocytes, and both the syngeneic and 
allogeneic MLR [147, 494, 496]. As has been demonstrated in the mouse and 
the rat, the incubation of synovial dendritic cells with autologous T cells resulted 
in the formation of dendritic cell-T cell clusters which contained the proliferating 
cells. The addition of antibodies to the HLA-DR molecule on the dendritic cell or 
the CO2 molecule on the T cell inhibited the formation of these clusters [ 494]. 
Dendritic cells are not phagocytic and are negative for the enzyme 
markers, peroxidase and NSE [147, 492, 522]. Apart from some question about 
weak expression of the CR3 complement receptor [ 494, 522], they do not 
express cell surface markers found on mononuclear phagocytes, T cells, B cells 
or NK cells [147, 494, 522]. 
1.2.3.3.4 Mucosal dendritic cells 
Dendritic cells have been identified histologically in many tissues (see 
above) including human lung [423]. Isolation from rat lung has also been 
reported [167, 396]. The literature regarding intestinal mucosal dendritic cells is 
considered in Chapters 4 and 5. 
1.2.3.3.5 Functional maturity of tissue dendritic cells 
One, as yet, unresolved question relates to the functional maturity of the 
tissue dendritic cell in comparison to lymphoid dendritic cells (splenic, lymph 
node or veiled cell). Does the tissue dendritic cell, like the Langerhans cell, need 
to contact antigen and migrate to draining lymph nodes in order to achieve 
functional maturity or is the Langerhans cell in a specialized micro-environment? 
Are tissue dendritic cells as competent as lymphoid dendritic cells? 
This question is difficult to answer because of the difficulties involved in 
obtaining purified populations of dendritic cells from tissues and the possible 
effects of the isolation process on function. For example, maturation may be 
induced by cytokines during culture. Apart from evidence presented above relat-
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ing to munne Langerhans cells and splenic dendritic cells, the only direct 
functional comparisons are between murine splenic and Peyer's patch dendritic 
cells [ 433, 435], murine splenic or lymph node and thymic dendritic cells [368, 
519], rat lymph node and lung dendritic cells [396], rat thymic and lymph node 
dendritic cells [519], and human peripheral blood and synovial fluid dendritic 
cells [see above]. (Dendritic cells from the thymus and Peyer's patches should 
probably be considered as lymphoid-derived, but for the purpose of this 
discussion will be considered non-lymphoid). (A number of other investigators 
have indirectly compared dendritic cells from different tissues. For example, liver 
dendritic cell-enriched populations were found to have equivalent stimulatory 
activity/ cell when compared to splenic dendritic cells [231]; thymic and splenic 
lymphostromal clusters had equivalent antigen-presenting cell function [255], 
and thymic dendritic cells were found to have M LR stimulatory activity similar to 
that which would have been expected from splenic dendritic cells [93]). 
The only clear difference in the direct comparisons was that thymic 
dendritic cells generated lower levels of alloreactive cytotoxic T lymphocytes in 
vitro than those from the spleen [368]. The significance of these findings is 
unclear. All other comparisons of function found equivalent dendritic cell activity 
per cell. The comparisons of peripheral blood and synovial fluid dendritic cells 
found, if anything, greater activity in peripheral blood dendritic cells (which would 
be expected to have the less mature precursors) [ 493, 492], but the use of 
impure populations makes this finding hard to interpret. 
The matter is as yet unresolved. Studies on the archetypal tissue dendritic 
cell, the Langerhans cell, consistently showed a thirty fold increase in antigen-
presenting cell function during several days in culture (Section 1.2.3.2). The 
evidence on dendritic cells from other tissues is scarce, and will of necessity, 
have any interpretation clouded by the need to dissociate and culture cells 
during the enrichment process. 
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1.2.3.4 Veiled cells 
The veiled or non-lymphoid cells of afferent lymphatics are migratory 
forms of dendritic cells en route from the peripheral tissues to the draining lymph 
nodes. They are normally found in very small numbers in thoracic duct lymph 
(0.03%-0.05% [300, 311, 387]). Lymphadenectomy results in increased numbers 
in the lymph, whilst irradiation causes a higher relative proportion by depleting 
radiosensitive lymphocytes [300, 387]. By using these methods, the phenotype 
and function of these cells has been studied in rodents [26, 233, 234, 288, 289, 
300, 311, 341, 378, 387, 388, 389] as well as in other species [72, 168]. 
The reported properties of veiled cells are similar to those of dendritic 
cells. They are bone-marrow derived, non-phagocytic, low density, and have 
irregular surface morphology. Various forms including the 11classical 11 veiled cell 
have been described [234, 311, 378, 387]. They express high levels of Class II 
MHC surface proteins, and are potent stimulators of various primary and 
secondary T cell responses [234, 300, 311, 341]. The demonstration of ve/led 
cells bearing bacteria and bacterial antigens in the afferent lymph of orally 
infected rats suggests a significant role in the transport of antigen [311]. 
1.2.3.5 The migration patterns of dendritic cells and their relationship 
to interdigitating cells 
Using enriched populations of labelled dendritic cells a number of invest-
igators have examined their migration pattern in vivo [22, 120, 236, 252]. When 
injected into the footpads of mice or rats, labelled dendritic cells were carried by 
the lymphatics to the draining lymph nodes [252] where they were identified as 
interdigitating cells in the paracortex [120]. Studies in nude mice showed that 
this process was not dependent on the presence of T lymphocytes [120, 236, 
252]. 
When injected intravenously, dendritic cells localized preferentially in the 
spleen and the liver after brief sequestration in the lungs. They were unable to 
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enter lymph nodes [120, 252], except by an indirect route through the 
lymphatics of the liver [120]. The principal site of localization was the spleen and 
this process depended on the presence of T cells. The dendritic cells were not 
just 11 homing 11 to their tissue of origin since mesenteric lymph node-derived 
dendritic cells also localized to the spleen [252]. 
Shortly after injection the dendritic cells were found in the red pulp of the 
spleen where they were thought to bind to the endothelium in the marginal 
zones. By 24 hours after injection the majority had migrated to the T cell areas of 
the white pulp where they may have developed into interdigitating cells. It is likely 
that these differences in location are reflected by differences in phenotype and 
possibly even function. Witmer and Steinman (1984) [514] demonstrated 
staining with an anti-dendritic cell antibody, 3301, only in the marginal zone of 
the spleen. Crowley et al (1989) [93] showed that two populations of dendritic 
cells are present in the spleen: a major, 33D1 + population in the marginal zone 
(which may represent a migratory cell), and a minor (10-20%), 3301 - population 
corresponding to a fixed, longer-lived interdigitating cell. Rhodes and Agger 
(1987) [388] also found phenotypic differences between dendritic cells from 
different locations. 
1.2.4 Ontogeny and cell lineage of dendritic cells 
There is considerable evidence that the lymphoid dendritic cell, fixed 
tissue dendritic cell, Langerhans cell, veiled cell and interdigitating cell represent 
different developmental stages of the same bone marrow-derived precursor and 
that there are significant differences between this cell lineage and the 
mononuclear phagocyte. 
For example, studies on the appearance of accessory cells in human and 
rat foetal development consistently indicate an intrinsic developmental hetero-
geneity. Janossy et al (1986) [197] detected, in human foetal tissue, a major 
population of accessory cells which expressed typical macrophage surface 
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markers and were found at sites of accumulation of classical tissue 
macrophages. These cells did not bear Class II MHC antigens except for a 
subset present in the gut and the liver. A minor population of Class II MHC-
positive accessory cells localized to sites characteristic of dendritic cells. These 
cells were the first cells in the body to express HLA-DR antigens and 
constitutively expressed all subsets of Class II MHC antigens by 23 weeks 
gestational age. Differences between macrophage and dendritic cell lineages 
were maintained throughout foetal development. Others came to similar 
conclusions after studying the distribution of non-lymphoid cells in the human 
[ 437] and the rat foetal gut [312, 484]. 
lmmunohistochemical studies of dendritic cells and macrophages in adult 
tissues have also demonstrated distinctive differences in their phenotype and, by 
implication, their lineage [15, 71, 135, 375, 383, 422], although not all authors 
would agree [124, 291]. 
Although it has been suggested that dendritic cells and macrophages are 
members of the same cell lineage, contradictory findings have been reported. 
For example, diametrically opposed differentiation pathways have been 
proposed (dermal macrophages into Langerhans cells [338] and, conversely, 
veiled accessory cells into macrophages [369]). The finding that injected 
dendritic cells did not give rise to sinus macrophages, tingible body 
macrophages or follicular dendritic cells [120] implies, at least, that dendritic 
cells do not differentiate into macrophages. The in vitro differentiation of 
macrophages into dendritic cells has yet to be demonstrated convincingly. 
Overall, there is little evidence to suggest that these cells are members of 
the same cell lineage although an understanding of the nature of the relationship 
between the dendritic cell and the mononuclear phagocyte is of importance. The 
evidence presented above suggests that dendritic cells differ from the mono-
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nuclear phagocyte system in terms of ontogeny, morphology, phenotype, 
function and behaviour in vitro and in vivo. 
1.2.5 
1.2.5.1 
The mechanism of action of dendritic cells 
Antigen processing 
Although dendritic cells do not phagocytose particles in vitro there is 
compelling evidence to suggest that they are able to induce primary T cell 
responses to both soluble and particulate antigens (See Table 1.4) [eg. 12, 80, 
223, 322]. A recent report demonstrated that the ability of a dendritic cell popul-
ation to present intact exogenous protein antigens is greatest in immature epi-
dermal Langerhans cells, and is inversely related to its ability to stimulate the 
MLR [401]. 
Studies of the mechanism of antigen processing have yielded conflicting 
results. Dendritic cell chloroquine-sensitivity was reported by some authors [12, 
80, 144], whereas others [213] could not detect any inhibitory effect. Two factors 
may explain these differences. Firstly, in the doses used, chloroquine may be 
toxic [213]. A dose greater than 15 mM in continuous culture [76] or 
pretreatment with doses of 300 mM [213] has a suppressive effect on T cell 
proliferation. It is also possible that chloroquine has effects other than on antigen 
processing, eg. on the function of the Class II MHC molecules [184]. In 
experiments on dendritic cell-T cell clustering, antigen-independent clustering at 
37°C was unaffected by chloroquine. Nor did chloroquine appear to inhibit T cell 
receptor-antigen-Class II MHC complex interaction, since its presence did not 
alter accessory-T cell binding at 40c. However, when any antigen-presenting 
cell was pretreated with chloroquine, the ability to bind helper T blasts in an 
antigen-dependent manner was inhibited for both soluble and allo-antigens at 
4°C. Proliferation of primed blasts in the secondary M LR was also blocked by 
pre-exposure to a low dose of chloroquine, whilst primary MLR responses were 
unaffected [114, 144, 184]. These observations imply a reversible effect of 
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chloroquine on Class II MHC protein function. The mechanism of any effect has 
yet to be explored. 
There are also differences in the reported efficacy of dendritic cells to 
process insolubilized protein antigens. T cell proliferative responses to 
ovalbumin bound to latex beads or methylated bovine serum albumin were 
similar to controls in one study [213], while in another, proliferation was 
enhanced by a hapten bound to large, soluble and insoluble antigens 
(polystyrene beads) [12]. Possible reasons for these differences include the use 
of populations of dendritic cells at different stages of differentiation, the degree 
of spontaneous dissociation of the antigens from the carrier and the accessibility 
of the proteins to the putative 11ectoenzyme 11 system. Clearly, there is a need for 
further investigation into the method by which dendritic cells process antigen. 
To explain synergistic effects between dendritic cells and macrophages, 
some authors have suggested that dendritic cells present peptide antigens 
following metabolic degradation by macrophages [144, 213]. In vitro mixing 
experiments using macrophages and dendritic cells gave variable results - some 
showed synergy [324], some suppression [242] and others showed no effect 
[223]. Increased macrophage production of the cytokine, IL-1, may amplify the 
function of dendritic cells [241], but there are many other factors which may 
affect their interaction. This area has yet to be systematically analysed. 
1.2.5.2 Dendritic cell-T cell cluster formation 
One unique feature of dendritic cells is their ability to form clusters with 
unsensitized antigen-reactive cells in culture [24, 118, 142, 184, 185, 188, 190, 
reviewed in 21, 442, 446]. These cells may be CD4+, cos+ [190] or B cells in 
association with CD4 + cells [188]. Cluster formation precedes, and seems 
essential for, mitogenesis. In the periodate model (Section 1.1.2.3), Austyn et al 
(1988) [24] found that clustering between dendritic cells and responding T cells 
occurred within 2 hours, was associated with T cell release and responsiveness 
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to IL-2 within 18 hours, and with DNA synthesis at 24 hours. Proliferative activity 
was confined to the cluster fraction at all times. 
Studies on the human MLR demonstrated (allo)-antigen-specificity. 
Clustered T cells were depleted of reactivity to a third party but responded 
rapidly to rechallenge with leucocytes from the original donor. The non-clustered 
cells were depleted in specific reactivity to the original donor but responded 
normally to a third party [118]. 
Inaba and Steinman [180, 184, 185] studied the mechanisms of T cell-
accessory cell interaction. All Class II MHC-bearing cells studied (dendritic cells, 
Langerhans cells, B cells, macrophages) interacted with T cells at 4°C or 37°C 
in an antigen-dependent fashion. The mechanism presumably involved the 
recognition of the antigen-Class 11 M HC complex on the accessory cell by the T 
cell receptor. In contrast, antigen-independent clustering occurred primarily with 
dendritic cells and was greatest at 37°C. This implies a requirement for some 
metabolic process rather than a simple receptor-ligand interaction. This property 
was unique to dendritic cells, was inducible in cultured Langerhans cells and 
paralleled their ability to induce primary responses in vitro. 
Subsequent studies on the nature of dendritic cell-T cell interaction in the 
primary MLR examined the effect of monoclonal antibodies directed at T cell 
adhesion molecules (specifically anti-H-2k, anti-1-A/-E, anti-LFA-1 and anti-CD4, 
amongst others). No antibody tested interfered with antigen-independent 
binding [185]. The last three groups of antibodies inhibited proliferation and IL-2 
production. Antigen-dependent binding was inhibited by antibodies to Class II 
MHC products as would be expected. Antibodies to CD4 and LFA-1 did not 
affect the early steps of cluster formation but seemed to retard blastogenesis 
(and IL-2 release) and cluster stability, respectively. 
Odum et al (1988) [357] examined the effect of monoclonal antibodies 
directed at various adhesion molecules and T cell antigens in both primary and 
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secondary responses in the human. In summary, they found that the primary 
MLR was inhibited by antibodies to CO2, 4, 5, 11 a, 11 c and Class II MHC 
antigens, whereas suppression of secondary proliferation occurred only in the 
presence of anti-CD 2, -CD4 and -Class 11 M HC antibodies. 
King and Katz (1989) [227] also used monoclonal antibodies directed 
against cell surface antigens to study human tonsillar dendritic cell-induced T 
cell responses. In the oxidative mitogenesis model, antibodies to Class I and 
Class II MHC antigens, CO2, CD4, CD11a, CD18, LFA-3 and ICAM-1 inhibited 
proliferation (whereas anti-CDS and -CD16 antibodies did not). Dendritic cell-T 
cell clustering was inhibited by anti-CO2, -CD11 a, -CD18, -LFA-3 and ICAM-1 
whereas antibodies to Class I and Class 11 M HC antigens and CD4 had no effect. 
Antibodies against the CD45 molecule did not affect cluster formation but did 
weaken their stability, suggesting a role in cell-cell adhesion. With these and 
other experimental data, some conclusions about the role of the intercellular 
adhesion molecules in cluster formation and the nature of the antigen-
independent interaction may be drawn. 
The observed effect of anti-CD4 antibody implies a role in signal trans-
duction, either directly or in concert with the CD3-T cell receptor complex, as 
well as in intercellular adhesion. Further support for such a role is provided by 
the association of CD4 with a cytoplasmic protein tyrosine kinase [339]. 
LFA-1-ICAM interactions contributed to the stability of the clusters without 
affecting initial binding, since after treatment with anti-LFA-1 0 , aggregates were 
easily disrupted and did not reassemble [185]. The effect on proliferation was 
variable [Table II , 185] and probably depends on many factors including the 
dosage and the time of administration. Others [ 483] showed that the binding of 
ligand to LFA-1 in the human resulted in the transduction of regulatory signals 
across the plasma membrane (anti-LFA-1 0 antibodies enhanced proliferation 
whilst those directed against LFA-1 /3 inhibited proliferation). 
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CD2/LFA3 adhesion [reviewed in 39] also plays an important role in the 
stabilization of dendritic cell-T cell clusters. However, it is unlikely to account for 
the antigen-independent dendritic cell-T cell clustering because the ligand, LFA-
3 is not unique to the dendritic cell and the interaction is operative in the 
absence of divalent cations and functions at 4°C. VLA interactions (very late 
antigens of activation) [reviewed in 39, 408] are also unlikely to play a role in 
antigen-independent binding in primary responses because of their widespread 
distribution and their appearance late in lymphocyte activation. These antigens 
may play a role in secondary immune responses. 
Evidence suggests that antigen-independent dendritic cell-T cell binding 
precedes antigen recognition [180, 184]. This may be a means of surveying T 
cells with subsequent responses depending on the interaction between the T 
cell receptor and the antigen-Class II MHC complex. The mechanism of this 
interaction is unknown and is an exciting area of future research. 
One possible factor is the degree of desialylation of MHC molecules. 
Dendritic cell-associated MHC molecules carried fewer sialic acid residues than 
the same molecules from other putative antigen-presenting cells [54]. It was 
proposed the the low net negative charge at the dendritic cell surface, together 
with the tendency to form veils may explain the ability to form antigen-
independent clusters. Neuraminidase treatment of thioglycollate-elicited 
macrophages enabled them to stimulate cos+ (but not CD4 +) T cells in the 
presence of IL-2 [159] and B cell antigen-presenting activity has also been 
shown to be enhanced by treatment with neuraminidase [126, 159, 224, 248]. 
The role of sialic acid residues in intercellular reactions is unclear and further 
work needs to be undertaken in this area. Several groups have proposed that 
other characteristics of the dendritic cell contribute to its potent antigen-
presenting cell activity, for example, the expression of subclasses of Class II 
MHC antigens subserving different functions [238]. Dendritic cells express the 
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antigens HLA-DR, -DP and -DO constitutively [65, 130, 149, 494, 522], but it is 
unlikely that this factor is critical for accessory cell activity - in spite of high level 
expression of -DR and -DO, both B cells [394] and alveolar macrophages [272] 
are poor stimulators of resting T cells. 
As discussed in Section 1.1, the main factor determining the mapping of 
immune responsiveness to a particular MHC gene is the ability of the MHC 
molecules to bind antigen. Class II MHC polymorphism in an individual confers 
survival advantage by minimizing the number of antigens which do not bind and 
to which the T cell cannot respond. Class II MHC polymorphism in a species 
confers even greater benefits [ 406]. For this reason the suggestion that Class II 
M HC subregion molecules act as restriction elements for the generation of either 
immune responsiveness (HLA-DR and 1-E) or suppression (HLA-DQ and I-A) 
[158] is unlikely to be proven. Arguments against this proposition are, firstly, that 
inbred strains of mice which do not express the surface proteins coded for by 
the 1-E locus (HLA-DR equivalent) [301] survive and, secondly, that T cell 
proliferation [ 464] and antigen-dependent dendritic cell-T cell binding in the 
mouse was blocked only in the presence of antibodies to both I-A and 1-E 
determinants [185]. 
1.2.5.3 Dendritic cells and cytokines 
Recent interest in the role of cytokines in inflammatory responses, as well 
as in haemopoietic cell differentiation, has provided some information as to the 
possible mechanism of action of dendritic cells. I will review the literature in three 
areas: the production of lymphokines by T cells activated by dendritic cells; the 
production of cytokines by dendritic cells themselves; and the effect of cytokines 
on dendritic cell maturation, differentiation and function. 
1.2.5.3.1 Dendritic cell-induced lymphokine production 
Dendritic cells activate resting T lymphocytes by a process which results 
in the release of IL-2 and the expression of IL-2 receptors on the T cell surface 
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(see Table 1.4 for references). Other lymphokines detectable in both the primary 
and secondary MLR include IL-4 and other 8-cell growth factors [381]. A novel 
IL-2-enhancing factor produced by co-culturing dendritic cells with periodate-
treated splenic T cells has also been described recently [108]. 
The site of origin of a tissue dendritic cell may influence the particular 
lymphokines secreted. For example, Peyer's patch dendritic cell-T cell clusters 
preferentially induce polyclonal lgA responses when mixed with either Peyer's 
patch or splenic B cells, whilst splenic dendritic cell-T cell clusters do not 
augment lgA secretion by either splenic or Peyer's patch B cells [ 434, 435]. 
1.2.5.3.2 Dendritic cell cytokine production 
T cell activation was thought to require the delivery of two signals: the 
presentation of antigen in conjunction with the products of the Class 11 M HC 
gene locus and the production of antigen-nonspecific factors, presumably IL-1 
[325]. Although IL-1 is a well documented costimulator, an absolute requirement 
for I L-1 has not been demonstrated [34, 99, 126]. I L-1 has been shown not to 
directly influence the proliferation of isolated T cells after mitogen-induced 
stimulation or in the MLR, even in the presence of allogeneic Class II MHC-
bearing cells (peritoneal macrophages) [241]. Similarly, antibodies to I L-\r and 
IL-1 /3 did not inhibit proliferation in dendritic cell-induced oxidative mitogenesis 
[King PD and Katz DR, cited in 227] or in the M LR [317]. 
Evidence suggests that IL-1 mediates its effects on the immune system 
by amplifying proliferative responses to limiting doses of dendritic cells, which 
cluster more efficiently with T cells before the onset of mitogenesis [241]. IL-1 is 
not required to be present continuously in culture since IL-1 pretreatment of 
dendritic cells generally resulted in greater proliferation [241] which was not 
inhibited by the addition of anti-lL-1 antibody [442]. Other cytokines have been 
tested and either had no effect (TN F, I L-2, I L-3) or decreased dendritic cell 
function (IFN--y) [241]. 
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IL-1 production by dendritic cells has been examined in a number of diff-
erent systems. Murine splenic dendritic cells did not produce detectable IL-1 
(D10.G4 T cell clone bioassay) or IL-\): RNA (IL-\): cDNA probe) in response to 
a wide range of stimuli (LPS, PMA, IFN--y, con A, PHA) [240]. Similarly, human 
dendritic cells did not produce detectable IL-1 0 or -13 using immunolabelling with 
both anti-lL-1 0 and anti-lL-1/3 antibodies [149,240,317]. 
In contrast to these experiments using purified populations of dendritic 
cells, other investigators have demonstrated IL-1 production in human 
peripheral blood- or synovial fluid-derived dendritic cells. Enriched populations 
of synovial dendritic cells were shown to produce IL-1 spontaneously and after 
stimulation with LPS, when assayed by both the mouse thymocyte proliferation 
assay and the murine T helper clone (D10.G4.1) proliferation assay [490]. The 
spontaneous production of an I L-1-like factor ( detected by mouse thymocyte 
proliferation) by cloned, adherent, rheumatoid synovial dendritic cells in long-
term culture has also been described [140]. These cells were classified as 
dendritic cells on the basis of morphology, the absence of phagocytosis and 
(weak) reactivity with antibody to HLA-DR (which intensified after treatment with 
IFN--y). Functional T cell stimulation assays using these cells were not reported. 
Both these studies have methodological flaws. For example, in the former study 
[ 490], contaminating synovial fluid mononuclear phagocytes could have 
produced the detectable I L-1. To show that I L-1 activity decreased with 
decreasing ratios of dendritic cells to monocytes, peripheral blood monocytes 
were used instead of the appropriate control, synovial fluid mononuclear cells. 
The cells in the second study were not adequately characterized and in fact, 
were not typical dendritic cells. 
Subsequent studies have confirmed by double-labelling with anti-lL-1 and 
monocyte-specific antibodies that the I L-1-producing cells in rheumatoid 
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synovial fluid were monocytes and that dendritic cells did not produce IL-1, 
either constitutively or in response to a number of stimuli [35]. 
In rodents, two other papers have described IL-1 production. Pereira et 
al, (1986) [368] demonstrated IL-1 production by both splenic and thymic 
dendritic cells using the thymocyte stimulation assay. These findings are difficult 
to reconcile with the data presented above and may be due to the production of 
another cytokine which is stimulatory in the bioassay or the presence of 
contaminating macrophages. Nagelkerken and Vriesman (1986) [342] could not 
detect secreted IL-1 from rat dendritic cells and claim to have demonstrated 
membrane-associated IL-1-like activity. They showed that dendritic cells 
stimulated the EL4 murine thymoma cell line by a mechanism which involved 
cell-cell contact and which did not require metabolically active stimulator cells. 
Although suggesting that this mechanism involved passively acquired IL-1, they 
acknowledged that other membrane structures distinct from the secreted form 
of IL-1 may have been involved in T cell activation. There is no evidence to 
suggest that other cytokines are produced by dendritic cells. 
The evidence suggests therefore that IL-1 is not produced by dendritic 
cells but that it amplifies dendritic cell function by unknown mechanisms. 
A recent paper using the anti-CD3 model of T cell mitogenesis in dual 
chamber experiments showed that soluble lymphocyte-activating factors were 
not required for T cell activation [180]. 
1.2.5.3.3 Effect of cytokines on dendritic cell differentiation and 
function 
IL-1 
As discussed above, IL-1, although not produced by splenic dendritic 
cells, acts upon them to cluster T cells more efficiently, thereby amplifying 
proliferative responses. IL-1 also enhanced thymocyte proliferative responses to 
thymic dendritic cell-enriched populations [189]. These responses were not due 
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to a carry over effect of IL-1 on T cells since pretreatment of dendritic cells 
resulted in levels of proliferation which were similar to those induced by the 
continuous presence of IL-1 and which were not blocked by monoclonal 
antibodies to IL-1. 
IL-1 also acted upon thymic precursor cells which were 1a- and nylon 
wool-adherent to give rise to typical dendritic cells. Other cytokines (IL-2, IL-3, 
IL-4 and GM-CSF) had no effect. Similar IL-1-inducible 1a- precursors were not 
detectable in bone marrow, spleen or lymph node. Thus IL-1 appears to have an 
additional effect on dendritic cell precursors (at least in the thymus) which results 
in their differentiation into functionally competent dendritic cells. 
GM-CSF 
A senes of papers recently examined the relationship between 
Langerhans cells and dendritic cells [156, 181, 416, 424, 515, 516]. In summary, 
these papers demonstrated that freshly isolated Langerhans cells were able to 
present antigen to primed T cells but were weak stimulators of the MLR; over 
several days in culture, Langerhans cells lost features found in freshly isolated 
and in vivo Langerhans cells (eg. F4/80 and 2.4G2 (Fe receptor) antigens, 
nonspecific esterase and ATPase activity and pinocytosis of exogenous 
horseradish per-oxidase), and at the same time developed morphological and 
functional characteristics of splenic dendritic cells. This maturation was 
dependent upon factors present in keratinocyte-conditioned medium, in 
particular, GM-CSF, whilst IL-1 enhanced this effect. 
Other workers [327] showed that GM-CSF augments primary antibody 
responses by enhancing the function of murine splenic antigen-presenting cells. 
These cells were obtained by short-term adherence and were a heterogeneous 
population, so the results are difficult to interpret. GM-CSF did not increase the 
function of either mature Langerhans cell or splenic dendritic cells [515], but it is 
possible that immature dendritic cells were present in the splenic antigen-
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presenting cell population and that their function was augmented by exposure to 
GM-CSF. Another recent paper suggests that GM-CSF enhances the MLR 
initiated by relatively low numbers of dendritic cells, an effect that is inhibited by 
anti-GM-CSF antiserum [336]. 
In summary, it is clear that control of dendritic cell function and maturation 
1s, 1n part, dependent on the release of cytokines in peripheral tissues. The 
complex cellular and molecular interactions are only just beginning to be 
unravelled. 
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1.3 MACROPHAGES AS ANTIGEN-PRESENTING CELLS 
The immunological literature is replete with studies demonstrating that 
macrophages are the predominant antigen-presenting cell in vitro and in vivo. 
There is no doubt that macrophages can express Class II MHC molecules and 
can present antigen to sensitized T cells [ eg. 179, 182], but a critical appraisal of 
the many reports consistently fails to establish a role for macrophages as 
primary T cell activators. 
The main experimental flaws have been described above in detail 
(Section 1.2.2). They include the use of sensitized responder T cells (ie. the 
assessment of secondary rather than primary responses), the failure to 
adequately determine the proportion of "contaminating" dendritic cells (and to 
see primary antigen-presenting cell activity co-purified with dendritic cell or 
macrophage enrichment) and the use of "nonstringent" responder cell 
populations. 
When antigen-presenting cell activity has been assessed rigorously using 
either macrophages alone or in comparison with dendritic cell-enriched popul-
ations, macrophages have been less potent or suppressive [163, 245, 272, 280, 
313,414,473]. The results of in vivo studies are similar [64, 281]. 
1.3.1 The relationship between dendritic cells and macrophages 
Macrophages are a heterogeneous group of cells which may vary consid-
erably in size, morphology, phenotype and function [eg. 266, 267, 309, 438]. 
There are some similarities with dendritic cells in that they are both bone-marrow 
derived, generally of low density, and dendritic in morphology. The question 
then arises, are dendritic cells a subset of macrophages? (This question is also 
considered in Section 1.2.4) 
The Langerhans cell is in some ways a hybrid between the macrophage 
and the dendritic cell. In situ, it expresses the mouse macrophage-specific 
antigen detected by the F4 /80 antibody, as well as the C3bi and F c receptors 
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[ 400, 416]. In culture, the F4 /80 antigen and F cR are lost, the expression of 
Class II MHC determinants is increased [516] and the cells more closely 
resemble the phenotype of dendritic cells. Freshly isolated Langerhans cells are 
more effective at presenting protein antigens to T cell clones than cultured 
Langerhans cells, which, in turn, are very potent stimulators of the primary MLR 
[401]. Thus, the Langerhans cell in situ more closely resembles the macrophage 
but, in culture or after contact with antigen, develops the characteristics of the 
dendritic cell. 
In contrast, there are very distinct differences between macrophages and 
dendritic cells. These include the constitutively high level expression of Class II 
MHC molecules, the ability to form long-term clusters with antigen-specific 
lymphocytes and to induce lymphokine (IL-2) secretion and responsiveness, 
and the failure to secrete IL-1 after stimulation with LPS [240]. 
These differences together with the evidence for a separate cell lineage 
(discussed in Section 1.2.4) strongly suggest that dendritic cells and 
macrophages are not different stages in the same differentiation pathway. A 
more likely explanation is that they are divergent pathways extending from a 
common precursor. 
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1.4 B CELLS AS ANTIGEN-PRESENTING CELLS 
The B cell possesses many of the properties of a potential antigen-
presenting cell. These include the ability to take up antigen by a specific receptor 
(cell surface immunoglobulin), to process and to display protein antigens in 
association with Class II MHC molecules, and to release growth factors 
[reviewed in 1, 18, 20, 84, 319]. A review comparing the properties of dendritic 
cells and B cells as antigen-presenting cells has been published recently [318]. 
In the following review, I will present the evidence that activated, but not 
resting, B cells can initiate in vitro primary T cell responses. Different models 
have been used in vivo to explore this question, but the balance of evidence 
suggests no role for resting B cells in the induction of primary T cell responses. 
1.4.1 B cell antigen-presenting cell function in vitro 
The observation that the interaction between T and B cells was 
genetically restricted to the I region of the MHC gene complex [296], and the 
phenomenon of hapten-carrier-linked recognition between T and B cells 
suggested to Chesnut and Grey (1985) [84] that antigen served as a bridging 
unit in these interactions. This, in turn, led to the study of the ability of B cells to 
process and present the hapten-carrier complex to T cells and their capacity to 
induce antigen-specific T cell responses [83]. 
1.4.1.1 Resting B cells 
The role of resting B cells in inducing primary T cell responses is still 
debated [18, 19, 20, 138, 198, 397]. Most studies examining B cell antigen-
presenting activity have used secondary responses. Studies examining resting B 
cells in the primary MLR have shown poor stimulation [249, 319] except when 
Mis determinants were disparate [501]. Particular problems pertain to obtaining 
pure populations of resting B cells since the isolation procedure (eg. the use of 
anti-mouse immunoglobulin) may result in the initiation of the activation process. 
Similarly LPS may be present in media additives [126]. When care is taken to 
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eliminate activated cells, small resting B cells appear to be inefficient accessory 
cells [250,319]. 
1.4.1.2 Activated B cells 
There is experimental evidence [126, 249, 250, 319, 501] indicating that 
the ability to stimulate T cells in primary responses depends on the state of acti-
vation (and hence size or density) of the B cell. Greatest stimulatory activity was 
seen in large, low-density, LPS- or anti-immunoglobulin stimulated B cell blasts 
whereas small, dense, resting B cells were non-stimulatory or, at best, weak 
stimulators. The state of activation also determined the radiosensitivity of 
antigen-presenting cell function. For example, exposure to LPS resulted in both 
increased activation and increased radioresistance [84, 319]. In contrast, the 
weak stimulation of resting B cells was radiosensitive [19, 84, 126, 319]. 
A number of differences in the properties of resting B cells and B cell 
blasts may account for their varying capacity to stimulate T cells. For example, 
cluster formation is not seen when resting B cells are mixed with allogeneic T 
cells in the primary MLR [118, 182, 319]. B cell blasts do form clusters and once 
bound, are able to subserve the accessory functions required for T cell prolifera-
tion. This property is critically dependent on the LFA-1 molecule [319]. 
Other mechanisms by which activated B cells may be more active 
inducers of T cell responses are reviewed in Chesnut and Grey (1985) [84] and 
include: 
a) the uptake of antigen 
Resting B cells are less efficient in their capacity to take up antigen either 
by fluid-phase pinocytosis or by adsorptive binding when 
compared to activated B cells [84, 88]. These differences however, 
do not explain the inability of resting B cells to stimulate T cells in 
either the MLR or the rabbit anti-mouse immunoglobulin model. 
37 
b) antigen processing 
Both resting and activated B cells degrade protein antigens effectively, so 
this is unlikely to account for their different stimulatory activity [84, 
138]. 
c) density of Class II MHC molecules 
Class II MHC molecule density increases during activation of B cells and 
then gradually falls to levels found in resting B cells. There is 
evidence to suggest that la density is not a critical factor in the 
antigen-presenting cell activity of activated B cells so this 
mechanism is unlikely to account for the observed differences. 
At present the major difference between resting and activated B cells in 
terms of T cell activation is the ability of B cell blasts to form clusters with T cells. 
1.4.1.3 Differences between B cell blasts and dendritic cells 
B cell blasts differ from dendritic cells in being less efficient at forming 
clusters and by being more dependent on the LFA-1 molecule for initial cell-cell 
adhesion [319]. Another important difference in the mouse is the expression of 
the mixed lymphocyte stimulatory (Mis) determinants [195, 395]. These antigens 
were first described because of their ability to stimulate MHC-identical 
lymphocytes to proliferate in vitro. In certain combinations, disparities at the Mis 
locus (loci) stimulate 20% of T cells in primary mixed leucocyte reactions 
(compared to <3% in allogeneic-MHC interactions [445]). The nature of the 
gene products has not yet been determined. There is evidence for both a direct 
interaction of these products with the MHC antigens [21 O, 286] and as 
accessory molecules expressed on antigen-presenting cells (with a 
complementary T cell Mis-reactive molecule distinct from the T cell receptor) 
[502]. B cells differ from both dendritic cells and macrophages in expressing 
these determinants [319, 502]. 
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1.4.2 
1.4.2.1 
In vivo studies of B cell antigen-presenting cell function 
The anti-µ-treated mouse model 
One model for the study of B cell antigen-presenting cell function in vivo is 
the anti-µ-treated mouse model [196, 253, 403, reviewed in 18]. Mice given 
repeated injections of rabbit or goat anti-mouse µ-chain antibodies from birth 
showed an almost total lack of lg+ B cells whilst T cell numbers and responses 
to lectins appeared normal. To study T cell sensitization (and, indirectly, antigen-
presenting cell activity), lymph nodes or splenic cells from immunized mice were 
assayed for their secondary proliferative responses when cultured in the 
presence of antigen, and for their ability to act as helper cells in plaque-forming 
cell assays. After immunization, the proliferation of antigen-stimulated lymph 
node (but not spleen) T cells in anti-µ-treated mice was impaired [196] unless 
the animals were reconstituted with B cells before immunization [ 403]. Although 
initially reported as suggesting that B cells were the initiating antigen-presenting 
cell in peripheral lymph nodes [196], subsequent experiments suggested that 
the T cells had been sensitized but had not been clonally expanded. Ron and 
Sprent (1987) [ 403] argued that unprimed T cells were sensitized to antigen by 
dendritic cells in lymph nodes, but that as dendritic cell numbers became 
limiting, the interaction between antigen-specific T cells and B cells resulted in 
clonal expansion. When lymph node T cells were examined for secondary 
proliferative responses in B cell deficient mice, the proportion of sensitized cells 
would be so low that no proliferation would be detectable. This hypothesis was 
supported by the findings of significant T helper cell function from primed anti-µ-
treated or irradiated mice [ 403]. 
Kurt-Jones et al (1988) [253] used the anti-µ-treated mouse model with 
the adoptive transfer of antigen-specific B cells to show that T cell "priming" only 
occurred when transferred B cells were specific for the immunizing hapten-
carrier conjugate. Using parental to F 1 cell transfer, they also showed that 
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11primed 11 T cells were restricted to Class II M HC recognition of the donor strain if 
memory B cells were used, but to both host and donor strain if activated B cells 
were used. It was argued that in the latter situation, anti-hapten antibody 
enhanced presentation of antigen by host non-B cell antigen-presenting cells, 
whereas in the former experiments, the transferred B cells functioned as antigen-
presenting cells in vivo. These experiments also failed to differentiate between 
sensitization and clonal expansion and may be consistent with the hypothesis 
stated above. Thus, the main conflict is whether the B cells are the sensitizing 
antigen-presenting cell or whether they contribute to the clonal expansion of 
sensitized lymphocytes. 
1.4.2.2 The chicken chimera model 
Chickens treated neonatally with cyclophosphamide will generate their 
own T cells and antigen-presenting cells but will not develop B cells because 
they no longer have stem cells capable of homing to the bursa [261]. Donor B 
cell precursors can reconstitute a mature B cell compartment with resultant 
tolerance to the donor alloantigens. When host and donor strains expressed 
different Class II MHC determinants, the antibody responses of these animals to 
T-independent antigens was normal, showing that they had functional B cells, 
yet their T-dependent responses were greatly impaired. These data suggested a 
breakdown in T-8 cell communication in the allogeneic chimeras. The antibody 
responses were restored when donor strain splenic antigen-presenting cells 
were injected simultaneously with antigen, whereas host strain antigen-
presenting cells had little effect. Thus the defect in the chimeras was not a lack 
of T cells able to recognize antigen associated with donor MHC. Nor was the 
defect due to the inability of the B cells to display antigen and receive T cell help. 
The defect was a lack of donor antigen-presenting cells capable of providing the 
triggering signals to activate virgin T cells. Donor strain splenocytes were 
effective whereas donor strain B cells were not. Bottomly and Janeway (1989) 
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[59] subsequently argued that these experiments demonstrated the failure of B 
cells to prime the subset of T cells responsible for providing help for B cell 
antibody production (T h2). They reasoned that the experiments did not 
demonstrate a failure to prime the CD4 + T cells which proliferate in response to 
antigen and which actively suppress B cell responses (Th 1). 
1.4.2.3 Other models 
Macatonia et al (1987) [282] showed that B cells which expressed antigen 
after skin painting failed to transfer sensitization for delayed-type 
hypersensitivity. Dendritic cells possess this property [239] and are able to 
stimulate T cells in vitro [282]. 
1.4.3 Overview 
The in vitro data suggest that activated B cells are capable of initiating 
primary immune responses and that any activity of resting B cells is attributable 
to 11contaminating 11 activated B cells , or B cells activated during the isolation 
procedure. Clearly then, B cells must be activated by some mechanism before 
they can sensitize resting T cells. This precludes an initiating role for B cells in 
antigen presentation. 
The in vivo data is controversial. The evidence from the anti-µ-treated 
mouse model is consistent with a priming role for B cells as well as a function as 
a clonal expander of T cells. Unfortunately, the function of dendritic cells has not 
yet been examined in this system, so indirect effects of the anti-µ-treatment on 
dendritic cells as well as other explanations may account for the observed differ-
ences. 
The elegant and more biologically 11 clean 11 , chicken chimera model 
suggests that B cells are not able to turn on virgin T cells. However not all the 
properties of different subsets of T cells were examined so further experiments 
need to be undertaken. 
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In Mother Nature's human experimental model, patients suffering from B 
cell deficiencies appear only to be susceptible to those infections handled by 
humoral immune mechanisms. Infections wl1ich are normally controlled by cell-
mediated immune responses, such as those due to viruses, fungi and 
intracellular bacteria, do not occur more frequently than would be expected. In a 
mouse model of imn1unodeficiency, antigen-presenting cell activity is equivalent 
to that of normal mice when tested in vitro, in spite of the B cell deficiencies 
[186] . This suggests that the initiation of T cell responses is unaffected by the B 
cell deficiency. Another soft argument is teleological. Examination of the 
immunoglobulin supergene family gives sor11e clues to the evolutionary 
development of T and B cells. The imrnunoglobulin heavy chain may have arisen 
as a duplication of the T cell receptor and may, in fact, be regarded as a 
secreted T cell receptor. (This would have conferred a survival advantage in that 
the actions of immunoglobulins would occur at sites distant from, and possibly, 
inaccessible to the cellular components of the immune system. The requirement 
for T cell help in the production of antibodies to most antigens is consistent with 
more recent development of B cells, and possibly, the co-evolution of a subset 
of T cells concerned with antibody synthesis, isotype switching etc.) The 
question therefore arises, what turned on T cells before B cells had evolved? 
Assuming that B cells evolved after T cells, it suggests that at least at one stage 
in evolution, B cells were not present to initiate T cell responses. Although there 
are conflicting claims for the role of B cells as antigen-presenting cells in vitro 
and in vivo, the bulk of evidence points to a secondary role. 
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1.5 EPITHELIAL CEL.L ANTIGEN PRESENTATION 
Since the initial demonstration of Class 11 M HC protein expression on 
guinea pig [512], murine [363] and human [ 418] small intestinal epithelium, 
there has been considerable interest in the possible role of such cells in the 
induction and control of lamina propria and intra-epithelial immune responses 
[reviewed in 45, 62, 31 O]. The following discussion will consider the normal and 
abnormal expression of these molecules on epithelial cells, and their possible 
role in antigen presentation. It will be argued that aberrant expression of Class II 
MHC proteins is a response to inflammation rather than being an initiator of it. 
These molecules may play a role in immune regulation, either positively or 
negatively, but play a n1inor role in the induction of primary T cell responses. 
1.5.1 Normal expression of Class II MHC molecules on gut 
epithelium 
Class II MHC surface antigens are either not detectable [312, 437, 484] or 
expressed weakly [358] on the gastrointestinal epithelium during foetal develop-
ment. After birth the expression of these molecules increases and reaches adult 
levels at about one month of age [312, 345]. In some species, increasing 
expression coincides with weaning [312] . A role for environmental 
immunological stirnuli in the induction of epithelial Class II MHC expression is 
also suggested by the absence of these determinants in germ-free animals [79], 
and in foetal gut grafts placed under the renal capsule [312]. Expression is also 
temporally related to the ability to induce oral tolerance [ 45]. 
In adult animals of most species studied, the pattern of distribution is 
similar. The Class 11 determinants are expressed by small intestinal villous 
epithelium [ 418, 420, 436], and follicle-associated epithelium [ 42] . The 
molecules are present on the distal two-thirds of the villi, whilst the crypt 
epithelium normally does not have detectable levels [ 418], unless directly 
adjacent to lymphoid nodules [ 436] . Both immunofluorescence and electron 
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demonstrated expression along the basolateral membrane and on the microvilli 
of the apical surface [157, 418], as well as intra-cytoplasmic staining. 
The epithelia of the stomach and the colon are generally negative [110, 
157, 418, 420, 421, 314], again with the exception of cells directly associated 
with lymphoid tissue in the human [ 436]. 
1.5.2 Function of epithelial Class II MHC determinants 
The pattern of staining of Class 11 M HC molecules on the intracellular 
granules of mature absorptive cells of the villus in the small intestine was 
observed to be similar to that of absorbed protein in the gut [312]. These 
similarities suggested that la molecules were involved in the normal pinocytic 
uptake and transport of macromolecules across the epithelial cell barrier in the 
phagolysosome system. Specialized molecules with structural similarities to 
Class I MHC molecules mediate the uptake of lgG from maternal milk [427] and 
are involved in the transepithelial transportation of immunoglobulins (Table 1.1 ). 
If Class II antigens did play a role in the absorption of luminal macromolecules, 
polymorphism and regional variations in expression could result in differences in 
their handling. These, in turn, may confer susceptibility to hypersensitivity 
diseases involving the gastrointestinal tract [312]. The recent elucidation of the 
structure of the Class I MHC molecule, HLA-A2 [44], makes it unlikely that the 
Class II M HC molecules (which probably have a similar antigen-binding site [66]) 
play a role in the transportation of macromolecules. However, it is still possible 
that epithelial cells mediate genetically-restricted Class II-dependent 
transportation and presentation of luminal antigens to intra-epithelial 
lymphocytes or the cells of the lamina propria [ 45, 62]. 
1.5.3 Abnormal expression of Class II MHC molecules 
A large number of natural and experimental stimuli result in increased 
levels or de nova expression of Class II MHC determinants in the gut epithelium. 
Examples include graft versus host disease [25, 299], graft versus host reaction 
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[145], Trichinella spiral is-induced inflammation [25], topical application of a 
contact allergan [200], coeliac disease [16, 419], inflammatory bowel disease 
[110,314, 374, 421] and infections eg. Campylobacter pylori gastritis [362]. The 
expression of Class II MHC appears to be mediated by IFN-1 [79] and may be 
modulated by intra-epithelial lymphocytes [79, 419]. 
Similar observations have been made in many other epithelia. For 
example, keratinocyte Class II MHC expression is induced by graft versus host 
disease [25, 32, 299], by the topical application of contact sensitizing agents 
[200], and by infections [ 4 72]. There are many more examples of aberrant Class 
II MHC antigen expression in the literature. 
1.5.4 Expression of Class II MHC subregion products 
In human foetal gut epithium, HLA-DR antigens may be expressed 
weakly, if at all. There is no evidence however, that the other subregion products 
(-DP or -DQ) are expressed [358]. In contrast to the universal presence of HLA-
DR in histologically normal adult gut epithelium, HLA-DP is seen rarely, and -DQ 
is almost never seen [ 419]. In gluten-sensitive enteropathy, there is increased 
expression of the subregion products in the order -DR> -DP> -DQ, with -DQ 
expression only occurring in patients who have a high epithelial density of T 
cells. 
1.5.5 Functional significance of aberrant Class II MHC antigen 
expression 
The interest in aberrant expression of Class 11 M HG has arisen because of 
the theoretical possibility that epithelia expressing these molecules could act as 
"non-professional 11 antigen-presenting cells. The immune responses initiated in 
this manner may be normal and result in the elimination of a luminal pathogen or 
result in systemic hyporesponsiveness ie. the induction of oral tolerance, for 
example, by Ts cell induction. Alternatively, the responses may be abnormal and 
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result in uncontrolled reactions and disease eg. inflammatory bowel disease or 
auto-immune disease [58, 146, 193]. 
There is a paucity of information on the functional role of aberrant Class II 
MHC molecules on the intestinal epithelial cell, so I will first examine the evidence 
for a role of the epithelial cell in auto-immune disease. 
1.5.5.1 Thyroid auto-immune disease 
Hanafusa et al (1983) [146] observed that thyroid epithelial cells from 
thyroidectomy specimens of patients suffering from auto-immune disease had 
aberrant expression of HLA-DR antigens. A hypothesis about the induction of 
endocrine auto-immunity was then proposed [58]: an unidentified environmental 
stimulus (eg. a viral infection with resultant IFN--y production) would induce 
epithelial HLA-DR expression. These molecules would then present auto-
antigens (eg. hormone receptors) to the immune system with subsequent 
activation of auto-reactive effector T and B cells. Other factors such as 
abnormalities of Ts pathways, may also be permissive in the development of 
overt auto-immune disease. This hypothesis was supported by observations 
that Class II MHC-bearing thyroid epithelial cells presented viral peptide antigens 
(but not intact virus) to antigen-specific cloned human T cells [277]. 
Furthermore, clones of T cells derived from thyroid glands of patients with 
Graves' disease were auto-reactive [276]. 
A number of factors, however, suggested that the aberrant expression 
was a secondary phenomenon related to the release of I FN--y by T cells. 
Although the initial proposition was that lectins such as PHA, Con A or 
pokeweed mitogen (PWM) could induce Class 11 M HC expression on thyrocytes 
directly [379], it became apparent that this effect was mediated by IFN--y [102, 
193, 503]. Furthermore, in contrast to initial reports [146], in vivo thyroid follicular 
cell Class II MHC antigen expression was always associated with lymphocytic 
infiltration [143, 503]. Finally, aberrant expression was not an exclusive property 
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of thyrocytes in auto-immune disease, but could be observed in other diseases 
[143]. Regardless of the underlying disease, the antigen-presenting cell activity 
of Class II MHC antigen-bearing thyrocytes was similar (assayed in the MLR 
under non-stringent conditions) . This resulted in a modification of the original 
hypothesis: that Class II MHC expression was an essential but insufficient factor 
for the induction of auto-immunity [143]. Since cultured intra-thyroidal T 
lymphocytes proliferated specifically in response to autologous Class II MHc+ 
thyroid follicular cells only in Graves' disease, it was postulated that auto-antigen 
presentation occurred only in auto-immune disease. The nature of the other 
necessary components is unclear. 
Other investigators have demonstrated weak autologous MLR stimulatory 
activity [96] and weak antigen-presenting activity [103] of Class II MHC+ thyroid 
cells or thyroid cell lines [160]. However it is possible that these results were due 
to contaminating cells in either the stimulating or responding cell populations. 
For example, Davies (1985) [96] induced Class II MHC expression on thyroid 
cell monolayers with the lectin, PHA, implying at least a significant T cell 
contamination. Dendritic cells have been demonstrated histologically in the 
thyroid [203] and may be the cell responsible for the observed stimulation. 
Subsequent work from the same group showed that a cloned rat thyrocyte line 
was able to stimulate the syngeneic MLR [160]. In these experiments there was 
considerable background proliferation in the responder cell populations raising 
some questions about methodology. 
In contrast to the work on human thyroid follicular cells, workers using 
murine cells could not demonstrate antigen presentation in vitro (testing both 
antigen-specific responses and the allogeneic MLR), in spite of the IFN--y-
induced expression of Class II MHC surface proteins [102]. A murine thyroid 
epithelial cell line, which had been induced to express la antigens with IFN--y, 
was also ineffective in stimulating a primary allogeneic MLR in the absence of a 
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co-stimulatory signal (which was PMA and not IL-1) [440]. Other researchers 
have suggested that the role of Class 11 M HC expression on non-lymphoid cells 
may be to induce tolerance against self-antigens and that auto-immune disease 
is the result of an antigen-specific Ts cell defect [193, 194, 258]. Alternatively, it 
is possible that enhanced expression of Class II MHC antigens in auto-immune 
disease merely reflects the involvement of effector T cells in tissue pathology 
[329] and has no pathogenic role. 
1.5.5.2 Histological studies 
Further evidence against a role for aberrant expression on non-lymphoid 
cells in the induction of immune responses is provided by histological studies 
examining the time course of Class 11 M HC expression in various disease states. 
For example, in cutaneous graft versus host disease [32] and gut graft versus 
host reaction [145], there was no evidence to suggest that the induction of Class 
II MHC antigens triggered the target tissue phase of the disease. The data 
suggest that the HLA-DR expression was the result of the infiltrates. Similarly, in 
skin biopsies from patients suffering from alopecia areata, an organ-specific dis-
order thought to involve auto-immune mechanisms, lymphocyte and 
macrophage infiltration consistently preceded ectopic H LA-DR expression on 
keratinocytes [226]. In addition in the human colon, epithelial expression of 
Class II M HC antigens was a non-specific response to inflammation and only 
occurred in association with lymphoid infiltrates in both infective colitis and 
inflammatory bowel disease [314]. 
1.5.5.3 Studies in transgenic mice 
A recent paper from Markman et al (1988) [295] provides further 
evidence against a role for epithelial cells in antigen presentation. In a transgenic 
mouse model, beta cells of the pancreatic islets expressed Class II MHC 
molecules (1-E) whilst bone marrow-derived cells did not. Foetal pancreatic 
grafts from 1-E+ transgenic mice into naive 1-E- mice were accepted indefinitely, 
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indicating that the 1-E+ beta cells were incapable of initiating an immune 
response. If the recipients were primed with splenic cells from wild-type 1-E+ 
mice, the grafts from the 1-E+ transgenic mice were rejected, whilst their 1-E-
littermates survived. This showed that the 1-E proteins could be recognized by 
the host immune cells when presented by effective antigen-presenting cells. 
In vitro the 1-E+ beta cells were unable to stimulate T cells reactive to 1-E 
plus a peptide antigen. In fact, antigen-specific unresponsiveness was induced. 
These observations suggested that the expression of Class 11 M HC antigens on 
non-lymphoid cells played a regulatory role and was involved in the maintenance 
of self-tolerance. T cell activation would be induced if other factors overcame the 
T cell paralysis. 
More recent papers [50, 27 4] also cast doubt on the Bottazzo-Feldmann 
hypothesis of autoimmunity. These authors used transgenic mice expressing I-A 
or 1-E, on pancreatic islet or acinar cells respectively, to show that the 
expression of Class II M HC antigens did not independently trigger an auto-
immune attack. In contrast to Markham et al (1988) [295] and Lo et al 1989 
[274], Boehme et al (1989) [50] did not demonstrate tolerance to the 
"allogeneic" Class II molecules. 
1.5.6 In vitro studies of gut epithelial cell antigen presentation 
Considering the interest in the expression of Class II MHC molecules on 
intestinal and other epithelia and their putative function in vivo, there are 
surprisingly few reports examining intestinal epithelial cell antigen presentation 
[48, 49, 308, 431]. Bland (1988) [45] attributes this to methodological problems, 
namely that enterocytes are friable, terminally differentiated, highly polarized and 
do not survive in culture for more than a few hours. 
Bland and Warren (1986) [ 48] showed that isolated rat enterocytes in 
continuous culture with sensitized lymph node-derived T cells did not stimulate 
proliferation in the presence of the specific antigen. They proposed that epithelial 
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cells activated antigen-specific Ts cells or other suppressive factors which 
inhibited proliferation. By using discontinuous cultures (ie. by removing the 
presumably dead enterocytes after 18 h), antigen-specific T cell proliferation was 
demonstrated. Anti-la anti-sera inhibited these secondary responses. Significant 
proliferation in the absence of stimulator epithelial cells indicated 11contamination 11 
of the responder cell population. Subsequent experiments demonstrated that 
enterocytes mediated suppression by antigen-dependent and -independent 
mechanisms. Antigen-specific inhibition was conferred by the induction of cos+ 
cells and was also blocked with antibodies to Class 11 M HC antigens. The origin 
of these cells was not determined. 
The authors suggested that epithelial cell presentation of antigen to the 
intra-epithelial lymphocyte was a possible mechanism of oral tolerance 
induction. Furthermore, increased expression of epithelial cell la antigens during 
inflammation would result in aberrant presentation of enterocyte antigens and 
the subsequent generation of cytotoxic activity. 
Mayer and Schlien (1987) [308], using freshly isolated human colonic 
epithelial cells induced both primary (allogeneic MLR) and secondary (antigen-
specific) activation in responder lymphocytes. These results are surprising given 
the failure of other investigators to demonstrate Class II M HC expression on the 
normal colonic epithelial cell (see Section 1.5.1 ). 
In further experiments, a colonic adenocarcinoma cell line (DLD1) stim-
ulated a primary MLR following the induction of Class II MHC molecules by IFN-
"f. Like Bland and Warren (1986) [ 48], they demonstrated preferential stimulation 
of cos+ Ts lymphocytes but these cells inhibited both T and B cell responses in 
an antigen-non-specific manner. Of even more interest was the observation that 
colonic epithelial cells obtained from patients suffering from inflammatory bowel 
disease (and with increased expression of HLA-DR, -DP and -DO) preferentially 
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stimulated CD4 + cells with the implication that the enterocyte played a role in 
immunoregulation [307]. 
Other workers using a colonic carcinoma cell line (HT-29) after inducing 
HLA-DR (-DP and -DO), could not detect MLR stimulatory activity [431]. It is not 
clear whether these conflicting results are a manifestation of the properties of 
different cell lines or whether they represent methodological problems. 
In any case, the arguments that Class II MHC antigen expression on the 
small intestinal epithelial cell plays a role in oral tolerance induction or, altern-
atively, in the initiation of T cell-mediated immune responses fail to explain the 
following observations: 
(i) oral tolerance can be induced by intrarectal instillation of antigen [S. 
Strober, PhD Thesis, cited 330]. 
(ii) T cell-mediated immune responses directed against gluten in patients 
suffering from coeliac disease can also be elicited by intrarectal 
administration of the appropriate antigen [275]. Neither the colonic 
nor the rectal epithelial cell expresses Class II MHC antigens, so 
they are apparently not essential for the responses described 
above. 
Arguments that antigen could be presented by the follicle-associated 
epithelium (FAE) which does express Class II MHC antigens would need to 
account for the observed interspecies differences, eg. rat FAE does not express 
Class II MHC [312] and the patchy or absent expression of Class II MHC 
antigens on M cells [ 43, 61]. 
1.5. 7 Conclusions 
What then is the function of epithelial cell la expression? It is appealing to 
propose immunoregulatory positive or negative feedback loops activated by 
Class II MHC molecules on epithelial cells. An alternative explanation is that 
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increased expression of these determinants enhances retention of sensitized T 
cells at sites of antigen deposition [ 442]. In secondary immune responses, 
CD4 + lymphoblasts are responsive to antigens presented with Class 11 M HC 
molecules on any cell, so that local induction of la focuses even further the 
effector responses at the inflammatory site. 
Intestinal (and other) epithelial cells lie at the interface between self and 
non-self where they are in an ideal position to regulate immune responses. 
Supporting evidence for such a role is provided by the detection of Class II MHC 
surface antigens and the ability to produce IL-1 [46]. The weight of experimental 
evidence in four separate epithelial systems (thyroid, skin [128], pancreas and 
gut) mitigates strongly against a role for the epithelial cell in primary T cell activ-
ation. A role in secondary immunoregulatory circuits is yet to be proven. 
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TABLE1.1 
IMMUNOGLOBULIN GENE SUPERFAMIL Y 
[Modified from 511] 
Molecule 
lmmunoglobulins: 
Heavy chains 
Kappa light chain 
Lambda light chain 
T cell receptor complex: 
a chain 
/3 chain 
'Y chain 
o chain 
CD3: 
'Y chain 
o chain 
E chain 
MHC proteins: 
Class I (a chain) 
Class II (a, f3 chains) 
/32-microglobulin 
Ligand or molecular 
association 
Antigen 
Antigen/MHC protein 
complex 
T cell receptor (TCR) 
TCR 
a chain - CDS 
-CD4 
Class I a-chain 
Function 
Antigen recognition 
Antigen recognition 
Signal transduction 
Antigen presentation 
T cell adhesion molecules: 
CO2 
LFA-3 (C058) 
T cell subset markers: 
CD4 
COB 
Neural molecules: 
Neural adhesion 
molecule (NCAM) 
Myelin associated 
glycoprotein (MAG) 
PO myelin protein 
LFA-3 
CO2 
Cell adhesion 
CO2 present on T cells, 
LFA-3 on accessory or 
target cell 
Stabilization of 
MHC Class II TCR - antigen - MHC 
MHC Class l-0'.3 domain protein complex and 
signal transduction 
NCAM (C056) Neural cell adhesion 
? Myelination 
Myelin protein 
lntercellular adhesion molecules: 
ICAM-1 (C054) Leucocyte function Adhesion 
ICAM-2 antigen (LFA)-1 
.82-microglobulin-associated-proteins: 
Tl heavy chain Not known Not known 
Oa heavy chain 
C01 a heavy chain 
Brain/lymphoid antigens: 
Thy-1 Not known Not known 
MRC OX-2 
lmmunoglobulin receptors: 
Poly lg R Multimeric lgA, lgM Epithelial transport 
Fc12b/y1 R Aggregated lgG 
Tumour antigen: 
Carcinoembryonic antigen 
(CEA) 
Growth factor receptors: 
Platelet-derived growth factor 
(PDGF receptor) 
Colony stimulating factor-1 
receptor 
Link protein: 
Not known 
PDGF 
CSF-1 
Vaccinia virus haemagglutinin [201 ] 
Cytomegalovirus proteins [29] 
Not known 
Cell division, etc 
Cell division, etc. 
Binding molecule 
between proteoglycan 
and hyaluronate chain 
TABLE 1.2 
INTEGRIN RECEPTOR SUPER FAM IL V 
[Modified from 408] 
Molecule 
LFA-1 family: 
Common /3 chain (CD18) 
LFA-1 a chain (CD11 a) 
Mac-1 (CD11 b) 
p150,95 (CD11 c) 
VLA (very late antigens 
of activation) family: 
Common f3 chain (CD29) 
VLA-1 
-2 (CDw49b) 
-3 
-4 (CDw49d) 
-5 
-6 (CDw49f) 
Glycoproteins llb/llla 
Ligand 
ICAM-1 -2 
' 
C3bi 
Fibrinogen 
Fibronectin 
von Willebrand factor 
Vitronectin 
Function 
Cell-Cell adhesion 
Complement binding 
Cell-Cell adhesion 
Cell adhesion, 
phagocytosis 
Platelet gplla 
Adhesion to collagen 
Fibronectin receptor 
Laminin receptor 
Platelet aggregation 
TABLE 1.3 
PHENOTYPE OF MURINE DENDRITIC CELLS 
Antibodies Specificity 
33D1 
TIB120 
821-2 
10-2.16 
11-5.2 
M1/42 
NLDC 145 
2D2C 
F4/80 
M1/70 
(Mac-1) 
2.4G2 
DC 
Class II MHC 
Class I MHC 
IDC 
Pgp 
F4/80 antigen 
C3bjR 
Spleen 
s 
+ 
+ 
s 
+ 
+ 
+ 
Origin of Dendritic Cell 
VC LN Thymus Skin PP 
s + + 
+ + + + + 
+ + 
+ + + + + 
+ + 
+ 
+ 
+ + 
J11d "8 cell" 
RA3-3A 1 /6.1 8 cell, 8220 
13/2 Common leucocyte 
53-6.7 CDS 
GK1 .5 (CD4) 
85.3 (Thy1) Other T cell 
30-H12 
(Thy 1.2) 
S100 
MAC-2 
MAC-3 
antigens 
Macrophage 
Macrophage 
s 
+ 
s 
+ 
s 
s 
s 
s 
+ 
s 
s 
+ 
+ 
+ 
[Adapted from References: 
93,244,319,355,388, 400,402,405, 416, 433] 
Abbreviations: DC dendritic cell 
IDC interdigitating cell 
vc veiled cell 
LN lymph node dendritic cell 
pp Peyer's patch dendritic cell 
s Subset of cells 
+ 
+ 
+ 
+ 
+ 
TABLE 1.4 
Dendritic Cell Properties 
Oxidative mitogenesis (periodate) 
Mitogen-induced T cell proliferation 
Antigen-induced T cell proliferation 
Syngeneic MLR 
Allogeneic M LR 
Formation of T cell clusters 
Induction of lymphokine release 
Induction of cytotoxic T lymphocytes 
Direct activation of CDS+ T cells 
References 
23,60, 136,227,231,232,241,487,519 
12, 24,136,142,184,212,235,241,521 
12*,80, 184, 213,217,223*,322*,462, 
463,469,487 
(Particulate antigens *) 
142,149,178,231,241,251,353,384, 
485,487 
12,142,149,179,182,185,190,231, 
237,241,251,259,317,319,343,381, 
384,412,413,444,451,463,485,487, 
519,521 
24,118,142,179,180,182,184,185, 
186,227,241,245,246,319,353 
23, 24,108,178,179,182,184,185,186, 
188,190,241,319,381,462 
215,283,354,398 
52, 53,190 
T cell-dependent antibody responses 121, 178, 183, 186, 187, 188, 241, 242, 
414 
Clonal expansion of lymphocytes 151, 260 
Graft rejection eg. 112, 119, 192,264,316 
Contact- and delayed-type hypersensitivity 64, 208, 211, 236, 386, 460, 461 
Reversal of specific immune response defect 55 
LEGENDS TO FIGURES 
Figure 1.1 Cell surface molecules 
Figure1.1a 
Representation of the alignment of complementarity determining regions 
(CDHs) in a hypothetical T cell receptor (TCR) (top of figure) over a 
peptide-MHC complex (bottom of figure) . This figure demonstrates the 
complementarity between the two surfaces and the alignment of CDR-1 
and CDR-2 (green, top figure) with the helices of the MHC molecule 
(yellow, bottom figure) and of CDR-3 (pink, top figure) with peptide 
determinants (pink, bottom figure). [Adapted from 97]. 
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Figure1.1b 
Binding of T cell surface molecules to specific ligands on the antigen-
presenting cell. The T cell receptor (TCR)-CD3 complex interacts with 
antigen in association with MHC molecules on the antigen-presenting cell. 
CD4/8 interact with MHC Class 11/1 molecules respectively. LFA-1 
interacts with ICAM-1 and -2 whilst CO2 interacts with LFA-3. [Modified 
from 39]. 
i 
I 
T Lymphocyte 
TCR 
CD4/8 CO2 
ICAM -1,2 MHC 
Class 11/1 
03 
LFA-3 
Antigen-presenting Cell 
·._ .. :: .... •. ·,:: :1_ ... -~ • 
Figure 1.2 
lmmunoperoxidase staining of parallel sections of murine small intestine 
using the antibodies: (a) F4/80 (anti-macrophage); and (b) TIB120 (anti-
Class II MHC). The methods are described in references 169, 172, 173. In 
brief, the tissues were fixed in periodate-lysine-paraformaldehyde (2%), 
embedded in O.C.T. compound and stored at -20°c. lmmunoperoxidase 
staining was carried out using the avidin-biotin-peroxidase (ABC) method 
with reagents supplied by Vector Laboratories (Burlingame, CA). The 
slides were prepared by Dr W. Allan. Both antibodies, F4/80 and TIB120, 
stain the intestinal lamina propria macrophages, whilst TIB120 appears to 
stain an additional population of irregular intestinal lamina propria cells 
(presumptive dendritic cells) and the epithelium. Both antibodies are rat 
lgG2b· 
a 
b 
CHAPTER 2 
THE DEVELOPMENT OF THE DISAGGREGATION TECHNIQUE AND 
PRELIMINARY CHARACTERIZATION OF THE INTESTINAL 
ANTIGEN-PRESENTING CELL 
11Take your hare when it is cased ... 11 
From ''The Art of Cookery" 
Hannah Glasse fl 17 4 7 
Usually misquoted as "First catch your 
hare". 
2.1 INTRODUCTION 
Prerequisites for the demonstration of antigen-presenting cell activity in 
disaggregated intestinal lamina propria cell suspensions include the 
development of the methodology for obtaining representative, viable and 
functional lamina propria cells and the characterization of an assay system, in 
this case the allogeneic MLR. This chapter describes the method for 
disaggregating intestinal lamina propna and outlines the functional 
characteristics of the MLR. 
The disaggregated cell suspension was initially shown to contain cells 
which could both induce and respond to mitogen-induced T cell activation. The 
MLR stimulatory activity of the cells was then assessed and found to be compar-
able to that of splenic cell preparations. Using cell depletion techniques, the MLR 
stimulatory cell was shown to express Class II MHC surface antigens but did not 
bear the surface markers or have other characteristics of T cells, B cells or 
macrophages. Finally, lamina propria cell suspensions were found to have 
greater antigen-presenting cell activity when directly compared to Peyer's patch 
cells. 
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2.2 MATERIALS AND METHODS 
2.2.1 Mice 
C57BL/6 and BALB / c mice were bred and maintained under specific 
pathogen free (SPF) conditions in the Animal Breeding Establishment of the 
John Curtin School of Medical Research, Australian National University or were 
purchased from the Animal Production Area of the NCI-Frederick Cancer 
Research Facility, Frederick, MD and maintained specific pathogen free at the 
Department of Cell Biology, M.D.Anderson Hospital and Tumor Institute, 
Houston, TX. Mice of both sexes aged between 8-16 weeks were used. 
2.2.2 Media 
Calcium- and magnesium-free Hank's balanced salt solution (CMF-
HBSS), supplemented with penicillin (100 U/ml) and gentamycin (60 U/ml) was 
used for isolation of cells from the lamina propria. Where indicated 0. 75 mM 
EDTA (Fluka, Buchs, Switzerland) was added. RPMI 1640 was supplemented 
with 2 mM L-glutamine (Sigma, St Louis, MO), penicillin (100 U/ml), gentamycin 
(60 U /ml) and 10% heat-inactivated foetal calf serum (FCS) (Flow Laboratories, 
Melbourne, Victoria). For cell culture experiments, 0.01 mM 2-mercaptoethanol 
(2ME) (BDH Chemicals Pty Ltd, Sydney, NSW) was added. 
2.2.3 Mouse tissues 
The small intestine or colon was dissected from C57BL/6 mice. The 
luminal contents were expressed, and where indicated the Peyer's patches were 
removed under a dissecting microscope. The intestine was split lengthwise and 
then cut into 1 cm segments. After brief washing in CMF-HBSS to remove 
remaining luminal contents, the intestines were placed in a Wheaton stirring flask 
and washed gently for 2-2.1 /2 h in CMF-HBSS with EDTA at 37°C. During this 
time, the medium was changed every 10-15 min until no increase in particulate 
matter was visible in the supernatant. Finally, after a 5 min wash in RPMI, the 
tissue was finely chopped, weighed and added to an enzyme cocktail containing 
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1.2 U/ml Dispase II (Boehringer-Mannheim, Tutzing, FRG), 10 U/ml collagenase 
CLSPA (Cooper Biomedical, Malvern, PA) and 5 U/ml DNase Type II 
(Calbiochem, Behring Diagnostics, La Jolla, CA) in glass Petri dishes siliconized 
with Coatasil (Ajax Chemicals, Sydney, NSW). Maximal yields were obtained 
when < 500 mg tissue was digested with 20 ml enzyme mixture. After 2-3 h 
incubation at 37°C under 5% CO2 with occasional gentle agitation, the digested 
tissue was mechanically disrupted by passage through a fine mesh stainless 
steel sieve. The cell suspension was then passed through six layers of cotton 
gauze to remove any particulate matter and washed three times. If necessary, 
the cells could be pelletted in RPMI 1640 containing 20% FCS and kept 
overnight at 4°C for use the next day without loss of antigen-presenting activity. 
Epithelial cells to be used as MLR stimulators were obtained by 
harvesting the supernatants from the EDTA-CMF-HBSS washes (after 
discarding the first two or three which contained excessive mucus and debris). 
FCS was added immediately to the supernatants which were centrifuged, 
resuspended in culture medium and pooled for use in M LR stimulation 
experiments. 
Spleen cells were obtained by passing spleens from C57BL/6 mice 
through a fine mesh stainless steel sieve, then centrifuging over Ficoll-Hypaque 
(Pharmacia, Uppsala, Sweden) (600g for 30 min at 20°C). The cells from the 
interface were washed, treated with mitomycin C (see below) and used in the 
MLR. 
Mesenteric lymph node (MLN) cells to be used as responders were 
removed from BALB/c mice, pushed through a fine mesh stainless steel sieve, 
washed, counted and viability assessed using Trypan blue. They were depleted 
of cells bearing Class II MHC molecules by incubating with a monoclonal 
antibody directed against murine Class II MHC antigens (see Table 2.1) and 
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using the technique of panning (Section 2.2.4). In the initial experiments, 1a+ 
cells were not removed. 
2.2.4 Panning to remove cells expressing particular antigens 
Bacteriological grade 90 mm Petri dishes were pretreated with 5 ml 
1/1000 rabbit anti-rat heavy and light chain lgG (RAR), (Nordic, Tilburg, The 
Netherlands), in phosphate-buffered saline (PBS) for 45 min at 4°C. The 
unbound antibody was removed by washing four times in PBS. Cells were 
incubated with a saturating amount of monoclonal antibody for 30 min at 4°C. 
After three washes, the antibody-binding cells were removed by panning [520]. 
After removing the unbound monoclonal antibody, 20-30x106 of the labelled 
cells suspended in 5 ml PBS/5% FCS were added to the RAR antibody-coated 
plates. Plates were kept for 75 min at 4°C and the non-adherent cells removed 
by gentle agitation and aspiration, centrifuged, then reapplied to a second RAR-
coated dish for another 75 min at 4°C. The remaining non-adherent cells were 
removed, washed, counted and used immediately or pelletted and kept 
overnight at 4°C. 
Antibodies used for cell depletion, immunocytochemistry and flow cyto-
metry included the culture supernatants of hybridoma cell lines secreting mono-
clonal antibodies listed in Table 2.1. 
2.2.5 Mitogen-induced proliferation of lamina propria cell suspen-
sions 
Concanavalin A (con A) (Sigma, St Louis, MO) and phytohaemagglutinin 
(PHA) (Commonwealth Serum Laboratories, Melbourne, Victoria) were added to 
constant numbers of disaggregated lamina propria cells (1 x1 o5 - 1 x1 o4 well) in 
varying concentrations (con A 0.05-50 mg/ml; PHA 0.4-400 mg/ml) and cultured 
for 2-3 days in flat-bottom 96-well plates. One microCurie of tritiated thymidine 
was added to each culture for the final 8 h. The contents of the wells were 
freeze-thawed and the cells harvested automatically onto glass fibre discs 
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(Whatman, Maidstone, UK) using a Dynatech CH-103 cell harvester. The assay 
was performed on a Packard TriCarb K60 scintillation counter following the 
addition of 5ml scintillant (0.5% 2,5-diphenyloxazole (PPO) in xylene). 
2.2.6 Mixed Leukocyte Reaction 
Cultures were performed in round-bottom 96-well plates (Linbro Flow 
Laboratories, McLean, VA). A constant number of responder MLN cells (2x1 o5) 
was incubated with varying numbers of stimulator cells (from the intestine or 
spleen). Cell proliferation in the stimulator population was prevented by 
pretreatment with mitomycin C (Sigma, St Louis, MO.) (5x106 cells/ml were 
incubated with mitomycin C at a final concentration of 25 mg/ml for 45 min at 
37°, then washed three times) or exposed to 2,500-3,000 Rads irradiation. The 
reaction was carried out in a total volume of 0.2 ml medium (see above). After 
four days, 1 µCi tritiated thymidine (Amersham Australia, Surry Hills, NSW or 
New England Nuclear, Boston, MA.) was added to each well and the incubation 
continued for a further 16 h. The plates were freeze-thawed and the cells 
harvested automatically onto glass fiber discs and counted as described in 
Section 2.2.5. 
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2.3 RESULTS 
2.3.1 Development of the disaggregation technique 
Application of previously published techniques for obtaining lamina 
propria cell suspensions (eg. Davies and Parrott, 1981 [95]) gave inconsistent 
results, so the methods were modified. The many variables examined included 
the use of mucolytic agents eg. dithiothrietol (OTT), type and concentration of 
enzymes, the length of incubation, the receptacle used for disaggregation, the 
medium used, the presence or absence of FCS, and the amount of tissue 
digested in a given volume of enzyme mixture. Figure 2.1 summarizes data from 
40 experiments examining cell yields in relation to the type and concentrations of 
enzymes and the length of incubation. Effective removal of the epithelial 
monolayer by washing with EDTA was confirmed by histological examination of 
the specimens on several occasions. The final technique is described in Section 
2.2.3. 
Factors critical to the successful application of the isolation procedure 
included: careful dissection of the intestines to ensure removal of blood vessels 
and fatty tissue; frequent washing in low concentrations of EDTA, the inclusion 
of DNase (to prevent cell clumping) and FCS (presumably to inhibit cytotoxic 
proteases [164]); the use of Petri dishes (rather than a stirring bar which was 
associated with poor viability); and siliconization to prevent loss of adherent cells 
during the enzymatic digestion. One of the most important factors was the 
amount of tissue digested (PG Holt. Personal communication). When more than 
500 mg tissue was digested in 20 ml enzyme mixture, cell yields and viability 
dropped considerably. For example, in one experiment, adding 400 mg tissue to 
20 ml enzyme mixture yielded 53x106 viable cells/g with 78% viability; adding 
1.02 g to the same volume resulted in 4x106 viable cells/g with < 10% viability. 
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2.3.2 Recovery of lamina propria and mesenteric lymph node cells 
Using the optimal procedure described in Section 2.2.3, disaggregation 
of intact small intestinal mucosa resulted in yields of 17 +4x106 per mouse (mean 
+ standard deviation, n=204 mice) with 78+16% viability as determined by 
Trypan blue exclusion. When the lamina propria and Peyer's patches were 
disaggregated separately, the average yield was 11.5+4x106 /mouse (n = 56) for 
Peyer's patches and 7 +3x 106 /mouse (n = 59) for the lamina propria. The yield 
from the colon was 7x106 cells/rnouse (n = 18) and from mesenteric lymph 
nodes was 39x106 /mouse. Following panning to remove cells expressing Class 
II M HC antigens (Tl B 120), the average yield of mesenteric node cells was 
52+7%. 
The yields of cells differed between the two institutions where the work 
was performed (the John Curtin School of Medical Research {JCSMR} and the 
MD Anderson Hospital and Tumor Institute {MDA} ). Yields of cells were 
compared using the Student's t test The differences were found to be 
statistically significant. Lamina propria yields were 7.0+3.0x106 /mouse at 
JCSMR versus 3.0+1.3x106/mouse at MDA (p<0.001) and Peyer's patch yields 
11.5+4.0x106/mouse at JCSMR versus 7.2+1.9x106/mouse at MDA (p<0.02). 
These data supported the visual observation that the number and size of Peyer 's 
patches was substantially greater at JCSMR than at MDA. This variable could 
reflect differences in feeding, or the nature of normal flora in mice in the two 
institutions. There was no clear functional difference between dendritic cells 
isolated in the two institutions, however. 
2.3.3 Mitogen-induced stimulation 
Isolated larT1ina propria cell suspensions proliferated in response to the 
mitogens, con A and PHA. Maximal proliferation with con A occurred with 
concentrations between 0.8-3.0 µg/ml for 1 x1 o5 cells/well and with PHA at 
concentrations between 25-50 µg/ml (Fig. 2.2). 
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2.3.4 Characterization of the MLR 
In the initial experiments, untreated or nylon-wool treated MLN cells were 
used. These cells gave unacceptably high background levels of stimulation (the 
syngeneic MLR) reaching a peak of 5-20,000 cpm between days 6 and 7 of 
culture. Removal of la+ cells by panning following incubation with TIB 120 (anti-
Class II MHC) consistently gave background levels of proliferation of < 500 cpm, 
whereas treatment with Tl B 120 alone (without panning) reduced the proliferation 
to half the control value. 
The time course of the MLR was determined using both unfractionated 
spleen and lamina propria cell suspensions as stimulators. Maximum levels of 
proliferation were comparable and occurred between 96-120 h of culture (Fig. 
2.3). To detern1ine whether the MLR stimulatory cells were adherent to plastic, 
splenic or lamina propria cells were cultured overnight and MLR stimulatory act-
ivity compared to cells left as a pellet overnight in RPMI containing 20°/o FCS at 
4°C (Fig. 2.4). Rather than decreased activity, overnight culture resulted in either 
increased or unchanged M LR stimulatory activity. 
2.3.5 Characteristics of mucosal cells stimulating the MLR 
Panning alone, which depletes surface immunoglobulin-bearing cells 
because the second antibody used cross-reacts with mouse immunoglobulin, 
resulted in removal of 41 +6°/o of the mucosa! cells; pretreatment with anti-la, 
57+14°/o. Other antibodies used in combinations (Lyt2, L3T4, F4/80, Pgp-1 and 
anti-mouse irnmunoglobulin), resulted in removal of 76+3%. Removal of la+ cells 
resulted in a shift in the stimulator dose-response curve so that, at low cell 
numbers, four to five times more cells were required to achieve the same level of 
tritiated thymidine uptake (Fig. 2.5). In addition, there was a 90-95% reduction in 
peak MLR stimulation (10.9 vs 113.5x1 o3 cpm at maximal stimulator cell 
number, Table 2.2). Treatment with other antibodies did not reduce the maximal 
MLR response. Cell depletion experiments using panning with 330 ·1 were 
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ineffective because it is not detectable on intestinal dendritic cells (see Chapter 
4) . Complement lysis experiments were not undertaken. In general, removal of 
the T cell (Lyt 2, L3T4, Thy ,-positive) or B cell (surface lg-positive) cells 
enriched for stimulator cells to the expected extent (given the proportion of 
lamina propria cells expressing T or B cell markers). Overnight plastic- or 
fibronectin-adherence decreased the proportion of macrophages to < 2% as 
judged by morphology. Removal of macrophages resulted in a significant 
increase in MLR stimulatory activity of the remaining non-adherent lamina 
propria cells (Fig. 2.6). These results suggest that the MLR stimulator cells in the 
intestinal lamina propria expressed Class II MHC antigens, but lacked the 
characteristics of macrophages, B cells or T cells. 
2.3.6 Epithelial cells as MLR stimulators 
Viability of small intestinal epithelial cells after 3-4 h in culture was < 30%. 
These cells were used in M LR experiments but did not stimulate proliferation 
(not shown). 
2.3. 7 Enrichment of MLR stimulatory cells 
Following the demonstration of M LR stimulatory activity in the lamina 
propria cell suspensions, attempts were made to enrich the antigen-presenting 
cells. Density gradient centrifugation using various concentrations of Percell 
(Pharmacia, Uppsala, Sweden) in both discontinuous and continuous gradients 
was unsuccessful, probably because of co-enrichment of low density 
suppressive cells (see Chapter 3). 
Other attempts at enrichment involved the use of a cocktail of antibodies 
for panning (Lyt2, L3T4, F4/80 and Pgp-1 ), and the use of temporarily adherent 
cells (ie. cells which were adherent to fibronectin-coated gelatinized flasks at 3 h 
but which became non-adherent during overnight culture). Neither approach 
resulted in significant or consistent enrichment. 
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2.3.8 Comparison of MLR stimulatory activity of lamina propria 
cells and Peyer's patch cells 
A comparison of Peyer's patch and non-Peyer's patch lamina propria cell 
suspensions in over 10 experiments consistently showed that the lamina propria 
fraction had 5-10 times greater MLR stimulatory activity per cell (Fig. 2.7). Similar 
results were noted when the incubation times were varied, suggesting that these 
differences were not due to different kinetics of MLR stimulation (Fig. 2.8). 
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2.4 DISCUSSION 
2.4.1 The development of the disaggregation technique 
Initial studies on immune responses in Peyer's patches failed to demon-
strate accessory cell activity in preparations obtained by mechanical dissociation 
[206], so that it was concluded that Peyer's patches were deficient in functional 
accessory cells. Similar observations were made from the study of lung-derived 
cell suspensions [reviewed in 164]. With the development of techniques for the 
enzymatic dissociation of tissue, it was clear that this deficiency was due to the 
failure of mechanical methods to release accessory cells from the connective 
tissue stroma [ 433]. When enzymatic and mechanical methods were directly 
compared, the latter resulted in lower yields, the selection of particular cell types 
and the liberation of suppressive factors eg. prostaglandin E2 [47,92]. 
On the other hand, the use of enzymatic methods in tissue disaggrega-
tion is also associated with particular problems. For example, trypsin treatment, 
amongst other effects [reviewed in 115], resulted in the loss of cell surface 
proteins [399], and impaired cellular cytotoxicity [ 425]. Other enzymes such as 
pronase and papain had variable effects depending on their concentration and 
duration of treatment [92]. Generally, the impairment of cellular function is 
completely reversible with time in culture [132, 225]. 
In spite of these possible adverse effects, enzymatic treatment of murine 
Payer's patch with the neutral protease, Dispase, yielded cell suspensions that 
were capable of accessory cell activity in vitro. Furthermore, Dispase treatment 
of murine splenic dendritic cells did not alter their stimulatory activity [ 433]. 
Treatment with collagenase generally has little effect on cellular function [132] or 
phenotype [166], although occasional batches may be overtly toxic [164]. Since 
broad spectrum proteases and/ or mixtures of enzymes are more efficient for 
tissue disruption than single enzymes alone [ 409], it was decided to examine the 
63 
use of multiple enzymes and the combination was found to give higher yields 
(Fig. 2.1 ). 
The final yields obtained were comparable with those published at the 
time, although methods reporting greater yields have since been published 
[reviewed in 481]. One important difference between our method and that of van 
der Heijden and Stok (1987) [481] is that our final proportion of epithelial cells 
was very low ( < 5%) compared to approximately 25% overall in their study. In 
our experiments the epithelial cells co-purified with other low density cells and 
caused cell losses by clumping, whereas van der Heijden and Stok (1987) were 
concerned with plaque-forming cell assays which presumably were unaffected 
by epithelial cells. 
There are many factors affecting the yield of cells using a particular dis-
aggregation technique. Examples include the age and strain [164], but possibly 
the most important is antigen-exposure. This may affect both the size and the 
cellular composition of Peyer's patches [90, 373, 428]. The use of Peyer's 
patches from specific pathogen-free mice resulted in lower yields when directly 
compared with mice housed in a conventional environment [eg. 287] and 
greater yields were obtained following inoculation with a specific micro-organism 
[77]. Other evidence [98] also points to selective effects of certain infections on 
immune function eg. the ability of dendritic cell-T cell clusters to induce poly-
clonal immunoglobulin secretion by cultures of Peyer's patch lymphoid cells is 
abrogated if the cultured stimulator cells are derived from mice infected with 
mouse hepatitis virus [78]. 
Our results demonstrated a difference in yields between 11SPF11 facilities. In 
addition, over the three year period during which the mouse experiments were 
performed, two viral diseases (ectromelia and mouse hepatitis virus) infected the 
laboratory animals for an unknown period before their discovery. 
64 
Intestinal lamina propria cell suspensions had MLR stimulatory activity 
and were capable of both stimulating and responding to mitogen-induced prolif-
eration. (These observations raise the possibility that significant T cell activation 
occurs in situ rather than, or as well as, in draining lymph nodes, but this 
question was not explored.) 
Attempts to characterize the MLR stimulatory cell confirmed the require-
ment for Class II MHC molecule expression and suggested that the cell was a 
dendritic cell. Attempts to enrich for this cell type were unsuccessful until the 
macrophages were removed from the cell suspension (See Chapter 3). 
An unexpected finding was the consistently greater MLR stimulatory 
activity in the unfractionated cell suspensions from the lamina propria when 
compared to Peyer's patches. In addition, there was clear evidence of inhibition 
of proliferation when large numbers of lamina propria cells were added. This 
raised the possibility of a suppressor cell population and led to the experiments 
in the following chapter. 
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TABLE 2.1 
Antibodies Used in Murine Experiments 
Name Determinant Class Reference 
TIB120 Class II MHC lgG2b J lmmunol 1981; 
1-Ab,d,q 1-Ed,k 
' 
127: 2488 
F4/80 F4 /80 antigen lgG2b Eur J lmmunol 
1981 ; 11 : 805 
M1/70 C3bi receptor lgG2b Eur J lmmunol 
(Mac-1) 1978; 8: 539; 
1979;9:301 
2.4G2 Fe receptor lgG2b J Exp Med 1979; 
150: 580 
IM7 Pgp-1 J Biol Chem 
1983; 258: 1014 
3301 Dendritic cell lgG2b Proc Natl Acad 
antigen Sci USA 1982; 
79: 161 
AT83 Thy 1 lgG2b Dr R Ceredig 
30-H12 Thy 1.2 lgG2b lmmunol Rev 
1979;47:63 
53-6.72 Lyt 2 lgG2a lmmunol Rev 
1979;47:63 
H0-2.2 Lyt 2.2 lgM lmmunogenetics 
1980; 10: 545 
GK-1.5 L3T4 lgG2b lmmunol Rev 
1983; 74: 29 
RA3-3A 1 /6.1 
J11d 
SAM 
B cell glycoprotein 
(8220) 
"B ceW 
Surface lg 
lgM 
lgM 
(sheep antimouse immunoglobulin) 
All antibodies except SAM were rat-derived 
Nature 1981; 
289:681 
J lmmunol 1981; 
127: 2496 
Table 2.2 
MLR stimulation: Comparison of different treatments of stimulator and responder 
cells. 
Stimulator cells (1 x1 o5 /well) and responder cells (2x1 o5 /well) were either 
untreated (control) or treated by incubating with TIB120 at 40c for 30 min and 
washing three times before plating (anti-la); by "panning" on rabbit anti-rat 
immunoglobulin-coated plastic Petri dishes without prior incubation with primary 
antibody (panning); or by incubating with Tl B 120 together with the "panning" 
treatment as described in the text (anti-la/panning) (Section 2.2.4). The figures 
in parentheses refer to the yields following the specified treatment as a 
percentage of the starting cell number. The MLR was performed as described in 
the text (Section 2.2.6). 
The first column and the first row indicate the uptake of tritiated thymidine 
when the stimulator and responder cells respectively were cultured alone. The 
other values in the Table indicate the uptake of tritiated thymidine when the 
stimulator and responder cells subjected to the specified treatments were 
cultured together in the allogeneic MLR. 
Table 2.2 MLR stimulation: Comparison of different treatments of stimulator and responder cells 
Uptake of [3H] thymidine (±SD) (cpm x 10-3) 
8.0±_ 1.4 4.0±_3.0 0.9±_0.3 0.2±_0.1 
Control 0.2±_0.04 92±3 41±4 89±5 88±4 (100%) 
Stimulator cell treatment 
Anti-la 1.0±_0.5 58±7 56±8 74±6 66±3 (84%) 
{1 x105 cells/well} 
Panning 0.7±_0.1 114±32 56±6 86±8 82±8 (63o/o) 
(yields after treatment) 
Anti-I~/ 0.3±_0.01 11±2 8±1 4±_0.3 8±5 
ganning 
(51%) 
Control Anti-la Panning Anti-I~/ 
ganning (100%) (99%) (58%) (52°/o) 
Responder cell treatment {2 x105 cells/ well} 
(yields after treatment) 
LEGENDS TO FIGURES 
Figure 2.1 
Disaggregation technique: Effect of enzyn,e concentration and length of 
incubation on cell yields. Mouse small intestines were removed, washed 
in EDTA to remove the epithelial cell n1onolayer and incubated with differ-
ent enzyme types and concentrations for the indicated times. The points 
are the means of between three (at time 16 h) and eleven (at time three 
hours) experiments. The variability ranged from < 10% to 400% and 
depended on factors which were not initially recognized, eg. the amount 
of tissue added per 20 ml enzyme cocktail (see discussion). The method 
was otherwise as described in the text. Dispase 0.12 U / ml, inverted trian-
gles; 0.24 U/ ml, circles ; 0.48 U/ ml, triangles ; 0.96 U/ml, open squares; 
Dispase 0.48 U / ml closed diamonds; with collagenase 1 O U / ml, closed 
squares. 
Figure 2.2 
Mitogen-induced lamina propria cell proliferation. Disaggregated lamina 
propria cells from C57BL/6 mice (1 x1 os /well) were incubated for 72 h in 
flat-bottom 96-well plates in 200 ml medium with increasing concentra-
tions of concanavalin A (con A) and phytohaemagglutinin (PHA). Tritiated 
thymidine was added for the final 8 h of culture. The plates were freeze-
thawed and the cells harvested automatically onto glass fibre discs. The 
results are the means ± SE of triplicate assays. PHA-stimulated, squares; 
con A-stimulated, triangles . The optimal stimulatory concentrations for 
PHA and con A were 25-50 µg/ml and 0.8-3.0 µg/ml respectively. 
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Figure 2.3 
MLR stimulation: Comparison of intestinal lamina propria and spleen 
cells. Spleen or lamina propria cells from C57BL/6 mice (2x1 as cells 
/well) were added to 2x1os untreated MLN cells from BALB/c mice for 
the indicated times. For the last 16 h of incubation 1 µCi tritiated thymidine 
was added to each well. The plates were freeze-thawed and the cells 
harvested automatically onto glass-fibre discs. Spleen and lamina propria 
controls incorporated < 1,000 cpm. Values are the mean + SE of triplicate 
assays. Lamina propria (LP) cells , triangles; spleen cells, squares; 
mesenteric lymph node (MLN) cells , circles. 
Figure 2.4 
MLR stimulation : Effect of pelletting or culturing cells overnight. The 
experiment was performed as for Figure 2.3. Open symbols, cells 
cultured overnight; closed symbols, cells pelletted overnight at 4°C in 
RPMI containing 20% FCS. 
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Figure 2.5 
MLR stimulation by lamina propria cells. The abscissa represents 
increasing numbers of unfractionated small intestinal lamina propria cells 
(open squares) or lamina propria cells that were depleted of cells 
expressing class II MHC antigens (la) by panning (closed squares). 
Lamina propria cells from C57BL/6 mice were added to 2x1 as 
mesenteric lymph node cells, depleted of la-bearing cells, from BALB/c 
mice. After 4 days, 1 µCi of [3H]-thymidine was added to each 
microculture and the cells were freeze-thawed and harvested onto glass 
fibre discs after a further 16 h. Unstimulated responder cells incorporated 
< 1000 cpm whilst irradiated stimulator controls incorporated < 500 cpm. 
Figure 2.6 
MLR stimulation: Effect of removing fibronectin-adherent cells. The 
experiment was performed as described in Figure 2.5. Open squares, 
unfractionated small intestinal lamina propria cells; closed squares, 
fibronectin-non-adherent cells. 
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Figure 2.7 
Comparison of MLR stimulation by Peyer's patch and lamina propna 
cells. The experiment was performed as described in Figure 2.5. Squares, 
unfractionated small intestinal lamina propria cells; triangles, 
unfractionated Peyer's patch cells. 
Figure 2.8 
Time course of MLR stimulation by Peyer's patch and lamina propria 
cells. The experiment was performed as described in Figure 2.5. 
Unfractionated lamina propria cells (squares) or Peyer's patch cells 
(triangles) were incubated for three days (open symbols) or five days 
(closed symbols) with 2x1 as la-depleted MLN cells. 
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CHAPTER 3 
INTESTINAL LAMINA PROPRIA MACROPHAGES 
"So then Dr Froyd said that all I needed was to 
cultivate a few inhibitions and get some sleep." 
From 11Gentlemen Prefer Blondes 11 
Anita Loos (1893-1981) 
3.1 INTRODUCTION 
The role of macrophages in the regulation of immune responses is 
complex and reflects the morphological, phenotypic and functional diversity of 
the mononuclear phagocyte lineage in vivo [268, 270, 348, 349, 370]. Additional 
variability is added by the isolation procedure and by in vitro manipulation. 
Reports attributing antigen-presenting cell activity in primary T cell responses to 
macrophages often failed to consider other factors which were discussed in 
Sections 1.1.2.1 and 1.2.2. Although macrophages do stimulate activated T 
lymphoblasts [179, 182], there is no evidence for a role in the initiation of primary 
T cell responses. 
There is, however, considerable evidence to suggest that macrophages 
are modulators of T cell activation. Effects in vitro are seen in two phases. In low 
numbers, macrophages enhance responses [182, 217, 242, 273, 311, 343], 
either by releasing IL-1 [217] which amplifies dendritic cell function [241], or by 
improving cell viability [ 445]. At high cell numbers, macrophages are 
suppressive. Examples are found in all species studied including the mouse 
[152,182, 187,190,313,343,353,354], the rat [163,165,231,311,341], the 
rabbit [212] and the human [107, 116, 390, 473, 477]. 
Particular functions which may be affected include: 
i) the primary MLR [343, 450, 477]; 
ii) the syngeneic MLR [353, 377]; 
iii) stimulation of T lymphoblasts [182]; 
iv) antigen- or mitogen-induced T cell proliferation [107, 116, 117, 161, 
162,163,1 65, 212,245,311,341,390,473]; 
v) the induction of cytotoxic T cells [190, 354]; 
vi) oxidative mitogenesis [231, 396]; and 
vii) B cell antibody production [113, 187,242,279,313,414]. 
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One mechanism of high-dose inhibition involves the release of 
eicosanoids, in particular, prostaglandin E2 (PGE2) [116, 212, 326, 354, 414]. 
This is not a universal finding [ 107, 116, 272, 273, 341, 4 73, 4 77], and other 
mechanisms have been proposed eg. mediation by oxygen reactive species 
[320], by low molecular weight peptides [273, 359], by a contact-dependent 
mechanism [ 454] or by the secretion of suppressor T cell factors [113]. 
To study the role of macrophages in murine intestinal immune responses, 
a method for obtaining homogenous populations of macrophages was devel-
oped and the cells characterized. Using depletion and reconstitution experi-
ments, intestinal macrophages were shown to mediate the high-dose 
suppression seen when lamina propria cells were used as stimulators in the 
MLR. The absence of high-dose supression seen when Peyer's patch cells were 
used, was a reflection of the small numbers of macrophages resident therein. 
The inhibition of MLR stimulatory activity was mediated by an indomethacin-
sensitive mechanism. 
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3.2 METHODS 
The materials and methods used for obtaining single suspensions of 
lamina propria or Peyer's patch cells and for performing the MLR was as 
described in Chapter 2. In order to minimize macrophage losses, one change 
was instituted to the protocol. Stimulator cell proliferation in the allogeneic one-
way MLR was prevented by irradiation (2,500-3,000 Rads) rather than by 
treatment with mitomycin C at 370c. 
3.2.1 Intestinal macrophages 
The isolated lamina propria cell suspension at 5-1Ox106 /ml was 
incubated for 2-3 h on fibronectin-coated gelatinized flasks [125]. Human serum 
from healthy donors, clotted at 370c was used as a source of fibronectin. Non-
adherent cells were discarded or pelletted, and the adherent cells further 
incubated overnight. Any cells which were no longer adherent after overnight 
incubation were removed by washing with RPMI at 370c and pooled with the 
other non-adherent cells. Adherent cells were harvested by incubating with 10 
mM EDTA in RPMI with 10% FCS for 10-15 min. These cells were washed three 
times, counted and viability assessed. Phagocytosis was assessed by 
incubating the cells for 2 h with 1 µm diameter fluorescent microspheres 
(Polysciences Inc., Warrington, PA) after readhering the cells onto glass slides. 
3.2.2 Resident peritoneal macrophages 
Resident peritoneal cells were harvested by peritoneal lavage with CMF-
HBSS and treated in parallel, including incubation overnight on fibronectin-
coated gelatinized flasks. 
3.2.3 Splenic macrophages 
Spleens were removed from C57BL/6 mice and the pulp was extruded 
through a fine wire mesh. The resulting cells were vortexed, pelletted and 
centrifuged over Ficoll-Paque (Pharmacia, Uppsala, Sweden) (600 g for 30 min 
at 20°c). The cells at the interface were washed three times in complete media 
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and allowed to adhere overnight to fibronectin-coated gelatinized flasks. The 
non-adherent cells were removed by washing three times with warm media and 
the adherent cells harvested after 10-15 min incubation in 10 mM EDTA in RPMI 
containing 10% FCS. These cells were washed three times and their viability 
assessed. 
3.2.4 Alveolar macrophages 
C57BL/6 mice were anaesthetized with ether and allowed to exsan-
guinate after the left renal artery and vein were severed. The trachea was iso-
lated with careful haemostasis and a blunt needle inserted and secured. Five or 
six aliquots of CMF-HBSS (increasing from 50 to 200 µI) were injected and re-
aspirated. The first aliquot was discarded and subsequent ones pooled. The 
cells were washed in RPMI containing 10% FCS, resuspended, counted and 
viability assessed. These cells were also incubated overnight on fibronectin-
coated gelatinized flasks and the adherent cells harvested as above. 
3.2.5 lmmunocytochemistry 
Cytocentrifuge slides were made using 2-1 Ox1 o4 cells in RPMI with 50% 
FCS on poly-L-lysine coated glass slides (0.1% poly-L-lysine (Sigma, St Louis, 
MO) for 10 min then air-dried). Specimens for cytology were stained using Diff-
Quik (Lab Aids, Narrabeen, NSW). 
For immunocytochemistry, the cytocentrifuge slides were air-dried 
overnight, and then blocked with horse serum (4 drops in 1 O ml PBS) for 30 min. 
Primary antibodies (see Chapter 2) were added and incubated at 200c for 30 
min. The slides were washed in PBS then biotinylated sheep anti-rat 
immunoglobulin (1 /200)(Amersham, Amersham, UK) was added for 30 min. 
After washing, avidin-biotin-peroxidase complex (Vector Labs., Burlingame, CA) 
was added for 1 h and the slides developed for 1 O min with 0.5 mg/ml 3,3' -
diaminobenzidine (Sigma, St Louis, MO), 10 mM imidazole (BDH Chemicals, 
Poole, UK) and 0.3% hydrogen peroxide in PBS (pH 7.3). Except for 33D1 (with 
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which we could not demonstrate staining) appropriate positive and negative 
controls were included. The slides were lightly counterstained in Mayer's 
hematoxylin (BDH, Poole, UK), washed, air-dried and mounted. Photography 
was performed using a Zeiss Axiophot Microscope. 
3.2.6 Cytofluorometry 
Cells were suspended at a concentration of 2-1Ox106 /ml in a solution 
containing the primary antibody for 30 min at 40c, washed three times, resusp-
ended at a concentration of 2x1 O 7 in 1/100 fluorescein isothiocyanate-labelled 
sheep anti-rat immunoglobulin (Silenus, Melbourne, Australia) or 1 /100 fluor-
escein-conjugated affinity-purified F(ab')2 fragment goat anti-rat lgG (heavy and 
light chain specific) (Cappel, Cooper Biomedical, Cochranville, PA), washed 
three times then analysed in a FAGS IV flow cytometer (Becton-Dickinson, 
Sunnyvale, CA), a FACScan (Becton Dickinson, Mountain View, CA) or a Coulter 
Epics C flow cytometer (Coulter Electronics, Hialeah, FL) . 
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3.3 RESULTS 
3.3.1 Yields 
Yields of adherent cells from the intact small intestinal mucosa, the non-
Peyer's patch lamina propria and the Peyer's patch were 3%, 10% and < 0.1 % 
respectively. Yields from the colonic lamina propria were also 10% (phenotypic 
and functional studies were not performed on these cells). 
Yields of macrophages from the peritoneum and lung were 2-
5x105 /mouse and 1-2x105/mouse respectively. Splenic yields were not 
recorded. The proportion of adherent cells which were macrophages as judged 
by morphology was > 90% from all three tissues and close to 99% from the lung. 
Viability in all cases was > 90%. 
3.3.2 Morphology and phenotype 
The majority of the adherent intestinal cells were classical macrophages 
morphologically, with an oval nucleus, basophilic cytoplasm and numerous 
inclusions often giving a 11foamy 11 appearance (Fig. 3.1). An average of 91% (3 
experiments) phagocytosed fluorescent latex beads (Fig. 3.2). The phenotype of 
peritoneal and intestinal macrophages was compared by immunocytochemistry. 
Peritoneal macrophages were strongly positive for the F4 /80 antigen and Pgp-1 , 
while 20-29% (average 24%) were positive for la. In contrast, intestinal 
macrophages, although staining weakly for Pgp-1, had no detectable F4 /80 
antigen and were 45-55% (average 47%) positive for la. Other markers which 
could not be detected on intestinal macrophages were 2.4G2 (anti-F cR) and 
33D1 (anti-dendritic cell) . 
These observations were confirmed and extended using flow cytometry. 
When compared to peritoneal macrophages, intestinal macrophages expressed 
very low levels of the macrophage-specific markers, F4 /80, 2.4G2 (the F c 
receptor), (Fig. 3.3) and M1 /70 (the C3bi receptor) at flow cytometry. The low 
level of F4 /80 antigen expression does not appear to be due to the enzyme 
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digestion, since peritoneal cell expression of F4 /80 antigen was unaffected by 
the enzyme cocktail (not shown). The effect of other steps of the disaggregation 
procedure on peritoneal macrophage F4 /80 expression was not examined. 
The majority of the intestinal macrophages expressed definite but low 
levels of Class II MHC antigens in keeping with previous observations using 
immunohistochemistry [169, 172]. A variable, but small subpopulation 
expressed high levels, probably reflecting varying degrees of activation of the 
macrophages in vivo, or the presence of small numbers of dendritic cells. The 
mean levels of expression were not as high as for lamina propria dendritic cells 
(see Chapter 4). 
Using flow cytometry, the phenotype of intestinal adherent cells was 
compared with that of resident peritoneal, splenic and alveolar macrophages 
(Fig. 3.4). Levels of expression of F4/80 antigen were highest in resident 
peritoneal macrophages, followed by alveolar and splenic macrophages which 
had similar levels, and finally intestinal adherent cells which had no detectable 
F4/80 antigen. The expression of Class II MHC antigens decreased in the 
opposite order with intestinal macrophages having the highest levels, followed 
by splenic, alveolar and finally peritoneal macrophages. Systematic analysis of 
the macrophages from these different sites was not undertaken since the 
objective was to demonstrate heterogeneity of F4/80 and Class II MHC 
expression. 
To ensure stringent antigen-presenting cell requirements (see Sections 
1.1.2.1 and 1.2.2) mesenteric lymph node responder cells were depleted of la-
bearing cells (see Section 2.2.3). Cytofluorometric analysis of this MHC-11-
depleted population demonstrated a homogenous population of T lymphocytes 
with CD4 + :cos+ = 70:30 (Fig. 3.5). The background levels of proliferation 
were always < 1,000 cpm and generally between 200-300 cpm. 
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3.3.3 The role of adherent cells as modulators of immune 
responses 
As discussed in Chapter 2, separated lamina propria cells stimulated 
maximal MLR responses at 5-1 O fold lower stimulator:responder ratios than 
Peyer's patch cells from the same animals (Fig. 2. 7). At high 
stimulator:responder ratios, the lamina propria cells were suppressive. Removal 
of cells adherent to fibronectin (macrophages) did not abrogate any stimulatory 
activity, but abolished the high dose suppression (Fig. 2.6). Suppression by 
lamina propria adherent cells was also reversible by indomethacin (2 µg/ml) 
(Figs. 3.6, 3. 7). The MLR stimulatory activity of Peyer's patch cells was 
unaffected by both the removal of adherent cells (not shown) and by the 
addition of indomethacin (Fig. 3.6). The action of indomethacin was presumed to 
involve suppression of eicosanoid synthesis since prostaglandin E2 (PGE2) has 
been shown to inhibit lymphocyte activation [reviewed in 174]. We confirmed 
that addition of PGE2 resulted in impairment of the MLR generated by both 
Peyer's patch and lamina propria cells (Fig. 3.8). 
Adding increasing numbers of adherent cells to a constant number of 
either lamina propria or Peyer's patch cells (depleted of adherent cells) resulted 
in a dose-dependent inhibition (Figs. 3.9, 3.10). For both lamina propria and 
Peyer's patch cells, this suppression was overcome by adding indomethacin. 
When adherent cells and indomethacin were added to lamina propria cells, no 
increase in proliferation was seen when compared to lamina propria cells alone 
at both maximal (Fig. 3.9) and submaximal (Fig. 3.10) levels. In contrast, adding 
increasing numbers of adherent cells and indomethacin to cultures of Peyer's 
patch cells resulted in levels of proliferation greater than for Peyer's patch cells 
alone (Fig. 3.9). 
Adherent cells also inhibited LPS-induced cell proliferation 1n a dose-
dependent manner (Fig. 3.11 ). 
73 
3.3.4 Adherent cells as inhibitors of the MLR 
Since fibronectin-adherence did not deplete MLR stimulators from the 
lamina propria, it appeared unlikely that the adherent cells would act as stimul-
ators. This was found to be the case (Fig. 3.12). In the presence of 
indomethacin, some stimulator activity was revealed, but only at high 
stimulator:responder ratio. Whether this represents a weak stimulatory activity of 
all the cells, or is attributable to a minor contaminant is unclear. The latter 
explanation seems the more likely since, although the adherent cells are a 
relatively homogenous population of macrophages, cells with morphological 
features of dendritic cells were sometimes seen. Experiments assessing the 
effect of the removal of dendritic cells using the anti-dendritic cell antibody, 33D1 
[356], and complement lysis were not performed. 
The M LR stimulatory activity of peritoneal macrophages and intestinal 
adherent cells were found to be much less than that of unfractionated lamina 
propria cells, both in the presence and absence of indomethacin (Fig. 3. 7). 
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3.4 DISCUSSION 
Macrophages have been shown to have a specific magnesium-
dependent receptor which binds fibronectin [33]. This property allowed the 
separation and recovery of macrophages from the lamina propria and an 
assessment of their function. 
The lamina propria contained relatively large numbers of la+ 
macrophages (10% of disaggregated lamina propria cell suspensions). Consist-
ent with immunohistochemical observations [172, 173, 514, Fig. 3.13], and with 
previously described yields from disaggregation experiments [287], we found a 
paucity of macrophages in the Peyer's patch lymphoid tissue. In contrast to their 
presumptive counterparts in vivo [172], isolated lamina propria macrophages 
did not express detectable F4/80 antigen at cytofluorometry, in spite of exhaust-
ive efforts to demonstrate it. Variables considered included the use of sera from 
different species as blocking agents, varying dilutions of both primary and sec-
ondary antibodies, the use of biotinylated and a number of different fluorescein-
conjugated second antibodies and different methods of fixation. The failure to 
demonstrate detectable F4 /80 expression may simply be a question of the sens-
itivity of the avidin-biotin complex (ABC) immunoperoxidase method in compari-
son with immunofluorescence. However, this does not explain the failure to 
detect F4 /80 antigen on intestinal macrophages using immunocytochemistry 
and the ABC technique. It suggests that a factor in the isolation procedure (apart 
from the enzymes used) may affect the (presumably already low) F4 /80 antigen 
expression. The mechanism probably involves the release of unspecified 
mediators during the disaggregation process, rather than being due to the 
various compounds used (EDTA, collagenase, Dispase, DNase etc.). This was 
not investigated further. An additional problem in assessing low level expression 
of markers on these cells was high autofluorescence and non-specific binding of 
both first and second antibodies. 
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A comparison of intestinal, splenic, alveolar and peritoneal macrophages 
showed considerable variation in levels of the F4 /80 antigen consistent with 
other studies [348]. The expression of the F4 /80 antigen tended to decline as 
Class II MHC antigen expression increased. Others have observed similar 
changes following macrophage activation, namely, down-regulation of the F4/80 
antigen, the F c receptor and the fucose-mannose receptor and increased Class 
II MHC antigen expression [109]. In spite of low levels of F4/80 antigen per cell 
on intestinal macrophages, quantitative studies of the level of F4 /80 antigen in 
tissues suggest that the gut is the major repository of macrophages in the 
mouse [268]. 
In spite of the constitutive expression of Class II MHC antigens on lamina 
propria macrophages, these cells were weak stimulators of the MLR and were 
suppressive, in part, by an indomethacin-sensitive mechanism. 
Initial studies on intestinal macrophages examined their morphological, 
ultra-structural, histochemical and immunohistochemical features and from 
these results function was inferred [reviewed in 310, 436, 468]. With the advent 
of techniques for the enzymatic disaggregation of intestinal mucosa their 
properties could be studied in vitro. The reported yields of macrophages from 
Peyer's patch are variable and range from < 1% [218, 229, 287] to 10% [489]. 
Enzymatic methods of disaggregation resulted in up to ten times greater yields 
[122, 230, 287] and released cells capable of stimulating T and B cell responses 
[287, 393]. It is not clear why these large discrepancies should occur, but they 
are possibly related to the removal of surrounding lamina propria which does 
contain a large proportion of macrophages. 
The surface antigen expression of isolated Peyer's patch macrophages 
has been examined in only two papers [24 7, 489]. The proportion expressing la 
molecules was 7-13% (immunofluorescence microscopy) and 65% 
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(immunoprecipitation) respectively. In comparison with peritoneal macrophages 
only a small proportion expressed F c receptors. 
Functional studies of Peyer's patch adherent cells are difficult to interpret. 
Some investigators have reported the ability to stimulate secondary T cell 
responses [287, 393] whilst others failed to demonstrate either primary or 
secondary responses [24 7]. These differences are partly explained by the 
observation that the MLR stimulator cells were non-adherent, low density cells 
[27, 433]. 
Prostaglandin-mediated suppression of immune responses 
PGE2 is a major product of the cyclo-oxygenase pathway of arachidonic 
acid metabolism in activated cells, particularly monocytes and macrophages. It 
binds to lymphocyte receptors and acts by stimulating adenylate cyclase and 
increasing intracellular cyclic AMP levels [372]. PGE2 inhibits T cell activation 
both by inhibiting the increase in free calcium concentration in the cytosol [87] 
(with the resultant impairment of IL-2 production) and by inhibiting the activation 
of protein kinase C [87]. 
Lymphocyte functions inhibited by PGE2 include the effector function of 
cytotoxic T cells and NK cells, and cellular proliferation in response to PHA and 
con A (but not PWM). Antigen- and mitogen-induced IL-2 release and IL-2-
dependent proliferation are also inhibited. Preincubation of lymphoid cells with 
PGE2 stimulates suppressor cells, an effect which may be mediated by a 
specific stimulatory effect of PGE2 on the expression of IFN--y receptors on 
cos+ cells [104]. The capacity of PGE2 to inhibit proliferation may therefore be 
either due to a direct effect on lymphocyte proliferation or the result of the 
activation of suppressor cells [86]. 
Macrophages, the major source of PGE2 in immune reactions, differ in 
their capacity to produce PGE2 upon stimulation by activating agents. System-
atic studies on intestinal macrophages have not been reported. 
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lndomethacin, in addition to inhibiting the cyclo-oxygenase pathway, also 
inhibits cAMP-dependent protein kinase and phosphodiesterase and may shunt 
the products of arachidonic acid metabolism to the lipoxygenase pathway. 
An alternative means by which macrophages could inhibit MLR stimula-
tory activity is by the 1-J-restricted induction of suppressor T cells and the 
production of Ts factors [17, 191, 337]. Particular problems relate to the nature 
of the 1-J determinants. No polymorphic gene or coding element which maps to 
the 1-J region has been identified and DNA probes spanning the 1-J region fail to 
hybridize with mRNA in 1-J + somatic T cell hybrids [reviewed in 337]. A number 
of mechanisms to explain the absence of an 1-J-coded protein product have 
been suggested. These include the proposal that 1-J molecules represent novel 
T cell receptors that recognize self-Class II molecules and/or receptors for Class 
II molecules, or that the 1-J region controls the post-translational modification of 
Class II MHC antigens or other proteins. The mechanisms involved have not 
been elucidated and much work needs to be done to clarify these issues. 
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LEGENDS TO FIGURES 
Figure 3.1 
Cytocentrifuge slides of fibronectin-adherent lamina propria cells stained 
with Diff-Quik (x 630). 
Figure 3.2 
lmmunofluorescence microscopy of fibronectin-adherent lamina propria 
cells. Cells were adhered onto glass slides and incubated for 2 h with 
fluorescent-labelled latex beads (1 µ diameter). Over 90% of cells were 
phagocytic. 
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Figure 3.3 
Flow cytometric analysis of antigen expression by fibronectin-adherent 
cells. (a) Fibronectin-adherent resident peritoneal cells from C57BL/6 
mice were incubated with no antibody (control), F4/80, Pgp-1 or 2.4G2; 
then washed and labelled with FITC-conjugated (Fab')2 goat anti-rat lgG 
and analysed by flow cytometry. Greater than 90% of the cells expressed 
high levels of F4 / 80, Pgp-1 and 2.4G2. (b) Fibronectin-adherent small 
intestinal lamina propria cells were labelled as for (a). Expression of 
F4/80 and 2.4G2 was much lower than on peritoneal macrophages and, 
if present, was difficult to detect because of high levels of nonspecific 
staining. 
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Figure 3.4 
Phenotypic analysis of fibronectin-adherent splenic, alveolar and 
peritoneal cells using flow cytometry. (a) Fibronectin-adherent splenic 
macrophages were labelled as for Figure 3.3 using no antibody (control) , 
TIB120 (anti-la) and F4/ 80. (An isotype-matched control gave binding 
identical to the no primary antibody control.) The mean fluorescence 
intensity for the whole population is indicated. The vertical line represents 
the fluorescence intensity above which only 5% of the no antibody and/ or 
isotype-matched control cells were found . A cell expressing greater 
fluorescence intensity than this value was considered positive . (b) 
Fibronectin-adherent alveolar macrophages were labelled as in Figure 3.3 
using no primary antibody (control) , TIB 120 and F4/ 80. (c) Fibronectin-
adherent peritoneal cells labelled as above. 
Macrophage Phenotype 
Splenlc Alveolar Peritoneal 
a b C 
Mean 24 
Control Mean 58 Mean 70 
-en 
:t:::: 
C 
::> 
I anti-la I Mean 105 I I I Mean 82 ~ I Ii I I Mean 29 cu 
~ 
.t:: 
£ 
cu 
-~ 
<D 
.0 
E 
::> 
C 
Q) 
() f" I Mean 85 I I I Mean 88 F4/80 I I I I Mean 112 
Log fluorescence (arbitrary units) 
Figure 3.5 
Flow cytometry of mesenteric lymph node responder cells. Mesenteric 
lymph node cells were incubated with TIB120 (anti-Class II MHC 
antibody), panned, then labelled with the specified antibodies, using the 
methods described in Figure 3.3. About 70% of the cells were L3T4 + 
whilst 30% were Lyt2 +. The cells also expressed Pgp-1 as demonstrated 
by the shift of the curve to the right. The other curves were no different 
from the control (no primary antibody) . Antibodies used included anti-la 
(TIB120), J11 d (B cell) and F4/ 80 (macrophage). 
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Figure 3.6 
MLR stimulation by lamina propria and Peyer's patch cells in the 
presence and absence of jndomethacin. The abscissa represents 
increasing numbers of unfractionated small intestinal lamina propria cells 
(squares) or Peyer's patch cells (triangles) that were incubated in the 
presence (closed symbols) or absence (open symbols) of indomethacin 
(2 µg/ml). Lamina propria cells from C57BL/ 6 mice were added to 2x105 
mesenteric lymph node cells, depleted of la-bearing cells, from BALB/c 
mice. After 4 days, 1 µCi of [3H]-thymidine was added to each 
microculture and the cells were freeze-thawed and harvested onto glass 
fibre discs after a further 16 h. Unstimulated responder cells and control 
stimulator cells incorporated < 1000 cpm and < 500 cpm respectively. 
The values are the means_±_ S.E. of triplicate assays. 
Figure 3.7 
MLR stimulatory activity: Comparison of unfractionated intestinal lamina 
propria cells, intestinal adherent cells and peritoneal macrophages in the 
presence and absence of indomethacin. The experiment was performed 
as described in Figure 3.6. Increasing numbers of lamina propria non-
adherent cells (squares), adherent cells (diamonds) and peritoneal 
macrophages (inverted triangles) were added to 2x1 o5 MLN cells in the 
presence (closed symbols) and absence (open symbols) of indomethacin 
(2 µg/ml). 
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Figure 3.8 
The effect of prostaglandin E2 (PGE2) on MLR stimulation. The abscissa 
represents increasing amounts of PGE2 added to microcultures 
containing 2x105 MLN cells together with 2x104 lamina propria cells 
(squares) or 2x105 Peyer's patch cells (triangles). The MLR was 
performed as described in Figure 3.6. 
Figure 3.9 
Lamina propria macrophage-induced suppression of the MLR and the 
effects of indomethacin. The experiment was performed as described in 
Figure 3.6. Increasing numbers of lamina propria macrophages (enriched 
by fibronectin adherence) were added to 2x1 o5 purified mesenteric lymph 
node responder cells cultured with 1 x1 o5 non-adherent lamina propria 
cells (squares) or 1x105 Peyer's patch cells (triangles) in the presence 
(closed symbols) or absence (open symbols) of indomethacin (2 µg/ml). 
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Figure 3.10 
Lamina propria macrophage-induced suppression of the MLR and the 
effect of indomethacin. The experiment was performed as described in 
Figures 3.6 and 3.9 except that 5x1 o4 non-adherent lamina propria cells 
were used (squares). This number resulted in submaximal MLR 
stimulation. 
Figure 3.11 
Suppression of LPS-induced proliferation by lamina propna 
macrophages. The abscissa represents increasing amounts of LPS 
added to 5x104 Peyer's patch (triangles) or lamina propria (squares) cells 
in the presence (closed symbols) or absence (open symbols) of 2x104 
intestinal macrophages. 
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Figure 3.12 
A comparison of MLR stimulatory activity of non-adherent and adherent 
lamina propria cells and the effect of indomethacin. The experiment was 
carried out as described in Figure 3.6. Increasing numbers of non-
adherent (to fibronectin) (open squares) or fibronectin-adherent with 
(open diamonds) or without (closed diamonds) indomethacin (2 µg/ml) 
were added to purified mesenteric lymph node responder cells. 
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Figure 3.13 
lmmunoperoxidase staining of a section through a murine small intestinal 
villus (upper left) and a Peyer's patch (lower right) using the anti-
macrophage antibody, F4 /80. The methods are described in references 
169, 172 and 173, and are summarized in the legend to Figure 1.2. The 
slides were prepared by Dr DA Hume. F4 /80 + cells can be identified 
only in the small intestinal villus. 

CHAPTER 4 
INTESTINAL LAMINA PROPRIA DENDRITIC CELLS 
"seek, and ye shall find ;" 
St Matthew 
4.1 INTRODUCTION 
Cells with the morphology and phenotype of veiled cells have been 
described in Peyer's patches from mouse [ 433], rat, guinea pig and pig [509]. 
Their presence in non-Peyer's patch lamina propria was also demonstrated in 
the guinea pig and pig but not in the rat [509]. The differences between species 
is not explained. Human intestinal dendritic cells will be considered in Chapter 5. 
Functional studies on dendritic cell-enriched populations from Peyer's 
patches showed that these cells were low-density, non-adherent and potent 
accessory cells in the oxidative mitogenesis model [433]. A particularly interest-
ing observation is that dendritic cell-T cell clusters originating from Peyer's 
patches preferentially induced splenic or Peyer's patch B cells to secrete lgA. 
[ 434, 435]. The mechanism is as yet unexplained. 
In this chapter, a method for obtaining populations of MLR stimulatory 
dendritic cells from murine intestinal lamina propria and Peyer's patches is 
described. These cells were as potent as splenic dendritic cells in their ability to 
stimulate the MLR. 
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4.2 METHODS 
The materials and methods used for obtaining adherent cell-depleted 
single cell suspensions from the intestinal lamina propria or Peyer's patches 
were as described in Chapters 2 and 3 unless otherwise stated. 
4.2.1 Cell Separation 
Disaggregated lamina propria or Peyer's patch cells at concentrations of 
10-20x106 /ml were layered onto 2-3 ml Nycodenz (Nyegaard, Oslo, Norway) 
and centrifuged at 600 g for 15 min at 200c. Cells at the interface or in the pellet 
were washed and resuspended in RPM I for further experiments. 
4.2.2 Splenic dendritic cells 
Splenic dendritic cells were obtained by a modification of a previously 
described technique [ 44 7]. Spleens from C57BL/6 mice were minced by 
pushing through a fine wire grid, washed and resuspended in serum-free media. 
The cells were seeded at 3x106 /ml in 185 cm2 tissue flasks (Nunclon, Roskilde, 
Denmark) at 50 ml per flask, and allowed to adhere for 2 h at 370c. Non-
adherent cells were removed by washing with H BSS and remaining adherent 
cells recultured in complete medium (F15 with 5% FCS and 1 o-5M 2-
mercaptoethanol) overnight. Non-adherent or loosely adherent cells were 
harvested by gentle pipetting and treated with anti-Thy 1.2 antibody (Serotec, 
Oxford, UK) and rabbit complement (Low Tax, Cedarlane, Ontario, Canada) with 
DNase 30 µg/ml. Dead cells were removed by separation on lsopaque-Ficoll 
(Pharmacia). To remove surface immunoglobulin- and Fe-receptor-bearing cells, 
the cell suspension was then rosetted with sheep erythrocytes coupled by 
chromium chloride (CrCl3) to hyperimmune sheep anti-mouse immunoglobulin 
(Division of Cell Biology, JCSMR). Following further separation on Ficoll, splenic 
dendritic cells were obtained. Yields from the spleen were 0.5-1 % [368]. The 
cells were >85% positive for expression of Class II MHC antigens by flow 
cytometry (Fig. 4.1 ). 
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4.2.3 Electron microscopy 
Cells were fixed in 3% glutaraldehyde/2% paraformaldehyde in 0.1 M 
cacodylate buffer (pH 7.4) and processed for scanning and transmission 
electron microscopy as described by Bucana et al, (1983) [70]. The cells were 
examined with a JEOL 1200X scanning electron microscope or a JEOL 1200EX 
transmission electron microscope. 
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4.3 
4.3.1 
RESULTS 
Enrichment of MLR stimulator cells 
The lamina propria and Peyer's patch cells that had been depleted of 
fibronectin-adherent macrophages could be further enriched for MLR-stimula-
tory activity by density gradient centrifugation. The yield of cells harvested at the 
Nycodenz interface (density < 1.068 g/ml) was 2. 7% of the starting cell number 
from both sites (see Table 4.1 ). These cells had 20-50x greater MLR-stimulatory 
activity than the initial, unfractionated lamina propria cell suspensions (Fig. 4.2). 
4.3.2 MLR stimulator cells in the colon 
Because of initial concern over the problem of eliminating bacterial 
contamination, fewer studies of lamina propria cells from the large intestine were 
performed. As noted above, the yield of cells from the small and large intestinal 
lamina propria was comparable. In experiments in which cells from small and 
large intestine of the same animals were compared the MLR-stimulating activity 
was not distinguishable (see below). 
4.3.3 Comparison of lamina propria, Peyer's patch and splenic 
dendritic cells 
Isolated dendritic cells from the lamina propria or Payer's patches were 
not distinguishable in terms of the number of cells required to induce a maximal 
MLR (Fig. 4.3). Morphologically, they are large cells which have oval, irregular or 
pleiomorphic nuclei and a basophilic cytoplasm. Characterization is best done 
by phase-contrast microscopy, immunofluorescence or by immunocyto-
chemistry, where they can be identified by their morphology and the expression 
of Class II MHC antigens (Fig. 4.4). Like splenic dendritic cells, they expressed 
very high levels of Class II MHC proteins with low, but detectable, levels of 
F4/80, Pgp-1 (Figs. 4.1 and 4.5), and the dendritic cell specific marker, 33D1 
(not shown). Other markers, in particular, surface immunoglobulin, were nega-
tive. The majority of the remaining cells in the intestinal low density fractions (20-
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35% of the total cell number at cytofluorometry) were Thy-1 +. The low density 
cells from the lamina propria of either the small or large intestine were greatly 
enriched for MLR-stimulatory activity (Fig. 4.6). 
When studied by electron microscopy, the cells exhibited the cytological 
features described previously for lymphoid dendritic cells. The nucleus was 
irregular with a peripheral rim of heterochromatin and small nucleoli. The cyto-
plasm contained well-developed mitochondria and scattered smooth vesicles 
but no evidence of phagolysosomes. The surface of the cells observed with the 
scanning electron microscope showed characteristic cytoplasmic processes 
often observed in cells from afferent lymphatics and referred to as veils [233] 
(Micrographs 4.1 a and 4.1 b). 
The function of dendritic cell-enriched intestinal cell populations was 
compared with that of splenic dendritic cells (Fig. 4. 7). MLR stimulatory activity 
was almost identical. When equal numbers of splenic and lamina propria 
dendritic cells were mixed together, there was no evidence of either enhanced or 
suppressed activity. Treatment of splenic dendritic cells with the enzyme cocktail 
used for disaggregation of the lamina propria for 2-3 h did not alter their MLR 
stimulatory activity (not shown). 
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4.4 DISCUSSION 
This study demonstrates the presence of M LR stimulatory cells in both 
the Peyer's patches, as described previously [ 433], and in the non-Peyer's 
patch lamina propria. These cells resemble the lymphoid dendritic cell first 
described by Steinman and Cohn (1973) [ 443], in their surface phenotype (la-
positive, absence of typical macrophage, T cell and B cell markers), their 
physical properties (low density, weakly or non-adherent, non-phagocytic) and 
their cytological and ultrastructural features (absence of secondary lysosomes, 
pleiomorphic nucleus). 
Intestinal macrophages could be differentiated from dendritic cells on the 
basis of morphology, function (macrophages are phagocytic, adherent 
overnight in culture, and suppress MLR stimulation), and the expression of Class 
II MHC antigens (dendritic cells express very high levels, Fig. 4.8). The MLR 
stimulator cells differed further from macrophages in failing to adhere to 
fibronectin. 
Other studies have demonstrated opposing actions of dendritic cells and 
macrophages on T cell responses in vitro and in vivo. For example, hapten-
specific tolerance was observed when haptenated, la+ -macrophages were 
injected intravenously. This macrophage-induced tolerance could be overcome 
by subsequent injection of haptenated dendritic cells [64]. (See also Chapter 3). 
Cells resembling dendritic cells have been isolated from afferent lymph 
draining the mesenteric nodes of the rat [290, 300, 311, 378] and other species. 
These so-called veiled cells, or non-lymphoid cells, express high levels of Class 
II MHC antigens and are potent antigen-presenting cells in vitro and in vivo [264, 
290, 300, 311, 378]. Like lamina propria dendritic cells, they lack most defineable 
macrophage markers [290]. Veiled cells in the rat and dendritic cells in the 
mouse are bone marrow-derived and have high rates of turnover [378, 449]. If 
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lamina propria dendritic cells are the precursors of similar cells in mouse afferent 
lymph, their turnover would be expected to be similarly rapid. 
There was consistently 5-10 times greater MLR stimulatory activity in the 
unfractionated lamina propria cell suspensions when compared to Peyer's 
patches. However, the yield of dendritic cells from the two sources was similar 
(Table 4.1) and maximal MLR stimulation occurred with similar numbers of puri-
fied stimulator cells from both the lamina propria and Peyer's patches (Fig. 4.3). 
In the unfractionated cell suspensions, the difference may represent a genuine 
decrease in Peyer's patch dendritic cell activity due to a deficiency of 
macrophage-derived factors. This possibility is supported by the data (Fig. 3.9) 
showing that macrophages can increase the sensitivity of the MLR to Peyer's 
patch cells. This effect may be mediated by macrophage production of IL-1 
which amplifies dendritic cell function [241]. 
When compared to splenic dendritic cells, lamina propria dendritic cells 
had similar MLR stimulatory activity (Fig. 4.7) . These observations are consistent 
with those of Spalding et al, (1983) [ 433] who demonstrated that splenic and 
Peyer's patch dendritic cells had equivalent T cell stimulatory ability in the oxi-
dative mitogenesis assay. In contrast, dendritic or Langerhans cells of the epi-
dermis are weak stimulators of the MLR upon initial isolation [181] but in the 
presence of granulocyte/ macrophage-colony stimulating factor (GM-CSF) and 
IL-1, in vitro rapidly mature into potent MLR stimulators [156, 515]. Tissue varia-
tions in cytokine production may account for the differences in maturity of 
dendritic cells at these sites. GM-CSF is produced constitutively by cells of the 
human intestinal lamina propria [380], but levels were not compared with those 
of the epidermis. An alternative explanation is that the isolation process 
produced different effects on cell maturation. 
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Table 4.1 
Fibronectin-
adherent 
Non-adherent 
High density* 
( > 1.068 g/ml) 
Low density 
( < 1.068 g/ml) 
Cell yields (% starting cell number) (range) 
Whole intestine 
3-5 
41 
(32-57) 
22 
(15-31) 
3 
(2-6) 
10 
(6-13) 
30 
(22-44) 
15 
(9-20) 
2 
(1-3) 
* The cells were predominantly small lymphocytes. 
< 0.1 
55 
(22-90) 
27 
(12-37) 
2 
(1-3) 
Table 4.1 details the yields at different stages of the isolation procedure as a 
percentage of the starting cell number. LP refers to the yields from lamina propria 
from which Peyer's patches have been removed and PP indicates the yields from 
Peyer's patches alone. 
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LEGENDS TO FIGURES 
Figure 4.1. 
Flow cytometric analysis of antigen expression by splenic dendritic cells. 
Splenic dendritic cells from C57BL/6 mice were incubated with no 
antibody (control), anti-la (TIB 120), F4/80 or Pgp-1 (PGP); then washed 
and labelled with FITC-conjugated (Fab')2 goat anti-rat lgG and analysed 
by flow cytometry. The abscissa represents fluorescence intensity 
(logarithmic scale, arbitrary units) and the y axis, cell number (linear 
scale, arbitrary units). The mean level of fluorescence intensity for each 
population of cells is indicated. The proportion of cells positive for each 
marker is also given. (The level of fluorescence at which a cell was 
considered to be positive was arbitrarily defined as that level which was 
not exceeded by > 5% of the control population.) Over 90% of the cells 
expressed high levels of la. The cells expressed intermediate levels of the 
Pgp-1 antigen, and low levels of the F4/80 antigen. 
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Figure 4.2. 
MLR stimulation by lamina propria dendritic cells and unfractionated cells . 
The abscissa represents increasing numbers of unfractionated small 
intestinal lamina propria cells ( open squares), lamina propria cells that 
were fibronectin-non-adherent and low density ( closed squares) and 
splenic dendritic cells ( closed diamonds). Lamina propria cells from 
C57BL/6 mice were added to 2x1 o5 mesenteric lymph node cells, 
depleted of la-bearing cells, from BALB/c mice. After 4 days, 1 µCi of 
tritiated thymidine was added to each microculture and the cells were 
freeze-thawed and harvested onto glass fibre discs after a further 16 h. 
Unstimulated responder cells incorporated < 1000 cpm and irradiated 
stimulator cells < 200 cpm. 
Figure 4.3. 
Comparison of MLR stimulation by dendritic cell-enriched populations 
from Payer's patches and intestinal lamina propria. The experiment was 
performed as described in Figure 4.2. Closed triangles, Payer's patch 
dendritic cell-enriched populations; closed squares, lamina propria 
dendritic cell-enriched populations. 
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Figure 4.4. 
lmmunocytochemistry of lamina propria dendritic cell-enriched 
populations. Cytospin slides of dendritic cell-enriched populations from 
the lamina propria were (a) stained with a modified Giemsa stain (Diff-
Quik); or (b) incubated sequentially with TIB120 (anti-Class II MHC) 
antibody, biotinylated sheep anti-rat immunoglobulin and avidin-biotin-
peroxidase complex, developed with diaminobenzidine and 
counterstained. Dendritic cells were large irregular cells with oval or 
pleiomorphic nuclei. 
a 
b 
Figure 4.5. 
Flow cytometric analysis of antigen expression by fibronectin-non-
adherent low density cells. The experiment was performed as in Figure 
4.1 using dendritic cell-enriched populations from C57BL/6 mice. Over 
70% of the cells expressed high levels of Class II M HC antigens. The cells 
were negative for surface immunoglobulin (using FITC-conjugated goat 
anti-mouse lgG) (not shown). 
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Figure 4.6. 
Fractionation of lamina propria dendritic cells from small or large intestine. 
Fibronectin-non-adherent cells from the small intestinal- (SI, squares) or 
large intestinal- (colon, inverted triangles) lamina propria were separated 
into low density ( < 1.068 g/ml, open symbols) or high density (> 1.068 
g/ml, closed symbols) fractions by centrifugation over a Nycodenz 
density gradient. Increasing numbers of cells were added to 2x1 o5 
purified mesenteric lymph node responder cells and the experiment was 
performed as described in Figure 4.2. 
Figure 4.7. 
Comparison of M LR stimulation by lamina propria and splenic dendritic 
cells. The experiment was performed as described in Figure 4.2. Closed 
squares, lamina propria dendritic cell-enriched populations (60-80% la+); 
closed diamonds, splenic dendritic cells; closed inverted triangles, equal 
numbers of splenic and lamina propria dendritic cells. 
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Flow cytometry of intestinal lamina propria macrophages and dendritic 
cells. Intestinal lamina propria fibronectin-adherent cells and fibronectin-
non-adherent, low density cells were incubated with an isotype-matched 
control (LP Mcp control) or with TIB120 (anti-Class II MHC antibody) (LP 
Mcp TIB 120 and DC TIB 120 respectively). The experiment was performed 
as described in Figure 4.1. The macrophages had low, but definite 
expression of Class II MHC antigens. The level of dendritic cell Class II 
MHC expression was at least one order of magnitude greater than the 
macrophages. 
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Micrograph 4.1 
Transmission electron micrograph of a murine intestinal lamina propria 
dendritic cell. The nucleus is irregular with a peripheral rim of 
heterochromatin and a small nucleolus. The cytoplasm contains 
scattered smooth vesicles with no evidence of phagolysosomes. Final 
magnification x 7,500. 
Micrograph 4.2 
Scanning electron micrograph of a murine intesinal lamina propna 
dendritic cell showing the characteristic cytoplasmic processes or veils. 
Final magnification x 6,700. 
4. 1 
CHAPTER 5 
HUMAN INTESTINAL DENDRITIC CELLS 
"and he that seeketh findeth ." 
St Matthew 
5.1 INTRODUCTION 
The experiments reported in the preceding chapters demonstrate the 
presence of MLR stimulatory dendritic cells in the Peyer's patches and lamina 
propria of the murine small intestine, and, with more limited data, in the murine 
colon. In contrast, murine intestinal macrophages were shown to inhibit the 
function of the dendritic cells in vitro. 
The following chapter describes a method for the partial enrichment and 
characterization of human colonic M LR stimulatory cells. These cells have the 
morphological, phenotypic and ultrastructural features of dendritic cells. 
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5.2 MATERIALS AND METHODS 
5.2.1 Mucosal specimens 
Specimens of intestine were obtained from patients undergoing surgery 
for colorectal cancer (30 patients), Crohn's disease (2) and non-malignant/non-
inflammatory conditions (3), including diverticular disease (2) and ischaemic 
colitis (1 ). The results of histological examination of adjacent tissue were 
recorded. Mucosa was taken at least 5 cm from tumours. 
5.2.2 Disaggregation of intestinal mucosa 
Full thickness specimens of mucosa were obtained and transported to 
the laboratory in ice cold HBSS supplemented with penicillin (100 IU/ml) and 
gentamicin (50 mg/ml). Disaggregation of the tissue was initiated in all cases 
within 1 h of resection. Tissue was disaggregated using a method based on 
modifications [134] of Bull and Bookman's (1977) [56, 73] original method. 
Strips of mucosa (2-3 cm x 0.5 cm) were dissected free from the muscularis and 
incubated with continuous stirring in Wheaton flasks in calcium-magnesium free 
HBSS (CMF-HBSS) containing 20 mM HEPES (pH 7.4), penicillin, gentamicin 
and 0.75 mM EDTA at 370c for 60 min. The tissue was washed in CMF-HBSS 
with EDTA for 30 min periods until there was no increase in particulate matter 
between washes (4-5 washes). The strips of tissue were then washed once in 
CMF-HBSS without EDTA. The tissue was minced finely (2 x 2 mm) and 
incubated overnight with gentle stirring in RPM I 1640 (Flow Labs, Australia) 
containing 10% heat-inactivated FCS (CSL Melbourne), 2 U/ml purified colla-
genase (CLSPA type, Worthington Biochemical Corp, Freehold, NJ.), 5 U/ml 
DNase II (Calbiochem, San Diego, CA.), 100 IU/ml penicillin, 50 mg/ml 
gentamycin, 100 U/ml nystatin, 20 mM HEPES and 2 mM glutamine. The 
undigested tissue fragments were then allowed to settle and the digest filtered 
through four layers of surgical gauze supported in a sterile Buchner funnel. The 
cells were washed (400 g, 1 O min at 40c) and resuspended in RPMI 1640 with 
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10% FCS. For isolation of lamina propria mononuclear cells and removal of red 
cells, neutrophils and debris, the cells were layered on to a Ficoll-Paque 
(Pharmacia Fine Chemicals AB, Uppsala, Sweden) density gradient (1.077 g/ml) 
and spun at 400 g for 30 min at 40c. Interface cells were harvested and washed 
twice. Viability was assessed by the exclusion of 0.1 % Trypan blue. Cytospin 
slides were prepared using 1 x1 o5 cells in a Shandon cytocentrifuge (500 rpm, 5 
min) followed by fixation in methanol and staining in Diff-Quik. 
5.2.3 Fibronectin adherence and binding to human 1-globulin 
The method of fibronectin adherence was as described in Section 3.2.1 . 
Bacteriological grade plastic Petri dishes were prepared with normal 
human 1-globulin (CSL, Melbourne) using a modification of the technique of 
Young and Steinman (1988) [521]. Pooled human 1-globulin (5 ml; 1 O mg/ml) 
was added to 100 mm dishes for 30 min at 200c. The plates were washed and 
the lamina propria cell suspension added at a final concentration of 5-10 
x106 /ml. After incubation at 370c for between 30 min and 4 h, the non-adherent 
cells were removed and the plates washed twice with warm medium. Adherent 
cells were harvested using EDTA in RPMI as described in Section 3.2.1. 
5.2.4 Carbonyl iron phagocytosis 
The lamina propria cell suspension at 2-3x1 O 7 /ml was added to 4 mg 
carbonyl iron powder (Sigma, St Louis, MO) and mixed thoroughly. The cells 
were incubated at 370c for 30 min with occasional mixing. The test-tube 
containing the cells was placed in a magnet (Dynal AS, Oslo, Norway) for 10 min 
at 4°C. The cells in suspension were transferred to a second tube which was 
placed in the magnet for a further 10 min at 40c. The remaining cells were 
removed, washed and counted. 
5.2.5 AET-Sheep red cell rosetting of T lymphocytes 
A 4% solution of 2-aminoethylisothiouronium bromide (AET) (pH 9.0) was 
mixed with packed sheep red blood cells (1-1 O days old) in a 4: 1 ratio (vol/vol) 
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for 20 min at 370c. The mixture was resuspended at a final concentration of 4% 
sheep red cells and used fresh. 
Colonic cell suspensions at a concentration of 107 /ml were mixed with 
equal volumes of AET-sheep red cells at 4% and RPMI/FCS (final concentration 
15%). The cells were centrifuged at 300 g at 200c for 1 O min and left on ice for a 
minimum of 1 h. The cells then were resuspended gently, layered over Ficoll-
Paque and centrifuged at 600 g at 200c for 25 min. The cells at the interface (T 
cell-depleted) were washed and used in subsequent experiments. When 
required, the rosetted T cells in the pellet were obtained after lysing the sheep 
red cells with 0.5 ml sterile water and washing three times in complete medium. 
5.2.6 Density gradient centrifugation 
Density gradients used included Ficoll-Paque (Pharmacia, Uppsala, 
Sweden), Nycodenz Monocytes (Nyegaard, Oslo, Norway), Lymphoprep 
(Nyegaard) and Percell (Pharmacia) both as continuous and discontinuous 
gradients. Continuous gradients were generated by centrifuging isotonic solu-
tions of 40%, 45% and 50% Percell at 30,000 g for 15 min in a Beckman L5-65B 
ultracentrifuge using 6.5 cm cellulose nitrate tubes (Beckman). 
5.2. 7 lmmunocytochemistry 
The methods used were as described in Section 3.2.5, using monoclonal 
antibodies directed against human cell surface antigens (Table 5.1) and biotin-
ylated sheep anti-mouse immunoglobulin (Amersham, Amersham, UK). To 
inactivate endogenous peroxidase activity, some air-dried slides were treated 
with 0.1 % (vol/vol) hydrogen peroxide in methanol for 30 min at 200c. The 
slides were rehydrated with decreasing concentrations of ethanol in water (90%, 
70%, 50%) before blocking. The methods were otherwise unchanged. 
5.2.8 Flow cytometry 
The methods were as described in Section 3.2.6 using monoclonal anti-
bodies directed against human cell surface antigens (Table 5.1) and FITC-con-
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jugated, affinity-purified anti-mouse immunoglobulin (Silenus, Hawthorn, 
Victoria) at a dilution of 1 :200. 
5.2.9 Electron microscopy 
Cells were fixed in 2% glutaraldehyde in 0.1 M phosphate buffer, pH 7.4 
for 2 hand post-fixed in 1% osmium tetroxide in 0.1 M phosphate buffer, pH 7.4 
for 90 min. For scanning electron microscopy, samples were then dehydrated, 
critical point dried and gold coated, with micrographs taken on a Hitachi 7000 
scanning attachment. For transmission electron microscopy, samples were "en 
bloc" stained in 1 % aqueous uranyl acetate for 1 h, dehydrated and embedded 
in "Spurrs" resin. Micrographs were taken on a Hitachi 7000 electron micro-
scope. 
5.2.10 Mixed leucocyte reactions 
Responder cells were derived from buffy coats prepared from normal 
blood donors (Red Cross Blood Transfusion Service, ACT). 
The buffy coat was diluted 1 :2 with HBSS and underlaid with Ficoll-Paque. 
The cells were centrifuged at 600 g for 30 min at 40c and the interface harvested 
and washed twice. The cells were resuspended at 10-20x106 /ml in the super-
natant of the L243 hybridoma cell line (anti-Class II MHC) for 30 min at 40c, 
washed three times and the antibody-labelled cells removed by panning or 
complement lysis. The technique of panning was as described in Section 2.2.4 
except that the plates were treated with affinity-purified rabbit anti-mouse 
immunoglobulin G (Cappel, Cochranville, PA). For complement lysis, the peri-
pheral blood mononuclear cells prelabelled with primary antibody were resusp-
ended at a final concentration of 107 /ml and complement (Pel-Freez, Rogers, 
AR or Cedar Lane, Hornby, Ontario) was added at a final dilution of 1 :5. The 
cells were incubated for 30 min at 370c, washed, layered over Ficoll-Paque to 
remove dead cells (600 g at 200c for 20 min) and then washed three times. The 
same method was used for lamina propria cells. 
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Responder peripheral blood mononuclear cells were also prepared from 
buffy coats using the method of Warren (1981) [ 498]. Peripheral blood mono-
nuclear cells were cultured in a preparation of lymphokine (see below) for 3 days 
to expand the population of lymphokine-reactive cells. Centrifugation of the 
cultured cells on discontinuous Percell gradients yielded a low density fraction 
( < 1.0623 g/ml) that contained monocytes, blast cells and medium-sized 
lymphocytes, and high density fractions ( < 1.0659 and < 1.0689 g/ml) that 
contained only small lymphocytes. 
The lymphokine preparation was prepared by stimulation of human tonsil 
lymphocytes (2x1o7 /ml) with PHA (25-50 mg/ml) in serum-free medium [499]. 
After a 2 h incubation, the cells were washed free of unbound mitogen and incu-
bated for a further 17 h. The supernatant was harvested, concentrated, and kept 
at -2ooc for further use. 
Responder cells were frozen 1n RPMI containing 20% FCS and 20°/o 
DMSO (Malinckrodt, Paris, KY) and kept in liquid nitrogen until use. They were 
thawed on the day of use. 
Cultures were perfor111ed 1n triplicate in round-bottom 96-well plates 
(Linbro Flow Labs, McLean, VA). A constant number of responder cells 
(generally 2x1 o5 /well) was incubated with varying numbers of irradiated stimu-
lators from the colon (2,500 Rads). The reaction was carried out in a total 
volume of 0.2 ml of medium supplemented with 5% AB serum. After 4 days, 1 
µCi tritiated thymidine (Amersham, Surry Hills, NSW) was added to each well 
and the incubation continued for a further 16 h. The plates were freeze-thawed 
and the cells harvested automatically onto glass-fibre discs (Whatman, 
Maidstone, UK) using a cell harvester (Dynatech CH-103). Non-aqueous 
scintillant (0.5% 2,5-diphenyloxazole in xylene) (5 ml/vial) was added and the 
assays performed on a Packard Tri-Carb K60 counter. 
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5.2.11 Method for enrichment of colonic dendritic cells 
The most effective depletion of macrophages and maximum enrichment 
of dendritic cells was obtained using the following method: 
The colonic cell suspension was incubated on human 1- globulin coated 
plastic Petri dishes for 2-4 h at 370c. The non-adherent cells were removed, 
washed and then treated with carbonyl iron (4 mg/107 cells) as described 
above. The remaining cells were incubated in siliconized dishes at 5-1Ox106 
cells/ml in RPMI containing 5% heat-inactivated pooled human AB serum 
overnight. The cells were removed, washed, resuspended at 5-1Ox106 cells/ml, 
underlaid with Nycodenz Monocytes (Nyegaard) (density 1.068 g/ml) and 
centrifuged at 600 g for 20 min at 200c. The low density (dendritic cell-enriched) 
cells and high density (T cell-enriched) cells were washed twice, counted and 
the viability was assessed. 
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5.3 RESULTS 
5.3.1 Cell yields and the development of the methods 
Cell yields after Ficoll-Paque were 15±-12x106 / g tissue. Recovery repre-
sented 69.± 15% of the number applied. The amount of tissue obtained from 
surgical specimens ranged from 5-21 g. The final yield of dendritic cell-enriched 
populations was always < 2%. 
Initial attempts to enrich for MLR stimulatory cells involved overnight 
adherence to fibronectin-coated gelatinized flasks and density gradient 
centrifugation (Nycodenz Monocytes and Percell at various densities). It was 
evident that this method did not allow the effective separation of human colonic 
macrophages from dendritic cells. Examination of the cytospin preparations and 
electron micrographs (Micrograph 5.1) showed that the low density, non-adher-
ent cells contained low, but significant (5-10%), numbers of macrophages. 
Similarly, the fibronectin-adherent cell fraction contained dendritic cells. 
Each of the techniques described in the Methods Section was used in 
different sequences and combinations to try to obtain populations of cells max-
imally enriched for dendritic cells with minimal macrophage contamination. The 
procedures were monitored for their effectiveness in removing macrophages 
and enriching for dendritic cells mainly by examining cytospin preparations and 
immunocytochemical slides (assessing the proportion of Class II MHC + or 
25F9+ cells, see below). In later experiments, flow cytometry was also used. To 
date, the best isolation technique is as described in Section 5.2.11. 
Effective removal of macrophages required at least two procedures. The 
use of human -y-globulin to immobilize the macrophages permitted their 
harvesting and use in subsequent experiments. Adherence to plastic did not 
remove as great a proportion of macrophages, whilst adherence to fibronectin 
resulted in populations of macrophages containing significant numbers of 
dendritic cells. Macrophages not adherent to -y-globulin-coated dishes were 
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depleted by carbonyl iron phagocytosis. The use of carbonyl iron phagocytosis 
as the initial step precluded comparative studies of MLR stimulation. If 
performed on the third day of the isolation, this procedure was not as effective in 
depleting the cell suspension of macrophages. This may be because the 
macrophages had exhausted their phagocytic capabilities by ingesting the 
cellular debris during the isolation procedure. 
5.3.2 lmmunocytochemistry 
5.3.2.1 Adherent cells (macrophage-enriched) 
The majority ( > 90%) of fibronectin- or plastic-adherent cells with the 
morphology of classical macrophages had detectable Class II MHC antigens 
when studied with immunocytochemistry (Fig. 5.2a). The mature macrophage 
marker, 25F9, also labelled virtually all the macrophages (Fig. 5.2b). The other 
macrophage markers used, OKM 1 and Leu-M5 were either not detectable on 
intestinal macrophages or present on small numbers ( < 5%) only. lmmunohisto-
chemical studies of intestinal macrophages [170] and immunocytochemistry of 
populations of macrophages isolated from the colon [134] demonstrated similar 
findings. 
5.3.2.2 Low density non-phagocytic non-adherent cells (dendritic 
cell-enriched) 
Cells with dendritic cell morphology were labelled with the antibody to 
Class II MHC antigens (Fig. 5.3). The monoclonal antibody, Leu-M5, directed 
against the p150,95 antigen (CD11 c) weakly labelled dendritic cells in three of 
eight experiments in which it was used (Fig. 5.4). None of the other antibodies 
used stained dendritic cells. 
5.3.2.3 Inactivation of endogenous peroxidase activity 
Some cytospin slides (particularly the plastic-adherent and high density 
fractions) contained significant numbers of eosinophils with endogenous per-
oxidase activity. The use of hydrogen peroxide in methanol effectively inactivated 
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this activity and produced preparations with better preservation of cellular 
morphology. However, the use of this step was associated with a loss of staining 
intensity with the ABC technique. 
5.3.3 Flow cytometry 
5.3.3.1 Adherent cells 
When the human -y-globulin-adherent cells were analysed using forward 
and side scatter, two populations were demonstrated (Figs. 5.5, 5.6). The larger 
cells expressed high levels of Class II M HC antigens but did not have detectable 
macrophage, Tor B cell antigens (Fig. 5.5). These cells had much higher levels 
of background fluorescence (nonspecific primary and secondary antibody 
staining and autofluorescence) than the smaller cells (Fig. 5.6). The population 
of smaller cells consisted of mainly T and B cells and comprised < 25% of the 
total cell number. 
5.3.3.2 Low density non-phagocytic non-adherent cells 
The low density non-adherent non-phagocytic cells also consisted of two 
populations when analysed using forward and side scatter characteristics (Figs. 
5.7, 5.8). When fluorescence was plotted against size or forward scatter (Fig. 
5.9), it was apparent that the highly fluorescent cells were spread over a wide 
size range. In addition, almost all the remaining small cells expressed intermedi-
ate levels of Class II MHC determinants. 
Analysis of a gated population of large cells (Fig. 5. 7) demonstrated high 
level expression of Class II MHC antigens, with no detectable macrophage, Tor 
B cell marker expression. This population comprised 40% of the total cell 
number. 
When the smaller population was analysed (Fig. 5.8), the cells expressed 
T cell markers (OKT3 and OKT 4) with intermediate and high levels of Class 11 
MHC antigens. Markers expressed on macrophages and B cells were 
undetectable or expressed only on small numbers of cells. 
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5.3.3.3 AET-SRC rosetting cells 
The cells obtained by AET-rosetting consisted of a homogenous popul-
ation of lymphocytes (mainly CD4 +) expressing low-intermediate levels of Class 
II MHC antigens (Fig. 5.10). 
5.3.3.4 MLR responder cells 
The peripheral blood responder lymphocytes consisted of a homogenous 
population of T cells with a CD4 +:CDS+ ratio = 70:30 (Fig. 5.11 ). There was no 
detectable expression of Class II M HC antigens on the cells treated with L243 
and either complement lysis or panning. 
5.3.4 MLR stimulation 
In the initial experiments using fibronectin-adherence, greater MLR stimul-
atory activity was always found in the low density, non-adherent cells (Fig. 5.12). 
There was, however, significant activity in the adherent fraction. This suggested 
either that there was significant contamination with dendritic cells (as suggested 
by their presence in cytospin and immunocytochemical slides) and/or that 
macrophages had MLR stimulatory activity. In order to differentiate between 
these two possibilities, the effect of adding macrophages to dendritic cell-
enriched populations was studied and the activities of the separate populations 
was directly compared. 
When added to dendritic cell-enriched populations, human colonic 
macrophages neither inhibited nor potentiated MLR stimulation, either in the 
presence or absence of indomethacin (Fig. 5.13) . 
The direct comparison of dendritic cell-enriched populations (40% 
dendritic cells) with macrophage-enriched populations (> 75% macrophages), 
non-adherent colonic lamina propria cells ( < 1% dendritic cells) (Fig. 5.14) and 
high density cells ( < 5% dendritic cells) (Fig. 5.15) showed greatly enhanced 
MLR stimulatory activity in the dendritic cell population. A small cross-contami-
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nation with dendritic cells can explain the weak activity of the macrophage-
enriched population but the converse does not hold true. 
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5.4 DISCUSSION 
Cells with the morphology of veiled cells were first described in the human 
intestinal lamina propria in tissue obtained from patients suffering from inflamma-
tory bowel diseases [507, 508]. These cells, which were neither phenotyped nor 
functionally characterized, may have been tissue dendritic cells, and were found 
in greater numbers in inflammed bowel than in normal controls. 
Dendritic cells have been obtained from human tissues including peri-
pheral blood, synovial fluid, tonsils, thymus and the lung (See Section 1.2.3). 
The isolation of human dendritic cells was associated with many of the problems 
encountered in the mouse eg. low cell numbers and the absence of specific cell 
surface markers. Particular problems have been encountered using human 
tissues. For example, human dendritic cells are fibronectin-adherent, at least in 
the short-term [129], so this property did not permit their separation from 
macrophages. In addition, the function and viability of human peripheral blood 
dendritic cells appears to be sensitive to the toxic effects of complement [521]. 
Colonic dendritic cell function was affected by complement so this method could 
not be used for enrichment. The purest populations of human dendritic cells 
reported to date were obtained by highly sophisticated techniques, including cell 
sorting by negative selection using a broad range of monoclonal antibodies 
[149, 317]. 
Particular importance was placed on the development of a method to 
effectively deplete the colonic cell suspensions of mononuclear phagocytes. 
This was because of the demonstration of a suppressive effect of mouse intesti-
nal lamina propria macrophages (Chapter 3), and the observation that cell 
populations need to be depleted of monocytes to see the rapid development of 
large cell aggregates in the human MLR [118]. In addition, there is still some 
controversy about the antigen-presenting cell function of the human intestinal 
macrophage. Mahida et al (1988) [292] reported the association of antigen-
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presenting cell activity with intestinal macrophages. These cells were obtained 
using fibronectin-adherence so that it is likely that there was a significant propor-
tion of "contaminating" dendritic cells. These investigators used cell depletion 
experiments (panning with a monoclonal antibody directed against human 
monocytes, 3C10) to demonstrate that MLR stimulatory activity was diminished. 
The data (Table 2, [292]) show that panning with 3C10 reduced the MLR stimu-
latory activity of the treated population to 55% of an unfractionated cell popula-
tion. Although statistically significant, these results are higher than would be 
expected if the MLR stimulatory cell was 3C10 positive. The omission of impor-
tant data make the interpretation of the cell-depletion experiments difficult. For 
example, an assessment of the effectiveness of the macrophage depletion was 
not included in the results. In addition, the appropriate control (colonic cells not 
incubated with monoclonal antibody and then panned) was not available for 
comparison. 
In these experiments, the differentiation of dendritic cells from intestinal 
macrophages was difficult because of their shared properties. These included 
fibronectin-adherence (dendritic cells weakly), low density and the expression of 
Class II MHC antigens (dendritic cells > macrophages). This distinction could 
be made, however, using several criteria. Firstly, macrophages had a 
characteristic morphology with oval or round nuclei and basophilic cytoplasm 
which contained varying numbers and sizes of phagolysosomes (Micrographs 
5.1, 5.2); the nuclei of dendritic cells were oval or pleiomorphic whilst the 
cytoplasm contained, if any inclusions, only small vesicles (Micrographs 5.2, 
5.3). Secondly, when cytospin preparations were examined, the majority of the 
macrophages expressed the antigen labelled by the antibody, 25F9. (This 
marker was not readily detectable at flow cytometry because it labels a 
predominantly intracellular, rather than a cell surface, antigen [170].) This 
antigen was not detectable on dendritic cells using either method. Thirdly, 
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macrophages could be distinguished from dendritic cells by their electron 
microscopic features (Micrographs 5.1-3 and Frontispiece); and finally, dendritic 
cells were not adherent to human -y-globulin and were not phagocytic. 
Our results showed that low density, fibronectin-adherent cells were 
potent stimulators of the MLR (Fig. 5.12), but that there were, on morphological 
grounds, low, but functionally significant, numbers of dendritic cells. The 
addition of macrophage-enriched cells to a constant number of low density 
dendritic cell-enriched population, resulted in neither suppression nor 
enhancement of MLR stimulatory activity, either in the presence of, or the 
absence of indomethacin. This suggested that human intestinal macrophages 
played no role in MLR stimulation in spite of their high level expression of Class II 
MHC antigens. 
When direct comparisons were made between macrophage-depleted, 
low density cells and human -y-globulin-binding macrophages, the greater MLR 
stimulatory activity was associated with the former. The levels of maximal prolif-
eration and stimulator:response curves of the dendritic cell-enriched populations 
are comparable to those using purified populations of human tonsillar dendritic 
cells [149]. 
Examination of the data presented reveals variations in the absolute levels 
of MLR-induced stimulation. There are at least two explanations to account for 
these differences. Firstly, the stimulation depended on the degree of mis-
matching between different pairs of allogeneic stimulators and responders, and 
secondly, in the initial experiments (Figs. 5.12, 5.13), a foreign antigen (FCS) 
was introduced into the assay system. 
In summary, dendritic cells are the major stimulators of the MLR in the 
human colonic lamina propria. Intestinal macrophages, in spite of expressing 
high levels of Class II MHC antigens, have no effect on MLR stimulation in vitro. 
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TABLE 5.1 
Monoclonal Antibodies Used in Human Experiments 
Name Determinant recognized Class Reference 
L243 Class II MHC, monomorphic lgG2a J lmmunol 1980; 
125:293 
25F9 Monocyte, macrophage lgG1 J lmmunol 1985; 
antigen 134: 1487 
OKT1 T cells lgG1 Proc Natl Acad Sci 
USA 1980; 77: 4914 
OKT3 CD3 lgG2a Proc Natl Acad Sci 
USA 1980; 77: 4914 
OKT4 CD4 lgG2b Proc Natl Acad Sci 
USA 1980; 77: 4914 
OKTB CDS lgG2a Proc Natl Acad Sci 
USA 1980; 77: 4914 
OKM1 CD11b lgG2b Proc Natl Acad Sci 
USA 1980; 77: 4914 
Leu M5 CD11c lgG2b Blood 1985; 65: 974 
Leu11b CD16 lgG1 Proc Natl Acad Sci 
USA 1985; 82: 1766 
All antibodies were mouse-derived 
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Figure 5.1 
Human colonic lamina propria macrophages. Cytocentrifuge slide of 
human colonic -y-globulin-adherent cells stained with Diff-Quik (modified 
Giemsa stain) (x 630). 
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Figure 5.2 
lmmunocytochemistry of colonic macrophages. Cytocentrifuge slides of 
-y-globulin-adherent cells were air-dried overnight and stained with (a) 
L243 (anti-Class II MHC) ; and (b) 25F9 (anti-macrophage), using the 
method described in Section 3.2.5. Inactivation of endogenous 
peroxidase using 0. i % H2o2 in methanol was not performed (x 630). 
a 
b 
Figure 5.3 
lmmunocytochemistry of low density, non-phagocytic, non-adherent 
colonic lamina propria cells. The technique was performed as described 
for Figure 5.2. The monoclonal antibodies used included (a) and (b) L243 
(anti-Class II MHC) (x 1000); and (c) Leu-M5 (anti-CD11c) (x 400). Note 
the irregular nuclear morphology and the tendency to form clusters with 
lymphocytes. 
b 
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Figure 5.4 
lmmunocytochemistry of low-density, fibronectin-non-adherent cells. The 
methods are as described in Figure 5.2 using 25F9 (anti-macrophage). 
The 25F9 + macrophages are readily discernable in the cell preparations. 
The antibody did not stain the cells with the irregular nuclear morphology 
and was used to assess the degree of macrophage contamination. (x 
400). 

Figure 5.5 
Flow cytometry of human colonic 1-globulin-adherent cells: Analysis of a 
gated population of large cells. Adherent cells were incubated with no 
antibody ( control) or the specified antibody, then washed and labelled 
with FITC-conjugated sheep anti -mouse lgG and analysed by flow 
cytometry (5000 events). The abscissae represent forward scatter (linear 
scale, arbitrary units) or fluorescence intensity (logarithmic scale, arbitrary 
units) as indicated . The ordinate axes represent side scatter (linear scale, 
arbitrary units) and cell number (linear scale, arbitrary units). The gated 
population comprised > 75% of the total numbers analysed. These cells 
expressed high levels of Class 11 M HC antigens but did not express any 
other markers. These are the same cell populations as illustrated in 
Figures 5.1 and 5.2. 
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Figure 5.6 
Flow cytometry of human colonic -y-globulin-adherent cells: Analysis of a 
gated population of small cells. The experiment was performed as 
described in Figure 5.5. The gated population comprised 16% of the total 
cell number analysed. These cells were mainly T cells (OKT3 +) with a 
subpopulation of B cells (Leu 16 +). 
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Figure 5.7 
Flow cytometry of human colonic low density non-adherent cells: Analysis 
of a gated population of large cells. Low density non-phagocytic non-
adherent human colonic lamina propria cells were incubated with no 
antibody ( control) or the specified antibody. Fluorescence labelling was 
performed as described in Figure 5.5. The gated population comprised 
40% of the total cell number analysed. All these cells expressed high 
levels of Class II M HC antigens. 
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Figure 5.8 
Flow cytometry of human colonic low density non-adherent cells: Analysis 
of a gated population of small cells. The experiment was performed as 
described in Figure 5. 7. The gated population comprised 40% of the total 
cell number analysed. A significant subpopulation of these cells were 
OKT3 + and OKT4 +. Double staining was not performed, but it is likely 
that these cells also expressed intermediate levels of Class II MHC 
antigen (see Figure 5.10). The T3- cells may be expressing high levels of 
Class II MHC antigens and may be small dendritic cells (see also Figure 
5.9). The cells were not Leu16 + (B cells). 
Human colonic low density non-adherent cells 
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Figure 5.9 
Flow cytometry of human colonic low density non-adherent cells: Dot-plot 
of fluorescence against forward scatter (cell size). The experiment was 
performed as described in Figure 5.7. The abscissae represent 
fluorescence intensity (logarithmic scale, arbitrary units) and the ordinate 
axes forward scatter (linear scale, arbitrary units). In the top graph, the 
cells were labelled with an isotype-matched control as described in Figure 
5.7, and 5,000 events analysed. The bottom graph represents labelling 
with L243 (anti-Class II MHC). The events with high fluorescence intensity 
spanned a wide range of sizes from very large (which may represent cell 
clusters) to a size approximating that of a lymphocyte. The smaller cells 
(lymphocyte size) expressed intermediate levels of L243 when compared 
to the isotype-matched control. 
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Figure 5.10 
Flow cytometry of human colonic lamina propria cells obtained by 
rosetting with AET-treated sheep red blood cells. The experiment was 
performed as described in Figure 5.5. The cells are a homogenous 
population of CD3 + cells expressing low-intermediate levels of Class II 
MHC antigens. The expression of all other markers was similar to that of 
the control (no primary antibody). 
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Figure 5.11 
Flow cytometry of responder human peripheral blood lymphocytes. 
Peripheral blood lymphocytes were incubated with L243 (anti-Class II 
MHC), washed and then "panned" to remove cells expressing Class II 
MHC antigens. The remaining cells were incubated with no antibody 
(control) or the specified antibody, washed and then labelled with FITC-
conjugated sheep anti-mouse immunoglobulin. The abscissae represent 
fluorescence intensity (logarithmic scale, arbitrary units) and the ordinate 
axes, cell number (linear scale, arbitrary units). The proportion of cells 
expressing each marker is indicated. (The cut-off was chosen by 
selecting a level of fluorescence intensity at which less than 5% of the 
control cells were positive.) 
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Figure 5.12 
MLR stimulation: Comparison of high- and low-density non-adherent 
intestinal lamina propria cells with fibronectin-adherent cells in the 
presence and absence of indomethacin. The abscissa represents 
increasing numbers of low-density (squares) and high-density (circles) 
non-adherent cells and fibronectin-adherent cells (triangles) that were 
incubated in the presence ( closed symbols) and absence ( open symbols) 
of indomethacin (2 µg/ml). Intestinal lamina propria cells were added to 
2x105 peripheral blood cells from an unrelated donor. After 4 days, 1 µCi 
of [3H]-thymidine was added to each microculture and the cells freeze-
thawed and harvested onto glass-fibre discs after a further 16 h. 
Unstimulated responder cells and control stimulator cells incorporated 
< 1000 cpm. The values are the means ± SEM of triplicate assays. The 
absolute yields of high-density, adherent and low density cells in this 
experiment were 50x106, 2x106 and 2.5x106 respectively. Assuming 
relative activities of 1: 10:50 from the graph, this indicates that 26%, 10% 
and 64% of the total activity was present in the respective fractions. 
Figure 5.13 
MLR stimulation: The effects of adding intestinal macrophages. The 
experiment was performed as described in Figure 5.12. Increasing 
numbers of human colonic macrophages (enriched by fibronectin-
adherence) were added to 2x1 o5 peripheral blood responder cells 
cultured with 5x1 o4 low-density non-adherent lamina propria cells in the 
presence (closed symbols) or absence (open symbols) of indomethacin 
(2 µg/ml). 
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Figure 5.14 
MLR stimulation: Comparison of high- and low-density lamina propna 
cells using two different responder cell populations. The experiment was 
performed as described in Figure 5.12. Increasing numbers of high-
density (circles) and low-density (squares) cells were added to 2x105 
peripheral blood cells obtained by panning with L243 (anti-Class II MHC) 
(open symbols) or using the method of Warren (1981) [498] (closed 
symbols). 
Figure 5.15 
MLR stimulation: Comparison of non-adherent lamina propria cells with 1-
globulin adherent cells and low-density, non-phagocytic, non-adherent 
cells. The experiment was performed as described in Figure 5.12. 
Increasing numbers of non-adherent lamina propria cells (inverted trian-
gles), 1-globulin adherent cells (triangles) and low-density, non-
phagocytic, non-adherent cells (squares) were added to 1x105 peripheral 
blood responder cells (obtained using the method of Warren, 1981 
[498]). 
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Micrograph 5.1 
Transmission electron micrograph of the low density cells prepared by 
density gradient centrifugation (Nycodenz Monocytes, density 1.068 
g/ml) of a single cell suspensio~ of human colonic lamina propria cells 
(from which macrophages had not been removed). In the low density 
fraction there are populations of both macrophages, which contain 
numerous phagolysosomes ( electron-dense and electron-lucent vesicles) 
of various sizes, and dendritic cells which are smaller, have an irregular 
nucleus with a peripheral rim of heterochromatin and do not contain 
phagolysomes. Final magnification x 3,600. 
Micrograph 5.2 
Transmission electron micrograph of an intestinal lamina propna 
macrophage. Final magnification x 5,900. 
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Micrograph 5.3 
Transmission electron micrograph of human colonic lamina propna 
dendritic cells demonstrating irregular nuclei, the absence of 
phagolysosomes and the irregular cytoplasmic processes. Final 
magnification x 13,000. 

CHAPTER 6 
DISCUSSION 
"The more we study, we the more discover our ignorance." 
Scenes from "The Magico Prodigioso of Calderon" 
Percy Bysshe Shelley (1792-1822) 
6.1 INTRODUCTION 
The study of the host response to foreign antigens has, for many years, 
bypassed the mucosal immune system. This has been both in the physical 
sense, by the direct inoculation of antigen into host tissues, and in terms of 
research interest, although there has been greater interest in the last two 
decades. 
Most environmental antigens are encountered during or after their 
passage through an epithelial barrier eg. the epidermis and dermis of the skin 
and the laminae propriae of the respiratory, gastrointestinal or genitourinary 
tracts. Each of these sites is a unique microenvironment. For example, the 
intestinal lamina propria surrounds a lumen containing a wide array of ingested 
food antigens proximally, while distally, there is passive diffusion of bacterial 
breakdown products, including LPS, through the lamina propria [385]. In spite of 
these differences, there are many similarities between the mucosa-associated 
lymphoid tissues (MALT), which are often classified as a unified system. Two 
responses, in particular, are characteristic of the mucosal route of exposure to 
most antigens - the preferential induction of T cell tolerance and/or lgA antibody 
production. These responses result in minimal inflammation and the ability of the 
epithelial barrier to subserve specific functions, eg. gas transfer, the absorption 
of nutrients, electrolytes and water, etc. When these responses are deranged, 
11 hypersensitivity11 diseases (eg. gluten-sensitive enteropathy, hypersensitivity 
pneumonitis, inflammatory bowel disease, etc.) may result. 
The main conclusions drawn from the experiments described 1n this 
thesis are that: 
(a) the intestinal lamina propria contains small, but significant numbers of 
antigen-presenting dendritic cells; and that 
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(b) intestinal macrophages are found predominantly in the non-Peyer's 
patch lamina propria and may oppose the effects of dendritic cells 
on T cell activation. 
In addition, the migration of monocytes into the intestinal lamina propria 
may result in differentiation into macrophages with a characteristic phenotype, 
and possibly, function. Other workers have suggested that dendritic cell 
functions are also affected by their environment (see below). 
This discussion will focus on the role of dendritic cells and macrophages 
in the induction of T cell activation and show how they may participate in the 
regulation of mucosa! immune responses in the gut. Particular points to be 
addressed include the unique properties of these cells in the intestinal lamina 
propria; their role in antigen handling; and mechanisms by which they may 
control T cell-mediated immune responses, with the consequent induction of 
either oral tolerance, specific mucosal protection or, rarely, chronic inflamma-
tion. 
Several excellent and more comprehensive reviews of intestinal immune 
responses have been published [36, 61, 105, 310, 350, 518] and the reader is 
referred to these for consideration of other aspects of intestinal immunity. 
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6.2 INTESTINAL MACROPHAGES - EFFECTS OF THE 
MICROENVIRONMENT 
Intestinal macrophages, like other tissue macrophages, are a hetero-
geneous population of cells [ 482]. Studies of their turnover have shown that 
peripheral blood monocytes migrate into tissues where they differentiate into 
tissue macrophages [ 482]. In the intestinal lamina propria, this process presum-
ably occurs in response to antigenic stimuli (including bacterial lipopoly-
saccharide {LPS}) and the components of the immune system, particularly the 
cytokines (eg. IFN-1 and GM-CSF). As a result of these complex interactions, 
macrophages can secrete any number of a wide range of secretory products 
[346], including substances which enhance immune responses eg. interleukin 1 
(IL-1 ), or which are immunosuppressive eg. prostaglandin E2 (PGE2). Although 
E-type prostaglandins are often regarded as being pro-inflammatory [eg. 284], 
analysis of many of their effects suggests a suppressive function, eg. the inhibi-
tion of cytokine-inducible Class II M HC expression [ 4 7 4, 488], the inhibition of T 
cell activation and down-regulation of the transferrin receptor by effects on 
protein kinase [87], the suppression of macrophage IL-1 activity [326], the 
inhibition of NK cell activity [127] and its effects on suppressor T cell induction 
[reviewed in Section 3.4]. Thus, at any point in time, the intestinal lamina propria 
contains macrophages, at varying stages of differentiation, presumably 
attempting to eliminate absorbed antigens or invasive microorganisms. In 
contrast to this postulated role of macrophages, the observations reported 
above suggest that activated intestinal macrophages suppress T cell responses. 
Are these two roles compatible? 
Before considering this point, another problem should be addressed, 
namely, can in vitro findings be extrapolated to the in vivo situation? Attempts to 
do so should always be made with great caution, since there are many 
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confounding factors, eg. the activation or selection of subsets of cells, or the 
disturbance of cellular function by the disaggregation process. 
In the lung, a situation similar to that of the intestine pertains. Alveolar 
macrophages in vitro down-regulate responses in an indomethacin-sensitive 
prostaglandin-mediated manner [116, 117, 163, 326]. Evidence that alveolar 
macrophages suppress pulmonary immune responses in vivo was provided by 
Thepen et al (1989) [470]. Alveolar (but not interstitial) macrophages were effect-
ively removed from the lungs of mice by the intratracheal instillation of liposomes 
containing dichloro-methylene-diphosphonate. Subsequent intratracheal 
administration of antigen resulted in enhanced pulmonary immune responses 
(plaque-forming cell assays) suggesting that elimination of alveolar 
macrophages abrogated their normally suppressive role. 
It is reasonable to assume, therefore, that intestinal macrophages also 
play a predominantly suppressive role in vivo. The question again arises, can 
intestinal macrophages effectively eliminate foreign antigens and have a moder-
ating effect on T cell responses? In teleological terms, it would be in the best 
interests of the host to minimize the adverse effects on absorptive function that 
may arise from the amplification of immunological responses to commonly 
encountered luminal antigens, eg. LPS. 
Some insights into this problem are provided by studies examining 
intestinal mononuclear cell responses to, and production of, various cytokines. 
Both GM-CSF and IL-1 are produced constitutively by the cells of the 
human colonic lamina propria [293, 380]. The basal low-level production of IL-1 /3 
by control colonic intestinal mononuclear cells was unaffected by exposure to 
LPS [293]. Mononuclear cells obtained from specimens resected from patients 
with inflammatory bowel disease, however, responded to LPS with increased IL-
1 /3 production. This observation was interpreted as suggesting that the IL-1 tr 
producing activated macrophages were derived from circulating monocytes and 
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implies that monocytes become refractory to the effects of LPS as they differen-
tiate into intestinal macrophages. Another interpretation is that refractory 
macrophages regain their sensitivity to LPS in response to cytokines produced 
by the lamina propria cells in inflammatory bowel disease. In both cases, it can 
be argued that intestinal macrophages are refractory to the effects of LPS in the 
normal colon. 
The use of in situ hybridization to detect IL-1o and IL-1 ~ m-RNA 
producing cells in the mouse intestine demonstrated only scattered positive cells 
in the stroma of intestinal villi and in the interfollicular areas of Peyer's patches 
[ 466]. These observations indicate either that the sensitivity of the assay was not 
great enough to detect low level production of IL-1 m-RNA and/or that there is a 
small subpopulation of intestinal macrophages producing the background levels 
of I L-1. These cells may be newly-arrived monocytes which respond to the 
environmental stimuli (eg. LPS, cytokines, etc), differentiate and become 
activated before they lose responsiveness to these signals and produce net 
negative effects on immune responses. In any case, there is evidence that 
intestinal macrophages have blunted responses to agents that normally result in 
activation. 
The mechanisms by which the responses are down-regulated are 
unknown, but a parallel may be drawn with the responses of murine peritoneal 
macrophages to GM-CSF [154]. Short-term incubation with GM-CSF primed 
macrophages for IFN--y+LPS-stimulated TNF0 release. In contrast, prolonged 
incubation with GM-CSF resulted in a markedly reduced responsiveness to IFN-
'Y + LPS, an effect which was probably PGE2-mediated. Thus, incubation of 
macrophages with GM-CSF resulted in the sequential generation of two 
products mediating activation and then suppression of immune responses. In 
this autoregulatory circuit, PGE2 limited GM-CSF-induced macrophage activa-
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tion. LPS also primes macrophages for prostaglandin production [5], indicating 
the presence of multiple mechanisms of negative feedback control. 
These processes are presumably affected by many other factors, but do 
argue for the presence of mechanisms to explain the apparently contradictory 
properties of the intestinal macrophage in vivo, namely, the effective elimination 
of invasive or particulate antigens, and the maintenance of a suppressive effect 
on the recruitment of other effector arms of the immune response. 
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6.3 DENDRITIC CELL FUNCTION IN THE INTESTINAL LAMINA 
PROPRIA 
In contrast to the postulated inhibitory effect of intestinal macrophages in 
vivo, the experimental data reported above suggest that dendritic cells stimulate 
T cell responses. In vitro, this was measured by the induction of T cell prolifera-
tion in the allogeneic MLR. Mesenteric lymph node cells were chosen as 
responder cells in order to simulate the conditions in the lamina propria as 
closely as possible, bearing in mind the known organ-specific trafficking of T 
lymphocytes [74, 199, 344, 455]. In terms of MLR stimulatory function, no differ-
ences could be demonstrated between enriched populations of dendritic cells 
obtained from the spleen, from the lamina propria and from Peyer's patches. 
This is in contrast to the potentiation of M LR stimulatory ability observed follow-
ing the culture of Langerhans cells with IL-1 and GM-CSF (See Discussion 
Chapter 4). It is likely that these disparities are a reflection of the factors affecting 
differentiation at varying sites, and suggests that intestinal dendritic cells are 
constantly exposed to antigen, IL-1 and GM-CSF. 
The demonstration that intestinal dendritic cells preferentially induce lgA 
secretion indicates that intestinal dendritic cells have other properties related to 
their environment. Spalding et al (1984) [ 434, 435] showed that successful 
induction of polyclonal lgA secretion by either Peyer's patch or splenic B cells 
was dependent upon their interaction with Peyer's patch-derived (but not 
spleen-derived) dendritic cell-T cell mixtures. These observations raised the 
possibility that Peyer's patch dendritic cells had special properties leading to the 
preferential induction of lgA secretion. Subsequent work [432] supported the 
hypothesis that the isotype of antibody secreted and the extent of pre-B cell 
differentiation was dependent on the lymphoid tissue source of dendritic cells 
(but not T cells). (These results need confirmation using purified populations of 
dendritic cells. In the experiments reported above, the degree of Peyer's patch 
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dendritic cell enrichment was not reported, but was presumably around 60% 
[ 433]. It is possible that the small numbers of intestinal T cells present in the 
"Peyer's patch dendritic cell" populations directed isotype switching to lgA. This 
result is possible because of the potent activity of transforming growth factor-,B 
(TGF ,a) in inducing lgA isotype secretion by LPS-stimulated B lymphocytes [89]) . 
On the other hand, immunoglobulin subclass and isotype secretion is 
also known to be regulated by subsets of T cells [218] with characteristic profiles 
of cytokine production [153, 328]. The final arbiters of the differential regulation 
of antibody production [eg. 89, 429, reviewed in 364, 452] are likely to be these 
T cell-derived products. 
Spalding and Griffin (1986) [ 432] suggested possible mechanisms to 
explain the observed interactions between dendritic, T and B cells. Firstly, 
Peyer's patch dendritic cells may selectively bind, from a heterogeneous 
population, subsets of T cells that would preferentially induce lgA secretion. 
Alternatively, dendritic cells may bind T cells nonselectively, but would then 
induce activation and differentiation of T cells into isotype-specific helper cells 
capable of providing the signals for antibody production. 
In summary, Peyer's patch dendritic cells appear to regulate B cell 
differentiation and preferentially induce lgA secretion. The final steps in this 
regulatory pathway involve the production of specific cytokines by T cell 
subsets. The early stages (the differentiation of dendritic cells in the intestinal 
lamina propria) may be the consequence of the interaction of dendritic cells with 
tissue-specific receptors and/or the effects of locally generated cytokines. The 
result is dendritic cells with properties determined by their environment - in the 
case of the intestine, fully immunocompetent dendritic cells. 
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Having considered the unique properties of intestinal macrophages and 
dendritic cells, I will now consider the role of these cells in intestinal antigen 
handling. 
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6.4 INTESTINAL LAMINA PROPRIA ANTIGEN UPTAKE 
Intact particles, macromolecules and soluble antigens are taken up from 
the intestinal lumen and transported into the lamina propria [31, 500, Section 
1.1.3, reviewed in 310, 350, 517]. The fate of such antigen and the subsequent 
generation of an immune response probably depends on many factors including 
the nature of the antigen itself, a history of previous exposure, the amount and 
frequency of antigen administration and various host factors. Inert particles can 
gain access to the systemic circulation and can be gradually excreted without 
initiating any immune responses at all [reviewed 350]. Most antigens are 
presumably taken up by lamina propria macrophages and dendritic cells - the 
resultant immune response is considered below. 
The various means by which antigens gain access to the lamina propria 
include: 
(a) non-specific uptake of antigens between epithelial cells, presumably 
associated with leaking intercellular tight junctions; 
(b) persorption, ie. the passage of macromolecules or small particulate 
antigens into the lamina propria by kneading between epithelial 
cells - a consequence of normal intestinal motility; 
(c) villus uptake of antigen via the exclusion zone. The villi undergo cycles 
of contraction and relaxation which are associated with the extru-
sion of cells from the villous tip. Uptake of antigen through gaps 
between epithelial cells occurs during the relaxation phase; 
(d) active uptake of antigen through the epithelial cell by non-specific 
endocytosis or by receptor-mediated uptake. Intracellular process-
ing may also result; and 
(e) transportation through the membranous epithelial (M) cell into the 
underlying Peyer's patch. 
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6.4.1 M cells in antigen handling 
[reviewed in 430, 517] 
The M cell acts as a conduit for the transportation of luminal antigens, 
including viruses and bacteria, to the extracellular space. These cells form part 
of the epithelial layer overlying intestinal follicles and can be distinguished from 
absorptive cells by their lack of a well-developed brush border, their decreased 
height and their proximity to the underlying lymphoid cells (which are often found 
in an indentation of the M cell cytoplasm called the "central hollow"). 
Macromolecules and micro-organisms shown to be transported to the 
underlying lamina propria include ferritin, horseradish peroxidase, wheat germ 
and other agglutinins, cholera toxin, reovirus types 1 and 3, mycobacteria, 
chlamydiae, Vibrio cholera and Cryptosporidium [517]. There is some evidence 
to suggest that the virulence of microorganisms is determined by the ability of M 
cells to take up and transport organisms to the subepithelial lymphoid tissue 
[ 430]. For example, for organisms that need to pentrate the mucosa to initiate 
infection (reovirus, poliovirus, Mycobacterium tuberculosis, salmonella) trans-
location to the lamina propria is a positive virulence factor. On the other hand, 
for non-invasive organisms which colonize the mucosal surface, eg. the RDEC-1 
strain of enteroadherent E. coli, M cell transportation may result in the initiation 
of immune responses and prevention of such colonization and/or elimination of 
the pathogenic organism. For these organisms, virulence requires a mechanism 
of adherence to the absorptive or M cell in the absence of pathways for trans-
location. 
Because of the proximity of the M cell to the underlying lymphoid tissue, 
immunological processing of luminal antigens and microorganisms is facilitated. 
The factors governing the adherence and transportation of antigens to the M cell 
is not known, nor is it known whether there is one or a number of pathways, nor, 
indeed whether antigens undergo processing within the M cell. It is conceivable 
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that these factors may influence the nature of the subsequent immune response. 
Alternatively, the M cell may play a purely passive role with the underlying 
lymphoid cells determining the outcome. 
6.4.2 Antigen handling by intestinal macrophages and dendritic 
cells 
What is the fate of the absorbed antigens? At least four possibilities exist. 
Firstly, the antigens may be completely degraded in situ eg. by the enzyme 
systems of resident or elicited macrophages. Another possibility is that 
macrophages sequester antigen in an inactive form and are either extruded into 
the gut lumen or migrate to, and become resident in an inactive site, eg. the 
draining lymph nodes or subserosal area. A third possible consequence is the 
release of either undegraded or partly degraded antigens into the surrounding 
tissue and subsequent uptake and presentation to T cells by dendritic cells. 
Finally, dendritic cells may directly take up antigens which are presented to T 
cells, either in situ or after migration to the draining nodes. 
This discussion is concerned primarily with the role of macrophages and 
dendritic cells in the regulation of T cell responses so their role in the degrada-
tion of absorbed antigens will not be considered. This and other important 
aspects of intestinal and other tissue macrophage function (eg. secretion of 
oxygen free radicals, neutral proteases and lysosomal enzymes) have been 
reviewed extensively elsewhere [155, 171, 262, 310, 391, 468, 480]. 
Both murine and human intestinal macrophages had evidence of pre-
vious phagocytic activity (Chapters 3 and 5). Large vacuoles (presumed phago-
lysosomes) were present and the expression of the monoclonal antibody, 25F9, 
on human macrophages strongly suggested previous endocytic activity [170]. 
112 
They also had features of "activation", a process which is associated with 
enhanced phagocytosis. These included the expression of Class II MHC 
antigens and the down-regulation of F c and complement receptors in both 
species, and the down-regulation of the F4 /80 antigen in the mouse (Chapters 3 
and 5). Although not examined in this work, others have shown that F c 
receptors are not normally expressed on macrophages in the human colon in 
vivo [291] and that expression increased with time in culture [513]. 
Absorbed antigens are more likely to be taken up by macrophages than 
by other cells because of their numerical superiority (10% of disaggregated 
lamina propria cells vs < 1 % dendritic cells). What then is the fate of these 
phagocytosed antigens? A potential mechanism for their removal may be by the 
shedding of antigen-laden macrophages into the intestinal lumen. The presence 
at immunohistochemistry of large numbers of macrophages with evidence of 
prior phagocytosis in the subepithelial regions of the colonic mucosa [170] is 
consistent with such a mechanism. Other supportive evidence is reviewed by Le 
Fevre et al (1979) [262] and includes the migration of latex-containing 
macrophages from Peyer's patch to the tips of nearby villi and their possible 
extrusion. This process is analogous to the migration of waste-laden 
macrophages from the lungs via the mucociliary elevator system. 
Another possible destination of antigen-laden macrophages is the drain-
ing lymph nodes. This pathway has been described in the intestine [263, 303] 
and the lung [148]. In a guinea pig model of melanosis coli, apoptotic bodies 
derived from surface intestinal epithelial cells were phagocytosed by intra-
epithelial macrophages and transported into the lamina propria [ 497]. These 
macrophages passed through fenestrations in the surface epithelial basement 
membrane, accumulated progressively in the lamina propria, entered the sub-
mucosa and finally migrated to the regional lymph nodes. This migration path-
way is analogous to the translocation of inert particles from alveolar spaces to 
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draining nodes in the lung [148] and need not be associated with active inflamm-
ation. 
The presence of bacterial antigens in association with veiled cells in the 
intestinal afferent lymph [311] suggests that dendritic cells transport antigen 
from the intestinal lamina propria in the same way that Langerhans cells migrate 
from the skin to its draining nodes. It is not clear whether these antigens are 
taken up by dendritic cells directly or indirectly after processing by 
macrophages. These and other aspects of dendritic cell-macrophage interaction 
need to be examined further. 
In summary, antigen once present in the lamina propria is taken up by 
macrophages and/or dendritic cells. It may be degraded in situ, eliminated by 
passing into the intestinal lumen within macrophages, or carried to the draining 
nodes by dendritic cells or macrophages. The subsequent reactions may be an 
active immune response, a null response or immunosuppression. The relative 
proportion of antigen eliminated from the intestinal lamina propria by each mech-
anism and the significance of each in the regulation of immune responses has 
yet to be determined. 
Having considered the properties of macrophages and dendritic cells in 
the unique environment of the intestinal lamina propria and their possible partici-
pation in lamina propria antigen handling, I will now review their roles in the reg-
ulation of immune responses following antigen exposure. In particular, I will try to 
relate their properties to the possible outcomes in the gut, namely, the induction 
of oral tolerance, the generation of T cell-mediated or B cell-mediated 
(predominantly lgA) responses or the development of hypersensitivity reactions. 
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6.5 ORAL TOLERANCE 
"Oral tolerance" is a state of specific immunological unresponsiveness 
induced by prior oral administration of antigen [330, reviewed in 81, 85]. In 1829, 
Dakin reported that South American Indians ate poison ivy leaves in an attempt 
to prevent contact hypersensitivity reactions to the plant [ cited in 330]. This 
observation raised the possibility that the oral ingestion of an antigen could 
modify subsequent systemic immune responses. This phenomenon was further 
explored this century following the studies of Beredska, Wells, Osborne and 
Chase which showed that feeding proteins to experimental animals could inhibit 
systemic responses (anaphylaxis and contact hypersensitivity) to the same 
antigens [reviewed in 330]. 
Oral tolerance induction affects various immune parameters including 
helper T cell function, T cell proliferation, delayed-type hypersensitivity and T-
dependent specific antibody production [85]. B cells themselves are potentially 
reactive as shown by studies bypassing the requirement for helper activity eg. 
by removing T cells and stimulating B cells with antigen plus LPS [335] or by the 
in vivo administration of T-independent antigens [471]. 
Several lines of evidence suggest that there are different mechanisms by 
which oral tolerance can be induced. In particular, the time course of induction 
of oral tolerance and the responses of different arms of the immune response 
vary. For example, feeding the antigens, ovalbumin [85] and gliadin [ 4 75], 
resulted in the dose-dependent suppression of both cell-mediated and humoral 
immune responses. In contrast, feeding cholera and related toxins, inhibited 
delayed-type hypersensitivity responses whilst having no effect on the genera-
tion of specific antibody [220]. Even when only one protein antigen is studied, 
for example, ovalbumin, variations in the duration of tolerance for cell-mediated 
and humoral immunity [ 457] and differences in the doses required to induce 
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tolerance in the effector arms of the immune response [334] imply that there are 
different means of generating systemic hyporesponsiveness. 
Mechanisms which have been suggested include antigen-processing 
[68], the generation of circulating antibodies [205], antigen-antibody complexes 
[eg. 14] or suppressive serum factors [304], and both T and B suppressor cells 
[reviewed in 220, 330]. Both MHC-influenced [331] and non-MHC-linked [205, 
257,304] mechanisms have been described. 
Intestinal handling of antigen plays an important role. In the early phase of 
oral tolerance induction, a serum factor, which passively transfers antigen-
specific oral tolerance for T cell- (but not B cell-) mediated immune responses to 
syngeneic recipients, can be identified one hour after feeding [67, 68, 220, 458]. 
Studies of the nature of this factor using ovalbumin suggest that the protein 
undergoes some form of subtle immunochemical modification resulting in 
antigenic material similar in size to native ovalbumin and reactive with anti-
ovalbumin antibodies [68]. Although removal of these immunoreactive 
ovalbumin antigens abrogated oral tolerance induction [68], modifications of the 
protein structure are likely to be more important than the quantity of unchanged 
antigen absorbed since: (i) serum levels of ovalbumin were unrelated to the 
development of tolerance [69] and; (ii) the parenteral administration of 
ovalbumin in a range of doses did not induce immunological hyporesponsive-
ness [ 458]. Other evidence suggesting some form of antigen-processing or 
modification is provided by studies using cholera toxin [219] . Formaldehyde-
modification of the protein conformation of cholera toxin before feeding did not 
affect the ability of the two antigenic forms to induce totally cross-reactive oral 
tolerance. This suggests that the putative suppressive serum protein has under-
gone some form of antigen-processing rather that being absorbed unchanged in 
its tertiary configuration. Another factor which may be important in the genera-
tion of oral tolerance may be the rate of delivery of antigen to the intestinal 
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lamina propria - antigen concentration is an important factor in the development 
of other forms of tolerance (see below). 
The nature of the cell responsible for the generation of such tolerogenic 
proteins is not known - possibilities include the M cell of the Peyer's patch, the 
enterocyte or the intestinal lamina propria macrophage. The generation of 
immune responses by bypassing the epithelium (eg. the injection of antigen 
directly into Peyer's patches [37]) implies that the former cells play a significant 
role. Other evidence, however, suggests that the epithelial cell is not as impor-
tant as a lymphoid cell in the generation of oral tolerance. Cyclophosphamide-
treated [ 458] or irradiated [69] mice lose the capacity to generate the tolero-
genic form of protein antigens in a manner which appears to be unrelated to the 
effects of the treatment on the donor epithelial cell. This ability may be reconsti-
tuted by the adoptive transfer of splenic lymphoid cells [69]. As discussed in 
Section 1.5.6, if the epithelial cell does play a role in oral tolerance induction, this 
function is unlikely to be a property of the expression of Class II MHC molecules 
on the small intestinal epithelial cell. 
Another mechanism for the suppression of delayed-type hypersensitivity 
is the generation of suppressor T cells which can be identified in Peyer's 
patches, mesenteric lymph nodes, thymus and spleen after feeding [305] . 
Transfer of "fed" serum to syngeneic recipients resulted in the induction of 
antigen-specific suppressor cells and was abrogated by treatment of the recipi-
ent (but not donor) animals with cyclophosphamide [220, 458]. These cells 
appeared to preferentially regulate the afferent limb of the immune response, 
since feeding the protein antigen, cholera toxin, in tolerogenic doses did not 
suppress the activity of mature delayed-type hypersensitivity effector cells. Other 
mechanisms are also involved since oral tolerance induction can occur in the 
absence of demonstrable splenic suppressor cells [256]. 
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The importance of the macrophage and its products in oral tolerance 
induction is illustrated by the abrogation of this response by agents which acti-
vate the "reticulo-endothelial system", eg. oestrogen, muramyl dipeptide, LPS 
and the graft versus host reaction [332, 333, 456, 459]. In addition, treatment 
with the anti-macrophage agent, carageenan, partially relieves the suppression 
of T cell responses induced by feeding protein antigens [305], whilst inhibitors of 
macrophage production of prostaglandins (eg. indomethacin) interfere with the 
induction of systemic tolerance in vivo [ 415]. 
6.5.1 Possible roles of macrophages and dendritic cells in oral 
tolerance induction 
Although oral tolerance is generally considered separately from systemic 
immunological tolerance, they may have similar mechanisms of induction, 
namely: (i) antigen sequestration; (ii) clonal deletion; (iii) generation of 
suppressor cells; and (iv) clonal anergy [reviewed in 351]. lmmunoregulatory 
mechanisms which may be involved in the intestine include: 
(i) antigen sequestration in the lumen by physical agents and antibody 
Cantigen exclusion" [61]) will not be considered here. 
(ii) defective antigen presentation 
The initial failure to demonstrate antigen-presenting cell activity in the 
intestine [37, 206] was the result of the inability of the physical disaggregation 
techniques to release antigen-presenting cells from the extracellular tissue matrix 
(See Discussion Chapter 2). Subsequent work demonstrated that potent 
antigen-presenting cells (dendritic cells) were present in murine Peyer's patches 
[ 433] and that both murine and human intestinal lamina propria cells were 
capable of stimulating the MLR. 
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(ii) generation of suppressor T cells 
Adoptive transfer of oral tolerance by T cells is well recognized [305, 392, 
reviewed in 330] but the mechanisms of suppressor cell generation have not 
been elucidated. Possible mechanisms were described in Section 4.4 and 
include prostaglandin-mediated CD8 + cell induction or the interaction with 1-J + 
antigen-presenting cells [332]. Complex immunoregulatory suppressor and 
contrasuppressor circuits have also been proposed [141, 228, 269, 465]. 
As discussed above, immunoreactive protein antigens, implicated in the 
generation of suppressor T cells, are observed in serum after feeding. Intestinal 
macrophages may play a role by modifying absorbed antigens to produce these 
tolerogenic forms. 
(iii) clonal anergy 
Feeding protein antigens tolerizes both cellular and humoral immunity, 
with the former generally being more consistently affected (see above). The 
development of clonal anergy, at least in B cells, depends on both the concen-
tration of the tolerogen, and the affinity of the cell to the antigen involved [351]. 
One conceivable function of the enterocyte or the M cell is the delivery of antigen 
in concentrations critical for tolerance induction. 
The induction of clonal anergy may involve intestinal macrophages either 
directly, by the release of prostaglandins or other cytokines, or indirectly by the 
generation of antigen-specific suppressor T cells. 
The presentation of antigen to T cell clones in the absence of IL-1 or other 
accessory cell-derived factors [271, 382] results in the transmission of a tolero-
genic signal and the induction of a long-lived state of proliferative non-
responsiveness. The compartmentalization of macrophages between the lamina 
propria and the Peyer's patch may explain the differences between the antigen-
presenting cell activity of the unfractionated cell suspensions from these distinct 
sites (ie. the lesser activity of the Peyer's patch cells may be due to the absence 
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of macrophage-induced synergistic factors) and suggests a possible mecha-
nism of clonal anergy - that is, the presentation of antigen to T cells by dendritic 
cells in the Peyer's patch in the absence of macrophage-derived factors, eg. IL-
1. 
However, these observations in vitro are obviously artefactual. In situ, 
macrophages far outnumber dendritic cells and are present in greater numbers 
than can be supported by culture medium in vitro (ie. > 1-2x106/ml). These 
facts, in the context of the experimental data reported above (Chapter 3), 
suggest that the net effect of these forces in the lamina propria is suppressive. 
Oral tolerance would therefore be the result of the balance between "weak" 
immunostimulatory and "stronger" immunosuppressive factors present in the 
intestinal lamina propria. The generation of intestinal immune responses would 
depend on the ability of invasive antigens to override these suppressive influ-
ences in the lamina propria or to be selectively taken up by the M cells of the 
Peyer's patch. In the Peyer's patch, the presence of immunostimulatory cells 
without suppressive macrophages enables the Peyer's patch to subserve its 
known functions of luminal antigen sampling and the initiation of mucosa! 
immune responses. 
(iv) clonal deletion 
Clonal selection - the maturation of the lymphocyte through a stage when 
any contact with a recognizable antigen leads to the death of that cell - is an 
important mechanism for the induction of T cell self-tolerance. Nossa! (1989) 
[351] distinguishes between clonal abortion - the elimination of a cell before it 
has become immunocompetent - and clonal deletion - the elimination of a previ-
ously functional lymphocyte. Clonal abortion within the thymus [6] may be the 
main mechanism of self-tolerance in the T cell compartment. This process 
requires antigen-presenting dendritic cells, but the end result (activation or elimi-
nation) is dependent on the maturational stage of the T cell [306] and not on the 
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properties of the dendritic cells. For example, splenic dendritic cells are potent 
activators of mature T cells, but were the most potent inactivators of young 
developing thymocytes [306]. 
A similar process may occur in draining lymph nodes, where T cells prolif-
erate in response to the entry of antigens [360]. In athymic nude mice, small 
numbers of T cells which have undergone extrathymic differentiation can be 
found. These cells are tolerant of self, as well as being capable of allogeneic 
responses [306]. These observations are consistent with the conclusion that the 
outcome of antigen-recognition is dependent on the maturational stage of the 
lymphocyte. The site of such extrathymic differentiation is not known, and may 
be the secondary lymphoid structures such as lymph nodes. 
The factors affecting the possible outcomes (proliferation and differentia-
tion into effector, helper or suppressor cells, ie. clonal "expansion", clonal 
anergy, clonal deletion, and perhaps even clonal abortion) remain to be eluci-
dated, but may include such parameters as antigen concentration, and cytokine 
production, amongst many others. 
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6.6 ROLE OF DENDRITIC CELLS AND MACROPHAGES IN 
NORMAL RESPONSES - IMMUNOHISTOCHEMICAL STUDIES 
The anatomical distribution of human intestinal macrophages and 
dendritic cells in normal and diseased tissues has been examined using enzyme 
and immunohistochemical techniques [10, 131, 170, 291, 422]. In normal tissue, 
macrophages were found to be concentrated towards the luminal surface and 
expressed the following phenotype: acid phosphatase+ , non-specific 
esterase+, HLA-DR+, CD4 +, CD11 b+ /-, macrophage-specific markers+ 
(25F9, EBM/11, 3C10, RFD?, Y1 /82A). 
Dendritic cells (RFD1 +, HLA-DR+, Heca-452+ {specific for an adhesion 
molecule on high endothelial venules}, acid phosphatase-) were found mainly in 
highly organised tissue present at the deeper layers in the gut wall, around the 
broad zone of scavenger macrophages at the bottom of ulcers and fissures in 
inflammatory bowel disease, in lymphoid aggregates adjacent to granulomas in 
Crohn's disease [ 422] and, in smaller numbers, in the subepithelial regions 
[291], and in the epithelium itself [ 497]. Localization of these cells in rodents also 
demonstrated the presence of macrophages at the site of antigen entry, eg. in 
the peri-epithelial region of the small intestine [169], and in the subepithelial 
dome of Peyer's patch [361, 514], whilst putative dendritic cells were identified in 
the subepithelial regions of the villi and Peyer's patch [312, 51 O] and in the 
epithelium [312] and the interfollicular area of Peyer's patch [510]. 
This pattern of distribution is in keeping with the proposed roles of intesti-
nal macrophages as phagocytic, degradative cells and dendritic cells as a 
"second line" defence involved in the presentation of persisting or evasive 
antigens to other effector arms of the immune response. 
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6.7 THE ROLE OF DENDRITIC CELLS AND MACROPHAGES IN 
INTESTINAL INFLAMMATION 
In tissue samples resected from patients suffering from chronic inflamma-
tory bowel disease, 11 scavenger 11 macrophages, arranged in band-like zones 
forming the bases of ulcers or fissures, were present in greater numbers than in 
control tissue [291, 422]. 
The granuloma of Crohn's disease was often localized along the draining 
lymphatics of the intestinal wall and in the mesenteric lymph nodes. These were 
composed of 11epithelioid 11 cells expressing acid phosphatase, non-specific 
esterase, HLA-DR, CD11 b, CD71, and the macrophage markers, EBM11, RFD9, 
3C10, Y1 /82A [131, 291, 422]. They were negative for the dendritic cell-assoc-
iated marker, RFD1 [422], although not all would agree [291]. There is also 
evidence for the presence of a population of recently elicited cells in the inflamm-
atory infiltrate as suggested by the presence of CD11 b +, 25F9- monocytes 
[170]. These may be the cells which are able to respond to LPS and activating 
cytokines by producing detectable IL-1 mRNA [466] and IL-1 itself [293]. Thus, 
in the state of chronic low grade inflammation which is regarded as normal in the 
intestinal mucosa, and in areas of acute and chronic inflammation, there are 
heterogeneous populations of macrophages which are derived from recently 
elicited macrophages. These may differentiate under the influence of the 
predominant regulatory factors into activated phagocytic tissue macrophages or 
epithelioid cells, and effectively eliminate or transport the putative pathogen 
through the lymphatics to draining nodes. 
Similarly there is considerable evidence pointing towards the dendritic cell 
playing a prominent role in chronic inflammatory diseases, eg. rheumatoid 
arthritis [reviewed 376] and infections [eg. 222]. In studies of ongoing inflamma-
tion, dendritic cells can be identified around blood vessels before the arrival of 
lymphocytes. When T cells do arrive, a significant proportion can be shown to 
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express activation markers. Furthermore, in the rheumatoid synov1um there 
appears to be a definite spatial organization of lymphocytes around dendritic 
cells [376] (possibly representing in vitro cluster formation). These observations 
suggest that the dendritic cell is involved in the recruitment, activation and orga-
nization of T lymphocytes in the inflammatory response. 
In immunohistochemical studies of dendritic cells in inflammatory bowel 
disease, increased numbers of dendritic cells were identified as part of orga-
nized lymphoid cell accumulations (predominantly T cells). These aggregates 
were found surrounding the bands of "scavenger" macrophages or were 
adjacent to granulomas [422] in Crohn's disease, whilst in ulcerative colitis, 
dendritic cells were identified in large numbers in association with lymphoid infil-
trates in the lamina propria [1 O]. 
Disaggregated mucosal tissue resected from patients suffering from 
inflammatory bowel disease contained larger numbers of veiled cells than tissue 
from controls [508]. These veiled cells were the targets of a process termed 
peripolesis, in which lymphocytes migrate around other cells, and which was 
sometimes followed by target cell lysis [507]. 
Thus, in inflammatory bowel disease, the presence of increased numbers 
of dendritic cells, their anatomical distribution and their known function as activa-
tors of T cell responses, suggests that they play a role in the initiation and 
continuation of the inflammatory response. The macrophage may subserve two 
functions - firstly, as an effector cell, and later as a regulatory (suppressive) cell. 
The net result would therefore depend on the putative effects of the predominant 
population - either the recently elicited "activated" monocyte or the "resident" 
suppressive tissue macrophage. 
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6.8 
6.8.1 
CONCLUSIONS 
Putative mechanisms of induction of intestinal T cell 
responses 
After consideration of the above information, it is possible to arrive at a 
reasonably cogent theory of intestinal antigen handling and the role of intestinal 
dendritic cells and macrophages in the induction of T cell responses: 
Luminal antigen is endocytosed by (Class 11 M HC positive or negative) 
epithelial cells and secreted from the basolateral membrane into the intestinal 
lamina propria via the basement membrane or via intraepithelial macrophages. 
The rate of antigen secretion from epithelial cells may be an important criterion in 
the development of clonal anergy, ie. the nature of the responses may depend 
on the local antigen concentration - which may in turn be regulated by the 
epithelial cell. 
The antigen may undergo some process (eg. attachment to a particular 
receptor or transport molecule) which renders it less immunogenic, and then 
travel into the systemic circulation in this form. Alternatively, the antigen may be 
taken up by macrophages or dendritic cells. The numerical preponderance of 
the former make this the more likely result. Successful destruction of the antigen 
(or microorganism) would presumably result in a net negative signal mediated, 
for example, by immunosuppressive molecules, such as PGE2. The tolerogenic 
protein antigen and prostaglandin-mediated inhibition of lymphocyte proliferation 
or induction of antigen-specific suppressor T cells would ensure systemic hypo-
responsiveness. 
Failure of the macrophage to successfully eliminate the antigen, even 
after activation by ambient LPS and cytokines (eg. GM-CSF and IFN--y) may 
cause release of the antigen together with dendritic cell-potentiating agents, eg. 
IL-1. Subsequent uptake and transportation of antigen to draining nodes by 
dendritic cells would result in induction of T cell-mediated responses with 
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recruitment of antigen-specific effector T cells to the site of inflammation or 
infection. IFN-1-induced Class II MHC expression on any cell may help focus this 
response. In addition, the intestinal dendritic cells would effect the preferential 
differentiation of B cells into lgA-producing plasma cells. 
Eventual eradication of the antigenic load would see a shift towards the 
net negative signals and the attraction of fewer monocytes to the focus of 
inflammation. The biphasic responses of elicited macrophages (secretion of 
"activating" cytokines initially and then subsequent generation of immuno-
suppressive signals) would help minimize the period of active inflammation in the 
gut. 
6.8.2 
6.8.2.1 
Further characterization of mucosal immune responses 
Intestinal lamina propria antigen handling 
The above discussion opens up many exciting avenues of research. 
Perhaps the most important experiments would be aimed at understanding the 
mechanisms by which oral tolerance and intestinal immune responses are 
generated, eg. by determining the nature of antigen handling in the lamina 
propria. One approach would be to observe the traffic of cells following oral 
administration of a labelled antigen eg. ovalbumin, in studies similar to those 
performed by Macatonia et al (1987) [282]. Initially, the time course of antigen 
trafficking would be determined by identifying the antigen using immunohisto-
chemistry or immunofluorescence. The nature of the antigen-bearing cell(s) 
could also be ascertained using double-labelling techniques. The appearance of 
antigen-bearing cells at different sites (eg. the lamina propria, Peyer's patches, 
mesenteric lymph nodes, spleen or other sites such as popliteal or inguinal 
lymph nodes) would indicate the route of antigen trafficking. Removal of 
recirculating cells (eg. by mesenteric lymphadenectomy and cannulation of the 
thoracic duct) would help clarify the importance of local (eg. the production of 
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macrophage suppressive agents) versus systemic factors (eg. suppressor T 
cells) in the generation of local immune responses. 
Subsequent work could be aimed at isolating antigen-bearing cells to 
verify the information supplied by the immunohistochemistry described above. 
The phenotype of the antigen-bearing cell would be determined using flow 
cytometry and a panel of monoclonal antibodies. If necessary, double labelling 
could be performed using FITC-conjugated antigen and phenotyping using 
monoclonal antibodies and an alternative chromogen, eg. rhodamine. 
Adoptive transfer experiments using cells exposed to antigen in vivo or in 
vitro would determine which cells were responsible for the induction of tolerance 
or sensitization [64]. Mixing experiments may also help to determine the nature 
of the interaction between the candidate antigen-bearing cells (macrophages 
and dendritic cells) and the effects of pharmacological intervention assessed 
(eg. inhibitors of prostaglandin synthetase or macrophage activating agents). 
Finally, and of major importance, methods of subverting oral tolerance induction 
could be explored with the ultimate goal being the development of successful 
oral vaccines. 
6.8.2.2 Regulation of macrophage and dendritic cell differentiation 
Another area of interest is the understanding of the mechanisms control-
ling macrophage and dendritic cell migration, differentiation and activation in the 
intestinal lamina propria. As discussed in Section 6.2 monocytes recently arrived 
in the lamina propria become down-regulated in their responses to LPS (in terms 
of IL-1 production). By minimizing immune activity in the lamina propria, the 
normal absorptive functions of the epithelial layer remain operative whilst 
"hypersensitivity" diseases may impair epithelial function and result in the failure 
of the host to survive. Factors controlling macrophage differentiation and activa-
tion could be undertaken using disaggregated cell suspensions in order to 
examine basal and stimulated cytokine production or the expression of m-RNA 
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for the cytokine of interest. Correlation of the findings with in vivo studies using in 
situ hybridization would also be required. 
Similarly, the factors controlling dendritic cell function need further invest-
igation. One particular point to be addressed is whether the preferential induc-
tion of lgA by intestinal dendritic cells is truly a property of the dendritic cell 
(either directly or indirectly by the induction of certain patterns of cytokine pro-
duction in T cells) or whether the T cell production of cytokines is dependent on 
the signals present in the mucosa! microenvironment and independent of the 
dendritic cell. Such studies would necessitate the use of pure populations of 
dendritic cells and T cells in mixing experiments using recombinant cytokines 
and/or the appropriate inhibitory anti-cytokine antibodies. 
6.8.2.3 The role of intestinal macrophages and dendritic cells in 
disease 
Ulcerative colitis and Crohn's disease are two conditions of unkown 
aetiology afflicting the human gastrointestinal tract [the immunological distur-
bances are reviewed in 106, 284]. Although commonly grouped together as 
"idiopathic inflammatory bowel disease", there is increasing evidence to suggest 
that the two conditions reflect two distinct pathogenic pathways. 
Ulcerative colitis is a diffuse condition which arises in the rectum, spreads 
proximally through the colon in continuity, and affects the superficial layers of 
the mucosa. A number of observations support the hypothesis that the epithelial 
cell is the target of a predominantly antibody-mediated immune response. 
Firstly, abnormal survival of the epithelial cell has been documented, even in 
quiescent disease [133]. Secondly, epithelial cell-associated antigens have been 
identified and characterized [94, 340] and are the putative targets of an auto-
immune process. In addition, studies on the pattern of immunoglobulin produc-
tion in ulcerative colitis show greatly enhanced production of lgG 1 and to a 
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lesser degree, lgG3 (in contrast to the increase of all lgG isotypes seen in 
Crohn's disease [reviewed in 284]) - a pattern which may be associated with the 
activation of subsets of T cells producing the cytokine, IL-4 [452, reviewed in 
364]. Increased production of IL-4 in the lamina propria of patients suffering from 
ulcerative colitis may also account for the observed impairment of lymphokine-
activated killer cell activity [254] if the generation of these cells is inhibited by IL-4 
as proposed by Kanoff and Strober (1989) [207]. 
Crohn's disease is a condition characterized by focal, transmural 
inflammation occurring anywhere in the gastrointestinal tract, with relative spar-
ing of the epithelial cell layer. The appearances histologically and at immuno-
histochemistry are those of a delayed-type hypersensitivity reaction with the 
granuloma being a significant feature. Studies on the cytokine production of 
mononuclear cells obtained from specimens resected from patients suffering 
from Crohn's disease have shown that they generate greater amounts of IL-1 
than those from controls and from patients with ulcerative colitis [380]. This 
factor participates in the induction of granulomata [214]. Similarly, the delayed-
type hypersensitivity reaction and granuloma formation may also reflect activa-
tion of a subset of T cells producing IL-2 and IFN--y [4, 153, 328]. 
Although possibly an incidental observation, the pattern of histological 
damage in Crohn's disease (focal, transmural, with granulomata in submucosal 
lymphoid tissue and draining lymph nodes) parallels the known migratory path-
ways of macrophages and dendritic cells. Increased numbers of both these cell 
types are seen in Crohn's disease (see Section 6. 7) but no consistent functional 
abnormality has yet been detected. This may due to our inability to identify the 
defect if it exists. Ways in which a macrophage abnormality may contribute to 
the pathogenesis of Crohn's disease include: 
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(i) a deficiency of the degradative pathways resulting in the inability of the 
host to eliminate a normal commensal gut microorganism or an 
"infective agent" which would not cause symptoms in a normal 
host; 
(ii) a heightened response to normal or abnormal gut flora resulting, for 
example, in the "overproduction" of cytokines and other inflammat-
ory mediators, recruitment and amplification of intestinal immune 
responses and disordered regulation; or 
(iii) a diminished host response. McElrath et al (1988) [315] hypothesized 
that the effectiveness of a granulomatous response required the 
destruction of parasitized host cells in a lymphokine-rich environ-
ment. A defect in this process may see persistence of an invasive 
microorganism and ongoing inflammation. 
The ability to isolate and enrich populations of cells, including 
macrophages, dendritic cells and T cells from the intestinal lamina propria and to 
examine them using complementary techniques (such as functional assays 
including cytokine production, immunohistochemistry, and molecular biological 
techniques such as in situ hybridization), should contribute to our understanding 
of their roles in the pathogenesis of inflammatory bowel disease and other cond-
itions. The ultimate objective will be to modulate the mechanisms governing 
regulation of intestinal immune responses in order to treat such conditions and 
to develop strategies for effective oral immunization. That is to: 
11Venienti occurite morbo 11 
(Confront disease at its onset) 
Satires iii 64 
Persius (A.O. 34-62). 
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